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Introduction: Microbes for Feasible Sustainability
On the 29th of July 2019, it was Earth Overshoot Day. On this symbolic day, the
natural sources the Earth can renew in one year are depleted. Ever since the first
Earth Overshoot Day on December 29th 1970, this day has steadily crept forward
every year [1, 2]. With an ever-growing world population causing food shortages
and climate change [3] (Figure 1.1), it becomes increasingly clear that this is not a
sustainable situation.
Microbes are pivotal agents of ecosystem and planetary functioning. They regu-
late and mediate biochemical cycles and recycle biological waste materials, consti-
tute key producers and sinks of greenhouse gases and play essential roles in the
quality and productivity maintenance of soil, sea, lakes and rivers. This excep-
tional diversity of applications that can be addressed by microbial technology can
contribute substantially on many levels towards sustainability [4, 5]. Microorgan-
isms can be used for many biotechnological tasks, including bio-fuel production
[6–8], commodity chemical synthesis [9–11], and production of industrial and bio-
pharmaceutical proteins [12–14]. As our knowledge about microorganisms grows,
so does the horizon of bio-products. Nowadays worldwide, a large variety of differ-
Figure 1.1: Ecological Footprint Atlas, [1]. Copyright 2019 Global Footprint Network. National
Footprint Accounts, 2019 Edition.
4ent microorganisms is used for industrial purpose, including bacteria, yeasts, fungi
and mammalian cell-lines [15–26]. Production with microorganisms can offer high
yields and pure products. Next to this, biological catalysis offers several advantages
over chemical synthesis, as it offers the opportunity for cheap and stereo-selective
production of chemical compounds [27]. Each organism has its own advantages and
disadvantages. For instance, in many cases yeasts are considered superior to bac-
teria such as Escherichia coli for industrial production due to their ability to glyco-
sylate, acetylate, fold, and perform many post-translational modifications required
for production of functional eukaryotic proteins. Bacteria, on the other hand, can
synthesize proteins with a higher yield than yeast [28, 29]. This has created an in-
dustrial landscape where for the production of one or few products a specific micro-
organism is selected based on its unique characteristics. To intercept the disadvan-
tages of the selected micro-organism and make most use of its specific advantages,
the entire industrial set-up is adjusted accordingly. However, the development of
synthetic biology as a tool to overcome specific characteristic disadvantages may
become an industrial game-changer.
Microbial Lifestyle Selection or Design?
Each living organism has a specific habitable environment. The possibility of a mi-
crobe to survive in an environment depends on a scale on many different factors,
including pH, temperature, aerobicity, salinity, and source availability. A classical
way to visualize and to do research on the different habitats of microbial communi-
ties is using a Winogradsky column. A Winogradsky column is a model microbial
ecosystem, prepared by filling a clear cylinder with for instance pond sediment with
some additional supplements and incubated with light. Over time, environmental
gradients develop, creating niches within the column. Esteban et al. studied the
developed enrichment cultures from each niche from a Winogradsky column incu-
bated for 60 days using a 16S RNA gene survey, and characterized the microbial
community dynamics (Figure 1.2) [30].
Microbes have an unique ability to adapt to varying environments, also described
as the strain robustness. Each ecological niche represent some specific characteris-
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tics of its inhabitants. When applied in industry, these characteristics mirror the
advantages and limitations of each species. Historically, microbes used in indus-
try have simple nutrient requirements, can be easily cultivated in a laboratory and
generally grow fast, resulting in over a hundred generations over few weeks. Many
bacteria, such as Escherichia coli or Pseudomonas putida, have a generation time in
the laboratory of 20 minutes, which results in over 500 generations per week. This
allows for relatively fast adaptation of the entire community to new environmental
conditions. Industrial microorganisms are in addition preferably safe, mesophilic,
robust to fluctuations in pH, temperature and oxygen, and secrete their product for
easy isolation. However, not one microbe has all these distinct characteristics, let
alone is able to reliably produce a specific product in high yields.
Traditional industrial microbiology was merged with molecular biology to yield
recombinant metabolic processes for the sustainable production of primary and sec-
ondary metabolites, proteins, bio-pharmaceuticals, and enzymes on an industrial
scale. Examples of this are listed extensively in the review written by Adrio and
Demain [16]. These include, but are not limited to: amino acids produced commer-
Figure 1.2: Winogradsky culture enrichment. A) a schematic visualisation of a Winogradsky col-
umn. B) A Biplot of the most abundant family-level taxa in the surface community of aWinogradsky
column after 60 days of incubation. C) A heat-map of the normalized relative abundances showing
Z-scores within the surface, interior and pond communities. Each row represents a unique genus
and the coloured bar represents the phylum to which it belongs [30].
6cially by Corynebacterium, Brevibacterium and Serratia strains, vitamins like biotin
produced by E. coli, or riboflavin and vitamin C made with Corynebacterium, or-
ganic acids like acetic acid made with E. coli, Corynebacterium or Acetobacter, lactic
acid for which a genetically engineered transgenic wine yeast is used, next to Lacto-
bacillus, Bacillus, Escherichia or Rhizopus, ethanol using Escherichia, Zymomonas and
Saccharomyces, antibiotics by Acremonium, Penicillium or Streptomyces, and a large
variety of other compounds including nucleosides with Bacillus, carotenoids with
Escherichia and solvents with Clostridium (Table 1.1) [16].
For over a hundred years, evolutionary methods have been applied to adapt
species. A good example to adapt species to new specific conditions is through
adaptive laboratory evolution (ALE) experiments. ALE is a frequently used and
well-known method in biological studies to harbour adaptive changes in the form
of mutations to accumulate in microbial populations during long term selection un-
der specific environmental conditions. With ALE experiments, microorganisms are
cultivated under strictly defined environmental conditions for a prolonged period
of time, ranging from days to weeks to even years, and are often followed by long
characterization studies and intensive analysis to define which random mutation
caused the desired phenotype. It was first applied by William Dallinger [15, 104].
Escherichia coli and Saccharomyces cerevisiae are the most prominent organisms ap-
plied in ALE experiments [105–107], pushing for higher yield of products, the use
of a different carbon source, or increased stress resistance to for example toxic sub-
stances, higher temperatures, varying pH or higher salinity. ALE allows for the
cultivation and phenotype selection of strains adapted to the conditions of choice.
This top-down approach takes a lot of time and resources, but do not require any
background knowledge [108].
Within the fast-developing field of Systems and Synthetic Biotechnology, mi-
croorganisms can be changed in a directed way. This field has opened up many
novel techniques to eliminate any disadvantages of industrially interesting bacterial
strains all together through a bottom-up approach. With an ever-growing toolkit
including model-driven circuit design, directed genome re-factoring, and metabolic
engineering, microorganisms can be completely redirected into the production of
novel natural or synthetic products, or even adapt a new lifestyle [16, 109–111].
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Table 1.1: Industrial Microbial Applications. Adapted from Adrio and Demain, 2010 [16]
Product Organism Species Source
Primary metabolites
Amino acids Bacteria Brevibacterium, Corynebacterium,
Escherichia, Serratia
[31–35]
[36–39]
Vitamins Bacteria Bacillus, Corynebacterium, Escherichia,
Gluconobacter, Pantoea, Serratia
[40–43]
[44, 45]
Organic acids Bacteria Acetobacter, Actinobacillus, Anaerobiospirillum,
Clostridium, Corynebacterium, Escherichia,
Lactobacillus, Mannheimia, Pichia,
Rhizopus, Yarrowia
[11, 46–49]
[50–54]
Fungi Candida, Kluyveromyces, Rhizopus,
Saccharomyces, Wine yeast
[55–59]
Alcohols Bacteria Clostridium, Escherichia, Klebsiella,
Lactobacillus, Zymomonas
[46, 60–63]
[64]
Fungi Saccharomyces [65]
Nucleosides Bacteria Bacillus [66]
Carotenoids Bacteria Escherichia [67]
Glucosamine Bacteria Escherichia [68]
Solvents Bacteria Clostridium, Escherichia [69, 70]
Secondary metabolites
Antibiotics Bacteria Amycolatopsis, Escherichia,
Saccharopolyspora, Streptomyces
[71–75]
[76–80]
[81, 82]
Fungi Acremonium, Aspergillus, Penicillium, [83, 84]
Anti-tumour agents Bacteria Sorangium, Streptomyces [85]
Cholesterol-lowering agents Fungi Aspergillus [86]
Antihelminthics Bacteria Streptomyces [87]
Bio-pharmaceuticals
Recombinant proteins Bacteria Escherichia, Ralstonia, Staphylococcus [88]
Fungi Hansenula, Pichia, Saccharomyces [28, 89]
Mammalian cells Chinese hamster ovary (CHO) cells,
mouse myeloma (NSO) cells,
baby hamster kidney (BHK) cells,
green monkey kidney cells,
human embryonic kidney (HEK) cells
[28, 29, 90–92]
Insect cells Lepidopteran cells (Spodoptera) [28, 93, 94]
Enzymes
Bacteria Bacillus, Escherichia [95, 96]
Fungi Aspergillus, Chrysosporium [97]
Miscellaneous
Rapamycin Bacteria Streptomyces [98]
Artemisin Bacteria Escherichia [99]
Fungi Saccharomyces [100, 101]
Spinosad Bacteria Saccharopolyspora [102]
Xanthan gum Bacteria Xanthomonas [103]
8This has indeed led to the development and cultivation of a multitude of industri-
ally competitive engineered strains [16].
Microbial lifestyle engineering
Due to their genetic accessibility, ease to culture in a lab-environment, and overall
mesophilic robustness, it is obvious that a few microorganisms are widely applied
in industry. However, that does not make these organisms perfect production plat-
forms. The microbes are also not easily interchangeable: if one microbe is selected
for a production process, all equipment has to be adapted for the specific needs and
characteristics it has. This research will thus focus on the adaptation of the lifestyle
of often-used microbes to develop new characteristics, and thus transform the mi-
crobe into the ultimate industrial workhorse.
Building an industrial workhorse
Thus far, there are only relatively few microbial organisms with a high degree of
genetic accessibility. A well-known and largely applied example is Escherichia coli:
easy to isolate and to maintain in a lab-environment, established as a great produc-
tion strain of recombinant proteins, and the availability of an extensive engineering
toolkit.
However, E. coli does have substantial downsides as opposed to other production
hosts. Solubility is an issue as some proteins are packed into inclusion bodies. The
bacteria have a limited growth temperature and pH range, which limits the products
that can be made and drives production costs up. In 2000, Riehle and colleagues
described the use of ALE to adapt six lines of E. coli for 2000 generations to the
stressful high temperature of 41.5◦C [105]. They postulated that with enough time
and evolutionary pressure the short generation time and large population sizes of
bacteria would ensure enough genomic mutations to adapt to higher temperatures.
Still, this is slow-going, labour-intensive work with currently unknown limitations.
One of the up-and-coming candidates to challenge the established industrial
work-horses is Pseudomonas putida. The gram-negative, rod-shaped P. putida
KT2440, a derivative of toluene-degrading wild-type P. putida strain mt-2, which
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was isolated from contaminated soil [112]. P. putida is in general renowned for its
metabolic versatility, large reducing power, and tolerance to toxins and solvents. In
particular, P. putida KT2440 is HV1-certified, genetically accessible, and has been
successfully engineered to produce various compounds of industrial interest. These
characteristics give P. putida KT2440 its high potential to be applied as the ultimate
industrial platform. P. putida is rapidly making its name as a recognized synthetic
biology and industrial workhorse.
Yet, also P. putida has substantial disadvantages for industrial applications, in-
cluding its strict aerobic character and its relatively limited temperature growth
range, which ranges from 18◦C to 41◦C. The constant requirement for homoge-
neously dissolved O2 in large-scale cultivation results in increased costs due to
aeration and stirring, and excludes the use of O2-sensitive enzymes and pathway
intermediates, as well as the production of O2-sensitive products. Several closely
related species in the Pseudomonas genus are facultative aerobes, suggesting that a
limited number of genetic modifications may be required to redesign P. putida to
adopt a micro-aerobic or even facultative anaerobic lifestyle. The latter has been ex-
perimentally attempted several times by engineering either anaerobic fermentation
[113, 114] or anaerobic respiration [115–117].
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The Design-Build-Test-Learn Cycle
Earlier attempts to resolve characteristic industrial disadvantages of bacteria like
E. coli or P. putida have shown that it is a long, slow and complicated process.
However, most attempts described have not made use of the current wealth of ge-
nomic, proteomic andmetabolomic data that is nowadays available. Technical prob-
lems can be tackled in and ordered approach, using a Design-Build-Test-Learn cy-
cle (DBTL-Cycle) (Figure 1.3). The DBTL-Cycle describes the process of using the
plethora of information to tackle synthetic biology problems in a bottom-up ap-
proach [118]. In the design phase, in silico methods such as genome-scale metabolic
models, domainome analysis, and transcriptomics are employed to design an ge-
nomically modified strain of interest. This goal can be to direct metabolic pathways
towards the production of new products, recode the genome to implement safety-
by-design, or to engineer the lifestyle of the micro-organism to be better suited for
industrial applications. During the build phase, the design is made by engineering
the genome in vitro. During the test-phase, specifically designed control experi-
ments are performed to determine the effectiveness of the design. All the informa-
tion that is gained from these experiments is fed back into the database used for the
design, either to improve it in case the results where not as expected, or to fuel new
research projects.
Introduction: An Ordered Approach to Feasible Bio-Based Sustainability
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Figure 1.3: The Design-Build-Test-Learn Cycle.
In summary, microbes are of growing importance in industry. However, not all
strains can equally well withstand the changes in environment that occur within
large bioreactors, lacking the robustness to function across a wide range of condi-
tions with little change in phenotype or fitness. New developments in biotechnol-
ogy and synthetic biology have made it possible to improve microbes for industrial
use, making their application towards sustainable industry more feasible. Classical
methods such as strain evolution can be sped up by fusing them with an ordered
approach, enabled by the wealth of genomic data available.
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Thesis Aim and Outline
The aim of this thesis is to increase the environmental robustness of the industrially
applied Pseudomonas putida KT2440 by applying an ordered approach and lifestyle
engineering towards more affordable sustainable industry. The DBTL-cycle will be
employed towards an ordered approach to tackle the main disadvantages for indus-
trial applications: the oxygen requirements and its temperature tolerance.
In order to gain insight into the microbial living environment, information on
the habitual restrictions in pH range and optimum, temperature range and opti-
mum and oxygen requirements of 2502 bacterial strains was obtained via the Gold
database [119]. Using MATLAB 2018b (The MathWorks, Natick, MA, USA), this
data was translated into an overview of bacterial living environments per oxygen
requirement (Supplementary data 1 and 2, Figure 1.4).
Looking at bacterial habitable environments based on temperature and pH per
oxygen requirement group, it becomes apparent that temperature and oxygen re-
quirements are often linked. The habitable pH range amongst bacteria does not
vary much and does not seem influenced by the other factors. Among the 57 obligate
anaerobic species and the 478 anaerobic, significantly more are thermophilic. Simi-
lar but less extreme thermophilic outliers are seen in the facultative aerobic species.
The relative increase in anaerobic species at higher temperatures makes sense, since
heat can limit oxygen availability in liquids. Overall, the aerobic, microaerobic and
obligate aerobic species are more clustered.
Introduction: An Ordered Approach to Feasible Bio-Based Sustainability
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Figure 1.4: Bacterial living environments based on their oxygen requirements, pH range and op-
timum and temperature range and optimum. Colour intensity indicates bacterial density on a log
scale. Per plot, the number of entries is indicated, representing the number of bacterial species listed
under these oxygen requirements were used. Acknowledgements for figure: K.J.A. Martens and J.J.
Koehorst.
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In this thesis, a structured approach was applied by first determining which mi-
crobial improvements industry is looking for (Chapter 2). To this purpose, a series
of interviews was conducted with companies from two different continents. Be-
sides pinpointing the fields of interest from an industrial perspective, the interviews
also clarified the limitations of the actual implementation of novel or (synthetically)
adapted strains developed. Since strain safety was determined highly important, the
claimed GRAS safety level of P. putida KT2440 was critically reviewed (Chapter 3).
A main interest in industry is increasing strain robustness. A major obstacle
for the breakthrough of P. putida KT2440 as biotechnological host is its obligate
aerobic metabolism. The in silico-directed strain improvement was initiated by the
adaptation of strict aerobic P. putida KT2440 to micro-oxic and anoxic conditions.
Adaptation to micro-oxic levels was done by first creating an in silico-guided design
for a recombinant P. putida KT2440 strain capable of anaerobic fermentation. The
bottlenecks uncovered were resolved by insertion of three genes via a plasmid, and
the recombinant strains were monitored through an adaptive laboratory evolution
method with oxygen gradients set up specifically for this purpose (Chapter 4). Per-
formance of the resulting adapted strains were tested under anoxic conditions, but
showed no improvement compared to a negative control strain. A more elaborate
in silico analysis was then performed, combining protein domain analysis, transcrip-
tomic analysis and genome-scale metabolic models to design a recombinant P. putida
KT2440 strain capable of anaerobic respiration (Chapter 5 ).
Another way to increase strain robustness is tackling their thermo-tolerance: the
temperature range at which an organism can grow. A strong connection between
NAD+ availability and thermo-tolerance was discovered. Replacement of one single
gene for that of a thermophilic heterolog in mesophilic prokaryotes P. putida and E.
coli showed improved thermo-tolerance. Insertion of the aspartate NAD+ biogener-
ation pathway in eukaryotic yeast S. cerevisiae resulted in a similar effect (Chapter
6). This discovery was patented (Appendix chapter 6) To determine the effect of this
on an industrial scale, a down-scaled millifluidics system was developed to mimic
temperature fluctuations that occur in large scale bioreactors (Chapter 7).
Finally, in Chapter 8 the different applications of microbial lifestyle engineering
for industrial applications are discussed, and a future outlook is presented.
Introduction: An Ordered Approach to Feasible Bio-Based Sustainability
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Rational lifestyle engineering using computational methods and synthetic biology has made
it possible to genetically improve industrial performance of microbial cell factories for the
production of a range of biobased chemicals. However, only an estimated one in 5,000 to
10,000 innovations make it through the Valley of Death to market implementation.
Because of a perceived lack of systemic exploration, a qualitative and exploratory study was
performed to gain in-depth insights into the views of industry and academia by conducting 12
interviews with 8 industrial participants and 4 academic participants. The characteristics that
any cell factory must have were schematically listed, and commonly recognised opportunities
were identified.
Industry is generally restricted in their research choices and flexibility by a series of technical,
sector dependent and social factors, which often do not have to be taken into consideration
in academia. Although it was found that academia must leave room to perform fundamental,
curiosity driven research for innovative solutions that cannot be implemented in industry di-
rectly, if an academic research project is aimed for industrial applications, the end-user must
be held in mind constantly to bridge the Valley of Death.
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Introduction
The demand for industrial production by microorganisms is ever increasing. In
1990, the global market value of industrial enzymes was close to a billion USD,
crossed the two billion USD mark in 2005 [1], was valued at over four and a half
billion USD in 2016 and is expected to reach over six billion USD in 2022 [2]. Nowa-
days, bacteria, yeasts, fungi, and micro-algae are used in the industrial production
processes of food, enzymes, vitamins, pharmaceuticals, biofuels, bioplastics, bio-
insecticides, nanocomposites for electronic devices and a large variety of chemicals
and enzymes with industrial value. The reasons to widely apply a diverse set of mi-
croorganisms are manifold; they represent a broad biochemical diversity, increase
the feasibility of large scale production, can produce sustainable products, reduce
processing time, require low energy input, increase cost effectiveness and can be
selected for non-toxicity [3–12]. However, as heavily as the current biotechnology
industry depends on production by microbes, production methods are not by far
as stable as desired due to the biological variability of microorganisms [13]. Many
external factors affect the production capacity of microorganisms, including tem-
perature, pH, oxygen, ion and carbon source availability, cell density, and biofilm
formation [14–23]. All factors combined, this microbial instability results in a high
variability in yield.
For industrial production purposes it would be ideal to select only one micro-
organism as the general production platform. By focusing research on a single
species the microbial toolkit would increase to improve stability in production and
production costs would decrease as more universal bioreactor set-ups could be used.
To be considered perfect, such an industrial microbial workhorse would have to
check many boxes: it must be safe to work with (preferably generally regarded as
safe, or GRAS), be genomically accessible, metabolically flexible, resistant to ex-
ternal industrial stress factors, grow on cheap medium, and be able to produce à la
carte a high variety of products with high and stable yields. The field of systems and
synthetic biology offers potential solutions for all of these requirements. By restruc-
turing the genome and thus the metabolic pathways of microorganisms, microbes
found in nature can be theoretically perfected to produce any à la carte product of
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interest in a safe way. Where random evolution and selection are common methods
to increase productivity, yield or performance of a species, in silico systems and in
vivo synthetic biology is offering all tools to not only adapt microorganisms to gain
novel characteristics in a directed way, but to create them.
Examples of research conducted in academia to improve microbial workhorses
include the process of making the industrially applied Escherichia colimore resilient
to temperature fluctuations [24]. Sandberg and colleagues exposed E. coli K-12
MG1655, which has an optimal growth temperature at 37◦C, to adaptive laboratory
evolution to improve strain performance at 42◦C. Another example is the lifestyle
adaptation of the industrially applied Pseudomonas putida, which was enriched with
three heterologous genes and exposed to micro-oxic conditions through oxygen gra-
dients [19]. So far, neither of these examples are actually applied in industry.
Table 2.1: Technology Readiness Lev-
els (TRLs) as instated by NASA [25].
TRL Definition
1 Basic principles observed and reported
2
Technology concept and/or application
formulated
3
Analytical and experimental critical
function and/or characteristic
proof-of-concept
4
Component validation in laboratory
environment
5
Component validation in relevant
environment
6
System/subsystem model or prototype
demonstration in relevant environment
7
System prototype demonstration in
relevant environment
8
Actual system completed and qualified
through test and demonstration
9
Actual system proven through
successful operation
This large gap for academic research to ad-
vance from the technological demonstration to
actual commercialization in industry is gener-
ally referred to as the "Valley of Death" [26]. In
life sciences, including pharmaceuticals, biotech-
nology and therapeutic medical device develop-
ment, it was estimated that only one in 5,000 to
10,000 innovations survive the long route from
development to product commercialization [27–
29]. There exists a large gap between results from
academic research and industrial product devel-
opment. The different levels of product develop-
ment are known as technology readiness levels,
or TRLs (Table 2.1). This nine level system was
instituted by NASA in the 1980s [25]. Academic
research generally only covers TRL 1 to 3. At TRL
4 to 7, the discovery is considered too applied for scientific funding, while the pri-
vate sector considers it too high risk to fund for market implementation. Industry
generally covers TRL 8 and 9.
Reasons for new technology to not survive the Valley of Death include cumber-
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some contracting or procurement of technology requirements, lack of exposure, lack
of entrepreneurial management, lack of adequate funding for further development,
and the lack of a strong link between technology development efforts and industrial
deployment [27–29]. In an effort to decrease the amount of research that does not
bridge the Valley of Death, funding committees now demand a direct collaboration
between academia with industrial partners. Still, the Valley of Death remains as
large as ever.
We approached multiple industrial and academic experts to discover their per-
ceptions on how to improve chances of research surviving the Valley of Death. We
aim to elucidate I) what factors influence the choice for an industrial micro-organism
and II) opportunities between academia and industry.
Methods
Due to a perceived lack of systemic exploration of the factors that influence if novel
research makes it through the Valley of Death to market implementation, a qualita-
tive and exploratory study was performed to gain a comprehensive insight into the
perception of industry and academia by conducting interviews.
Recruitment and Procedure
Recruitment took place by gathering a convenience sample based on our direct net-
work and visited conferences. A list was devised of possible participants, from
which 15 companies were selected based on their location, Europe or America, and
field of research, pharmaceuticals, food, industrial chemicals, or production organ-
ism development. Some companies selected cover a combination of these fields. A
variety of large and small and new and established companies were selected care-
fully from each continent, to determine the effect of a different regulation in indus-
trial applications of bacteria and GMOs in particular, and over different companies
from different sectors. Chief executive officers or chief technical officers were mainly
approached to ensure the most overhead view on proceedings and the clearest per-
spective on the general aim, flexibility and workings of the company. In three cases,
we were redirected to someone else within the company. Of the fifteen companies
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approached, nine agreed to participate, five did not answer, and one declined partic-
ipation citing confidentiality over proprietary information. Of the nine companies
that agreed, one decided to withdraw from participating as they could not obtain
consent from their legal department after receiving the transcripts.
Of the convenience sample, 4 European universities were selected based on their
diverting expertise, similarly to companies. All universities approached agreed to
participate. Three of the academic participants had present or past experience in
working at a company. All participants were engaged in collaborations with mul-
tiple industrial sectors. The distribution of companies over continent and field are
shown in Table 2.2.
Table 2.2: Participants in the interviews: the field occupied by participating companies and aca-
demics, and location.
Pharmaceuticals Food Chemicals
Development of
production platforms
Combination Total
Industry Europe 1 1 1 1 1 5
USA 1 1 1 3
Academia Europe 1 1 2 4
Potential participants were approached up to three times via email to make an
appointment. If possible, interviews were conducted in person, otherwise face-to-
face through Skype, WebEx or Bluejeans, according to the participants preference.
During one interview, the camera of the participant failed and the interview was
done by voice only. Both through e-mail and at the start of each interview the aim
and methodology of the research was explained to the participants. Before the start
of each interview, participants were presented with written information and contact
details, and were asked to sign a declaration of consent. Interviews were conducted
over a period of 8 months, from April to November 2019. After 8 interviews, the
content of answers started to show overlap with previous interviews indicating data
saturation.
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Interviews
Based on literature and experience [19, 30–34], a topic list was constructed to guide
the interviews:
1. Choice of production platform was addressed by questions such as which
production organism is used now, what influences the choice for a production
organism, including limitations or possible restrictions, company and set-up
flexibility and what a production organism would need for the participating
companies to switch.
2. Opportunities between industry and academia was addressed by questions
including common ground, differences, challenges, opportunities, interest-
ing fields of research, impact of science in industry, and collaboration. This
topic included the presentation of a simplified overview of industrial produc-
tion from the Design-Build-Test-Learn cycle [35] via laboratory scale to in-
dustrial production scale, where participants could indicate the main bottle-
necks which indirectly represent the main short-term research opportunities
for academia (Figure2.1). The presented figure was used to stimulate in-depth
discussion on challenges and opportunities.
Figure 2.1: Overview of industrial development and production process. The schematic covers the
main steps between the DBT-cycle and the industrial production scale.
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Prior to data collection, the interview questions were discussed with an expert
working in academia and working closely with industry, from which adjustments
were made. Adjustments were focused on making the questions more open-ended
and general to prevent bias and allow for a more in-depth discussion by leaving
room for follow up questions (form S2). The use of appreciative inquiry in the ques-
tions [36] encouraged and inspired the participants to answer according to their
own perspectives, ideas and experiences, as opposed to following a strict interview
structure. In practice, this means that questions are asked with a positive spin, to
focus more on solutions rather than on problems. A pilot interview with an expert
working both in industry and academia was then held, indicating that the quali-
tative face-to-face interviews offered the expected in-depth information and clarity
for both the participant and the interviewer, as it allowed for elaboration on specific
topics, insight into technical differences or company aims. Special care was taken
during the interviews tomake sure there is a consensus of participants on definitions
and terms used, by asking follow-up questions. Each interview was conducted by
two members of the research team. The 13 interviews lasted on average 41 minutes,
ranging from 26 to 54minutes. With the participants’ verbal andwritten consent, all
interviews were audio-taped and transcribed (intelligent verbatim style). The data
was pseudonymized. When necessary, audio files were used to confirm transcripts
and listen to excerpts within their original context. Transcripts and specific quotes
used from each transcript were shared with the participants to consent upon prior
to analysis. All participants responded, and minor editorial changes were made.
Results
Data was processed using the six steps for qualitative data analysis [37]. All anal-
ysis was done by the two interviewers, LK and EAG. In the first step, transcripts
were made and carefully read. In the second step, codes were formulated manually
using the research questions. Thirdly, the transcripts were coded using the formu-
lated top-down codes, and where necessary deriving new codes from the data. The
processing of the transcripts was conducted via inductive category formation using
QCAmap [38], according to a thematic content analysis [37, 39]. The interview-
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ers discussed their respective individual top-down and bottom-up codes to define a
final set of codes. In the fourth step, all codes were clustered into the research ques-
tions: A) Choice of Production Platform, and B) Opportunities between Industry
and Academia. In step five and six, recurring themes found to affect multiple codes
were derived from the data and defined carefully. The nine themes found affect ei-
ther one or both research questions, and relate to the aims of industry and academia.
To support the themes found, direct quotes are provided in the result section, se-
lected to represent participants’ opinions, views and experiences. An overview of
the clusters, codes and derived themes can be found in Table 2.3.
Table 2.3: Themes, research questions and codes of transcriptions. Top-down codes were formed
before coding, bottom-up codes were derived during transcription.
Themes Top-down codes Bottom-up codes
Research Question 1: Choice of production platform
• I) Characteristics of microbial produc-
tion platform
• II) Industrial process and set-up flexi-
bility
• III) Regulations
• IV) Public perception
• What production platform is used
• Characteristics of used production
platform
• Flexibility on industrial set-up
• Limitations on choice of production
platform
• External influences on choice of pro-
duction platform
Research Question 2: Opportunities between industry and academia
• V) Genome engineering
• VI) Scale-up
• VII) Increase strain robustness
• Opportunities and developments
• Distance between industry and
academia
• Impact of industry on academia
• Personal or company aim
• Influence of industrial experiences
The aims of industry and academia
• VIII) Curiosity-driven versus solution-
based research
• IX) The rise of small companies
• What production platform is used
• Characteristics of used production
platform
• Flexibility on industrial set-up
• Opportunities and developments
• Distance between industry and
academia
• Impact of industry on academia
• Limitations on choice of production
platform
• External influences on choice of pro-
duction platform
• Personal or company aim
• Influence of industrial experiences
• Communication
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(A) Choice of production platform
Four main themes affect the choice for a certain production organism: I) Character-
istics of microbial production platform, II) Industrial process and set-up flexibility,
III) Regulations, and IV) Public perception (Table 2.4).
Table 2.4: Factors affecting the choice of production platform with representa-
tional quotes from participants from industry (I) or academia (A), indicated
by their numerical identifier.
Factor Representative Quote Source
I. Characteristics of microbial production platform
Titre-rate-yield
"The micro-organism itself is not so relevant, the whole picture should be okay.
Generally speaking, you can say that for any fermentation process you need to have
a good titre, a good rate and a good yield, so the famous try-numbers, titre-rate-yield."
I.2
Toolbox availability
"I think trying to predict and overcome toxicity problems of given molecules
to given organisms is very difficult. Trying to adapt one organism to secrete
something where another does it more naturally is very difficult. I don’t see why
you would do it, I think it is a better strategy to develop the broadest range of
tools for different organisms including extremophiles."
I.5
"Genetic accessibility, wealth of available data, free available data" A.6
Genomic Accessibility
"If a host is genetically accessible we can start to metabolically engineer it
from day one, that is preferred to do six or nine months of
method development to even get DNA inside the cell."
I.12
"[The main advantage] is that we don’t have to worry about the genetic tools" A.11
Product of interest
"The higher the cell complexity is, the more advanced the product should be.
This statement somehow mimics necessary R&D expenses
that need to be covered by cost calculations."
A.9
"These microbes have not been evolved to make a 100 grams per liter of compounds
A or B, so we typically start with a selection where we screen different hosts
for tolerance towards the products."
I.12
Expertise available
"Everybody needs to be trained on the new host, and please don’t forget that as soon
as you have transferred something to a production line, there will be lots of questions
coming up in the aftermath. For instance, downstream processing matters need to be
checked and must fulfill given constraints, too. That requires experts who care for
those questions."
I.9
Production of unwanted
side-products
"We produce flavour and fragrance ingredients (...) they should smell and taste
in the right way afterwards, after purification, so what we have to avoid is off odours."
I.3
Fundamental interests
"There is this fundamental interest in understanding how new insights, new activities in
new networks emerged under natural conditions because if we are able to domesticate
the corresponding mechanisms then we should be able to reproduce them in the
laboratory and make them work much faster and much more efficiently. The basic
questions that we are interested in are not limited to [micro − organism], it just
happens that [micro − organism] is a very good experimental system to address them."
A.10
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Factor Representative Quote Source
II. Industrial process and set-up flexibility
Investment requirements
"It depends on the numbers, and on the cost, but changes in bioreactor setup
of course mean that you have to either build or find another bioreactor."
I.3
Choice of industrial
setup
"[The producer] might want a semi-continuous process. The cell may have
high productivity but it dies after a week; they will swap that out to something
that has a lower productivity but can last for three weeks in a continuous or
semi-continuous culture. It’s all about space-time yield for low value products."
I.5
Downstream processing
"There is also the downstream processing part. In essence, you need to separate
your product equally simple from the broth as you can do with established hosts."
I.9
Complete industrial process
"If your fermentation is going too fast, faster than the downstream can handle,
you’re creating a bottleneck."
I.2
Stage of development
"[Producers] will like small changes where they don’t have to invest in new capital
(...) but if it’s a process that’s not been implemented at pilot scale then they’re more
likely to make a radical change as long as it’s consistent with their engineers’
understanding of what the eventual process will look like."
I.5
III. Regulations
GMO regulations
"If you’re heading for products of food, feed, flavour or fragrance markets,
you may face severe opposition regarding the use of recombinant strains, per se."
I.9
Safety regulations
"All proteins that are produced for food and feed, they have to apply to EFSA or
FDA regulations, and the more similar you can do a process, the more easy it is
to get permission."
I.4
IV. Public Perception
Social acceptability
"Sometimes the social acceptability of it as well. I mean you might find that
Klebsiella or Salmonella would be good hosts to make something and you could
use perfectly viable lab strains. But they might prefer Lactobacillus because it’s
a food grade organism and public perception ultimately might be very different."
I.5
Halal or Kosher
"It’s not just GMO regulations, it’s not just FDA and what have you, it’s also these
kinds of considerations [like halal or kosher] that must be taken into account.
So you really have to think through all the consequences if you want to
introduce a new microbe in your process and make other products."
I.2
The factors that influence the choice of production platform in industry and
academia can thus be divided into technical factors, like the characteristics of the
production platform and industrial process and set-up flexibility, sector-specific fac-
tors like regulations, and social factors like public perception. In industry there are
many technical, sector-based and social restrictions to choosing a production host.
As they must keep the end-user in mind throughout the entire development and
production process, products must be made as cost-effective, fast, green and safe as
possible.
For academia, mostly technical factors play a role when deciding to work with
a specific micro-organism. These boil down to toolbox availability, genomic acces-
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sibility, product of interest and fundamental interests. Only the latter is specific to
academia, the rest is shared with industry. This means that academics are more free
to work with any micro-organism, even with microbes that cannot be applied (yet)
in industrial processes.
(B) Opportunities between Academia and Industry
To determine what the main future opportunities are, participants were asked for
future research of interest, bottlenecks and what scientific progress they expected to
have most impact (Figure 2.2).
Figure 2.2: Venn diagram of research areas of interest per field. A schematic overview of the research
areas indicated as interesting by academia (left) and industry (right). Overlapping research of
interest is in the middle. Per subject, the identifier of each participant is indicated. Identifiers of
academic collaborators are printed in bold.
From this overview, three main technical themes could be deduced: V) Genome
engineering, VI) Scale-up, and VII) Improve robustness. These will be discussed in
more detail.
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V) Genome engineering
When presented with Figure 2.1, most industrial participants identified the whole
or part of the DBTL-cycle as the main opportunity for improvement.
"You test [a new design], you find something out and then you have to
design, you get a lot of data, you get some results, you don’t understand
them, and you have to analyse. The learn part is the bottleneck because
all the other things are automatable or scalable to some extent, so the
learning bit is not." Interviewee 3
For industry, the possibility to affordably construct an entire genome combined
with the rise of novel tools such as CRISPR-Cas for genome engineering substantially
ease this bottleneck.
"On the build side [of the DBTL-cycle] there’s a lot of change. Synthetic
DNA is becoming cheaper and cheaper by the day, sequencing is becom-
ing cheaper by the day, CRISPR is like 6 years old and [recently] there
was a new version released that really put the whole town plus all of the
genetic engineering upside down. [...] It’s just changing the timelines
and the ability so much." Interviewee 12
For academia, such tools pose promising ways to improve upon fundamental
research, which could eventually be required for understanding strain design.
"I would hope that it will accelerate the way at which we can generate
industrially meaningful strains, and it will expand the extent of manip-
ulation that we can achieve. So rather than looking at one gene or one
pathway, we should hopefully be able to look at one entire section of
metabolism in one go, and this would hopefully have a very good influ-
ence on the strain design that we want to achieve." Interviewee 6
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VI) Scale-up
To reliably scale-up results obtained in perfect lab-conditions to industrial scale is
challenging at best. Scaling-up was recognised as the second main bottleneck. Even
in academia, the importance of reliable scale-up to bridge the Valley of Death was
recognised:
"You can develop the most sophisticated CRISPR system, the most so-
phisticated recombineering, the most sophisticated reactions, you can do
wonderful things in the lab: if you cannot scale them up, then industry
will not be interested, period." Interviewee 10
From an industrial point of view, there are few different reasons why scale-up
can be a bottleneck, besides technical difficulties:
"The availability of equipment is actually the whole bottleneck. There
is not a lot of pilot facilities in the US, so either you build your own or
you go to Europe for piloting. That’s non-trivial. I think there’s a lot
of syn-bio companies that are mostly comprised of genetic engineers or
metabolic engineers that have never seen a large-scale fermentor and a
large scale production process including purification. So if you start a
scale-up trajectory without people that know what they’re doing then
it’s going to be a bottleneck. But if you have a team, [...] then you should
be able to do that in a pretty smooth trajectory. There’s always going to
be surprises and hiccups. What I’ve also seen is that lots of syn-bio com-
panies have very aggressive timelines, probably due to their investors
pushing really hard, and then they are going to take short-cuts and that’s
going to blow up in your face. There is not a technical bottleneck, but it’s
more of a managerial bottleneck at that point." Interviewee 12
VII) Improve strain robustness
When asked directly, all participants indicated that the robustness of their used or
preferred production platform could be improved. Reasons for improving robust-
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ness circle back to scale-up without fail, since industrially used production organ-
isms are grown in conditions that are strictly controlled.
"Robustness in an industrial sense is that it is operationally robust:
meaning it is not very sensitive to infections, it is not very sensitive to
minor variations that you always have in the conditions of the process,
e.g. due to scale. So there should be some tolerance in the microbes
to slight variations in the process conditions, which of course we try to
control that as much as possible." Interviewee 2
In the few cases that robustness was not recognised as an issue, it was solely
because the production platform of interest already performed optimally at large
scale:
"We experience our micro-organism is very robust under the conditions
that are relevant to us, that is industrial fermentors, so we don’t see a
need for further improvement there." Interviewee 3
Robustness is thus only deemed important to aid production platforms to per-
form reliably on industrial scale. Even in academia, this link was made.
"Fluctuations on large scale are much more prominent then on small
scale, and constant performance through larger fluctuations in large
scale most probably could be improved." Interviewee 6
Overall, the long- and short-term interests of academia and industry align very
well. However, there were some differences in interest. In industry, interests were
often very practical, all leading to an increase in titre-rate-yield. Subjects included
the use of a different C-source, separated growth- and production cycles, and ease
down-stream processing. Amongst academia, topics of interest that did not align
with those in industry were less aimed at application and practicality, but of a more
fundamental or futuristic nature. These included for example the development of
new fermentation concepts, expanding of research to global scale and studying evo-
lution.
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The aims of industry and academia
Two themes where found vital in this difference in aim, and as such influence both
research questions: VIII) Curiosity-driven versus solution-based research, and IX)
the rise of small companies.
VIII) Curiosity-driven versus solution-based research
The precarious balance between curiosity-driven research and solution-based re-
search, the latter mainly with industrial application in mind or on stakeholders’
demand, can be defined most clearly by looking at the collaborations between
academia and industry. All participants, both from industry and academia, indi-
cated current involvement in projects of collaboration. However, these collabora-
tions are not necessarily initiated by industry nor based on industrial interests. By
academics, it was more described as follows:
"It’s rarely the case that somebody [from industry] comes to me and says
"This is something that you should work on", but of course you talk to peo-
ple at conferences, at seminars, and you try to understand what the prob-
lems are, and you try to find out if you can solve some of these problems
with the tools that you have available. But it’s a bit of a balance, I try to
make sure that a substantial part of our activities does not have a direct
line. In a way, it’s curiosity driven." Interviewee 6
Collaborations between academia and industry are not based on a demand-
supply model, but rather on academics trying to fill existing or predicted gaps in
industry. All academic partners did indicate a strong influence on their work from
industry, even if not direct. However, a way to deal with this potential struggle was
explained:
"We are driven by curiosity and obviously we have to frame our curios-
ity and our personal interest in the interest of our sponsors, and in the
interest of society, and this is perfectly fine. Just remember that the big
artist in the Renaissance were sponsored by the popes, by the emperors
and so, and [the artists] had to produce things that [the sponsors] liked.
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I think this is not completely shocking that we are constrained by the
ideas of our sponsors. I think that our challenge [...] has a point even
of enjoyment. It is how you connect your own personal interest and our
own curiosity with these big demands that your sponsors have for your
research." Interviewee 10
Industry thus does not approach academia with questions, but rather shops
around at conferences for interesting opportunities they can easily adapt and apply.
This indicates that they rely heavily on research performed in academia to make
large strides in innovation.
Industry indicates this when finding new investment opportunities:
"The biggest opportunities lie in the combination for a company like us,
or a hospital research group for example, that have developed something
novel, something proprietary, but [they, academia] have no understand-
ing of the hurdles they’ll face or the means to demonstrate its viability
to be a competitive product in the market. Because that’s what’s going
to be necessary to attract investment. To give it a chance of survival."
Interviewee 5
The clear distinction between technical, sector-driven and social factors influ-
encing main research choices and definition of opportunities can be derived from
the difference in the main aim of each field. Where industry looks for applications
and adaptable solutions to day-to-day problems, academics aim to discover answers
to fundamental questions without being limited by end-user demands. Communi-
cation to align these different aims towards one goal is vital:
"First of all, there has to be good communication, because academia
works in a completely different way to industry. Industry is all about
timelines, deadlines, deliverables, project management, progress to-
wards measurable output. Academia is about testing, discovery, interest-
ing products, interesting processes, new methods, means of discovering
where science can go." Interviewee 5
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IX) The rise of small companies
Small companies that specialise in commercialising academic findings are called
start-ups. Start-ups do not only focus on technical factors, but work on the sector-
based and social factors that might influence the successful industrial introduction
of their product as well.
Some see start-ups as a natural way to close the gap between academia and in-
dustry, by presenting interesting research ready for commercialisation on a silver
platter:
"It’s those partnerships in between, it’s the networking and the identi-
fication of viable product opportunities that are emerging from either
academic groups, hospital groups, virtual companies and then the part-
nerships that takes that feasibility demonstration onto viability. That’s
where the opportunity is. Bridging that gap from feasibility to viability.
Because that’s what derisks it, and brings in funding to take it forward.
I think otherwise so many things can sit in academia, very interesting,
very exciting, and probably more so in Europe than in the United States,
and they just don’t see the light of day because they haven’t taken the
next step and that’s where certainly a company like ours, but other small
companies can come in and make that difference." Interviewee 5
Others indicate that the rise of start-ups widens the gap between academia and
industry. However, they do understand why companies prefer dealing with compa-
nies:
"What we observe is that all these new developments, new technologies
and everything, is mostly the business of small companies. The big com-
panies just become very conservative. [...] Big companies prefer to deal
with smaller companies than dealing directly with scientists, and the rea-
son [...] is that scientists have too big a mouth. That means that the mo-
ment you have discovered something interesting you immediately start
spreading the word, and this is something that the companies don’t like
at all." Interviewee 10
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Discussion
The importance of technical, sector-based and social factors
The importance of three factors, technical, sector-based and social, can be found
when considering currently applied industrial microorganisms. Current host sys-
tems widely applied include bacteria, yeasts, filamentous fungi and unicellular al-
gae. Industrially applied strains all come with their own strengths and drawbacks
[5, 40, 41]. Technical factors for this are the ability to produce complex chemicals,
growth speed, the ability to perform post-translational modifications and the use of
cheap medium components. Sector-based factors include the used micro-organism
to be a natural producer of the product of interest, the fermentation and production
process to fit within the complete industrial process, or familiarity with working
with a specific strain from out the company history. Social factors for the wide ap-
plication of these production hosts include public familiarity and the GRAS status
of a species.
Academic participants only cited technical reasons for the selection of a micro-
organism such as ease to work with, genomic accessibility and wealth of publicly
available data. In industry, sector-based factors such as product of interest, and so-
cial influences derived from demands of the end-user or regulations applied by the
government also strongly influence choices made. Still, the main research oppor-
tunities and future prospects found are of a technical nature. Genome engineering
opportunities, scale-up, and increased strain robustness all focus on improving the
production process from a technical point of view. Mismatches leading to an inno-
vation not making it through the Valley of Death thus may occur when the social
and sector-based aspects are not kept in mind.
Changing the used production organisms in an established industrial process
is considered a rigorous industrial shift, depending heavily on research. Adapting
an existing production process is expensive, requires specific scientific knowledge
and takes time to develop and test. When changing production platform affects the
industrial setup, the gain in yield and characteristics has to be phenomenal to make
up for the money of the investment. Additionally, microbes with possibly more
interesting traits to better produce specific substances are being discovered every
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day. It is thus not surprising that there is a lot of research focused not on finding
the perfect production host for specific purposes, but on the de novo design and
construct of one. This is either done by making a minimal cell, only including traits
specifically selected as required for survival, or by adapting an existing production
microbial platform.
Computational methods are paving the way towards big data processing towards
one goal of interest, in any available species. However, implementation and testing
of many different designs through the DBTL cycle and predictability of gene ex-
pression were identified as the bottlenecks towards progress, by both industrial and
academic participants. This offers a great research opportunity for academia.
External influences on the connection between academia and industry
The main differences arise from the difference in perspective between academia and
industry. Where academia focuses on solving one problem at a time, industry al-
ways keeps the bigger picture in mind. At the same time, academia is encouraged
to perform curiosity driven research, answering fundamental questions. Where in-
dustry works on solving the problems of today, academia focuses on the problems of
tomorrow. In spite of this difference in aim, both parties need each other for fund-
ing, direction, creativity, innovation and exploring boundaries. Both parties also
agree that communication could be improved to improve cooperation and increase
opportunities for process or product development and introduction to the market.
These differences found between the general aims, way of thinking and factors
included in decision-making between academia and industry can be largely brought
back to the different technology readiness levels (TRLs) they operate on [25]. As
earlier indicated, academia works at TRL 1-3 while industry focuses on TRL 8-9.
The enormous gap left from TRL 4-7 is the most high-risk phase of new product
development.
To close this gap, a solution may have naturally emerged. In between established
industry and academia, a third party can be distinguished: small start-up compa-
nies. Rather than direct adaptation of academic research in industry, new companies
emerge straight out of academia, which are acquired by large companies when prov-
ing particularly promising. Closely linked to both industry and academia, the rules
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in start-up companies appear to be different. In short, they are set up specifically to
bridge TRL 4-7. Small companies are more willing to take risks, and easier change
their production platform. The continuous process of using novel advanced tech-
nologies to form a firm has moved to the heart of innovation strategy [42]. Start-up
initiatives focusing on the technical, sector-based and social factors by presenting
the best, most lucrative results achieved in academia on a silver platter, attracting
their own initial funding and stirring commercial interest. This trend is currently
seen throughout many different sectors, with the well-known example of the once-
startup multinational IT company Facebook acquiring multiple startups [43].
Government funded science indicated a first academic revolution. En-
trepreneurial science, where collaborations were formed with industry, indicated
the second academic revolution [44]. Nowadays, government funded research often
even requires collaborations with industrial partners, as seen in European projects
such as EmPowerPutida, P4SB or IBISBA [45, 46]. The swift rise of start-ups has
chimed in a third academic revolution, where patenting novel discoveries will grow
in importance. This has impacted the role of academia. All academic and some
industrial participants have indicated a growing distance between academia and
industry, impacting the communication and collaborations. Some have indicated
this growing distance to be worrisome; start-up companies present commercialized
techniques that can be quickly integrated in any company, masking the years of uni-
versity driven research and development that occurred before forming the start-up.
However, the natural rise of start-ups should be seen as an opportunity. Start-ups
can ease the transition of academic research to actual industrial application, closing
the Valley of Death by forming an independent bridge between the academics and
industry. It also opens up room for academics to focus on what they do best: ed-
ucation and research. It was earlier recognised [47] that having opportunities in
academia to translate their research effectively into concrete products benefits aca-
demic institutions, faculty members, industry, and society [44]. A case could be
made for collaborations to include some attention for the possibility of develop-
ment of start-ups, which might lead to more attention to promising results and how
to grow them into market applications from an early point on.
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Strengths and limitations
As after approximately 8 interviews data saturation occurred, where no new infor-
mation was introduced, it indicates a good reflection of the community. The large
spread of different companies in different biotechnology sectors, of different sizes
and spread over different locations around the globe have served to generalise the
community adequately so the universal bottlenecks, challenges and opportunities
could be easily recognised. However, another interesting approach to this research
could be in the subtle differences from companies in different continents. A larger
sample would be more reflective of the continental community. Companies and
research facilities from other continents could add to this. Additionally, only Euro-
pean academic instances were included in the research.
Conclusions
Within biotechnology, production platform development is a main branch of re-
search. Existing production platforms are improved, or new ones are developed.
From an academic point of view, accessibility and ease to work with are the main
reasons to choose for one micro-organism. For industry, technical factors such as the
characteristics, industrial process and set-up flexibility, sector-based factors such as
regulations and social factors such as public perception are important influences. To
ensure research innovation makes it through the Valley of Death to market commer-
cialisation, these factors must be taken into account early on.
Universally recognised research topics of interests are genome engineering,
scale-up, and improved strain robustness. The main cause for lack of market intro-
duction are the vastly different technology readiness levels that academia and indus-
try operate on. Industry always focuses on solution-based research to improve the
titre-rate-yield, while academia focuses on curiosity-driven, fundamental research,
steps removed from industrial application. Neither party wants this to change, while
both indicate a need for improved communication so that no opportunities are lost.
Start-ups can serve as the bridge over the Valley of Death, connecting feasibility to
viability, by acting as a communication channel between academia where the re-
search originates, and industry to help set-up and fund along the way.
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Pseudomonas putida is rapidly becoming a workhorse for industrial production due to its
metabolic versatility, genetic accessibility and stress-resistance properties. Often, the P. putida
strain KT2440 is described as Generally Regarded as Safe, or GRAS. This description is incor-
rect. Pseudomonas putida KT2440 is HV1 certified, not GRAS.
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After the discovery and full sequencing of the bacterium thus far known as Pseu-
domonas putida KT2440 [1–3], this strain has rapidly become a workhorse for in-
dustrial biotechnology owing to its metabolic versatility, genetic accessibility and
stress-resistance properties [4–6]. This specific set of characteristics is made more
accessible by the recent expansion of its metabolic toolkit, including specific in-
ducible promoters [7] and introduction of the CRISPR-system [8–10]. Its many
benefits as a species have launched P. putida KT2440 as a model organism for in-
dustrial production of biobased chemicals such as citrulline [11], muconate [12],
precursors of biobased plastics [13], precursor of biodegradable plastics [5, 14] and
waste biodegradation purposes [15, 16].
Often P. putidaKT2440, and sometimes the P. putida species, is described as Gen-
erally Regarded as Safe, or GRAS, indicating it is safe to use as a food additive [17]
(e.g. [4, 6–10, 15, 16, 18–53]).
When a reference is given by the authors for this GRAS claim, the following is
used: the US Food and Drug Regulation Administration (FDA) report, specifically
the FDA vol. 47, no. 77, Appendix E, page 17197, Certified host-vector systems
from April 21st, 1982 (see supplementary file) [54]. However, P. putida KT2440 is
herein not certified as GRAS, but as Host-Vector (HV) system safety level 1: “HV1
– Pseudomonas putida strain KT2440 with plasmid vectors pKT262, pKT263 and
pKT264”. The HV1 certification indicates that P. putida KT2440 is determined to be
safe to work with at a P1 (or ML1) facility, as elaborately described by the FDA on
page 17181 of the report [54]. Similarly to E. coli K12, no additional safety measures
are required to work with this strain.
The GRAS status determined by the FDA is only awarded to chemicals or spe-
cific strains of microorganisms that are proven to be safe for ingestion [17]. This is
not proven for P. putida KT2440, contrary to food-related microorganisms such as
Lactobacillus helveticus R0052, Lactobacillus casei subsp. paracasei Lpc-37, Bifidobac-
terium bifidum R0071, or Streptococcus salivarius K12, which are examples of strains
that carry the GRAS status. Intense literature research suggests the GRAS refer-
ence occurs due to incorrect transitive referencing. A full GRAS certificate list can
be found at the FDA website: https://www.accessdata.fda.gov/scripts/fdcc/
?set=GRASNotices.
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However, this does not mean that P. putida KT2440 is unsafe to work with. The
safety of the strain is proven by the overall absence of virulence factors [19, 55]
and the intensive research over the past 40 years by a large community without any
fortuitous cases of infection reported. This correct certification does therefore not
change the many useful applications of this strain. Furthermore, the widespread
use of KT2440, the massive evidence of safe performance and the development of
more refined methods for risk assessment than those available in the early 80s ask
for a revised classification of the strains at stake under the current FDA and EFSA
regulations.
As a note, the phylogenetic classification of P. putida KT2440 within the P. putida
group has been questioned for long [56], and recent work has provided a new clas-
sification [57] (Moore et al., in preparation). However, for the purpose of safety
certification, the specific bacterium formerly known as P. putida KT2440 remains
classified as HV1, regardless of its precise phylogenetic status.
We urge other scientists to properly describe the safety status of all used strains,
since we also discovered the same is true for for example Corynebacterium glutam-
icum. Similarly to P. putida KT2440, C. glutamicum is sometimes reported to have
GRAS status (e. g. [58–61]), but when checked using the website stated above, only
cultured corn starch fermented by C. glutamicum is GRAS, not the organism itself.
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Pseudomonas putida is a metabolically versatile, genetically accessible, and stress-robust species
with outstanding potential to be used as a workhorse for industrial applications. While in-
dustry recognises the importance of robustness under micro-oxic conditions for a stable pro-
duction process, the obligate aerobic nature of P. putida, attributed to its inability to produce
sufficient ATP andmaintain its redox balance without molecular oxygen, severely limits its use
for biotechnology applications. Here, a combination of genome-scale metabolic modelling and
comparative genomics is used to pinpoint essential O2-dependent processes. These explain the
inability of the strain to grow under anoxic conditions: a deficient ATP generation and an in-
ability to synthesize essential metabolites. Based on this, several P. putida recombinant strains
were constructed harbouring acetate kinase from Escherichia coli for ATP production, and a
class I dihydroorotate dehydrogenase and a class III anaerobic ribonucleotide triphosphate
reductase from Lactobacillus lactis for the synthesis of essential metabolites. Initial computa-
tional designs were fine-tuned by means of adaptive laboratory evolution. We demonstrated
the value of combining in silico approaches, experimental validation and adaptive laboratory
evolution for microbial design by making the strictly aerobic Pseudomonas putida able to grow
under micro-oxic conditions.
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Introduction
The Pseudomonas genus is known for its metabolic versatility, high supply of reduc-
ing power, and tolerance to toxins and solvents [1–3]. In particular, Pseudomonas
putida KT2440 is HV1 certified (safe to use in an ML1 or P1 environment), ge-
netically accessible [4–9], and has been successfully engineered to produce vari-
ous compounds of industrial interest [10, 11]. Therefore, P. putida KT2440 is a
recognized synthetic biology- and industrial workhorse [4, 10–13]. Genome-scale,
constraint-based models of metabolism (GSMs) have been developed to analyse its
bio-degradative and biotechnological capacities [4–9]. GSMs provide a comprehen-
sive list of all genome-encoded reactions of an organism and can be used to make
predictions of growth in different media and/or environmental conditions [14].
Several species in the Pseudomonas genus are facultative anaerobes (e.g P. aerug-
inosa, P. fluorescens, P. denitrificans), suggesting that the strictly aerobic P. putida
could be designed towards a micro-aerobic or even facultative anaerobic lifestyle
with a limited number of genetic modifications. The latter has been experimentally
attempted several times by engineering either anaerobic fermentation or anaerobic
respiration.
The first attempt to create a P. putida strain capable of anaerobic fermentation
was by Sohn et al. [6]. They created a GSM of P. putida KT2440 from which they
concluded that P. putida KT2440 cannot grow anaerobically due to insufficient ATP
generation. Anaerobic ATP generation was then enhanced through the expression
of acetate kinase via a plasmid, which resulted in 10 times more surviving P. putida
KT2440 cells in minimal medium with glucose as only carbon source after 8 days of
exposure to anoxic conditions.
In a later in vivo study, Nikel et al. [15] reasoned that in the absence of aerobic
respiration there is not only a lack of ATP generation, but also an accumulation of
NADH that cannot be re-oxidized to NAD+ via the electron transfer chain. There-
fore they expressed acetate kinase, pyruvate decarboxylase and alcohol dehydroge-
nase II to facilitate energy generation and redox rebalancing, respectively. This ap-
proach also yielded approximately 10 times more surviving P. putida KT2440 cells
compared to the control strain after 7 days of exposure to anoxic conditions, with a
Anaerobic Fermentation
4
65
viability rate of 58±4% when both these enzymes were expressed versus 37±3% for
sole expression of acetate kinase [6, 15].
In a different approach Steen et al. [16] introduced the nitrate or nitrite respi-
ration machinery in P. putida KT2440. Nitrate and nitrite respiration are common
anaerobic alternatives to O2 respiration in other Pseudomonas species, but are com-
pletely absent in P. putida strains. Therefore, Steen et al. separately expressed the
nar or nir-nor operons from P. aeruginosa ATCC 17933 in P. putida KT2440 to en-
able nitrate or nitrite respiration respectively. P. putida KT2440 expressing the nar
operon yielded a 50-fold higher number of colony forming units (CFUs) compared
to the control strain when incubated for 5 days under anoxic conditions in the pres-
ence of nitrate, and P. putida KT2440 expressing the nir-nor operon displayed an up
to 80-fold higher number of CFUs in the presence of nitrite.
Another approach to attempt anaerobic respiration in P. putida was the use of
phenazines to transfer electrons from the cell to an electrode, to re-establish func-
tioning of the electron transfer chain under oxygen limiting conditions. Schmitz et
al. [17] expressed seven core phenazine biosynthesis genes phzA-G and the two spe-
cific genes phzM and phzS required for pyocyanin synthesis from P. aeruginosa PAO1
into P. putidaKT2440. They observed that phenazines facilitate electron discharge to
the electrode, although the wild-type P. putida KT2440 unexpectedly also showed a
limited ability to interact with the electrode. The production of phenazines resulted
in sustained metabolism under oxygen-limited conditions for up to two weeks, with
doubled biomass production in the presence of a poised electrode when compared
to wild-type P. putida KT2440.
Similarly, Lai and colleagues [18] showed that adding the redox mediators thio-
nine chloride, tris(2,2’-bipyridine)cobalt(II) diperchlorate, or potassium hexacyano-
ferrate(III) to the culture medium could enable wild-type P. putida F1 to discharge
electrons to an electrode. This resulted in survival of P. putida F1 under anoxic con-
ditions over 300 hours with a higher adenylate energy charge, indicating the cells
could generate energy using the anode as terminal electron acceptor.
The attempts for anaerobic fermentation or anaerobic respiration yielded simi-
lar levels of survival under anoxic conditions. None of the studies reported growth
of the strains under anoxic conditions [6, 15–18]. Overall, anaerobic fermentation
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would be preferred over anaerobic respiration since this eliminates the need of sup-
plementing the electron acceptor (oxygen or nitrate/nitrite) homogeneously through
the bioreactor, and fermentation often results in products of industrial value such
as lactate. Recombinant strain behaviour through fermentation under micro-oxic
conditions was not explored in any of the aforementioned studies.
In this work, we explore the roles oxygen plays in P. putida KT2440 by focusing
on growth under anoxic in silico and micro-oxic conditions in silico and in vivo. In
our pursuit of these goals we took advantage of the available knowledge on P. putida
KT2440 metabolism, as well as of the wealth of genomic data on P. putida KT2440
and other Pseudomonas species [14]. Specifically, we used a GSM to probe P. putida
KT2440 metabolism, while comparative genomics was used to pinpoint the distinct
genetic features of Pseudomonas species capable of growing under anoxic conditions
through anaerobic fermentation. These in silico approaches identified several lim-
itations of P. putida KT2440 to grow under micro-oxic or anoxic conditions. These
limitations were systematically addressed in recombinant P. putida KT2440 strains,
which were then exposed to micro-oxic conditions through an oxygen gradient set-
up to evaluate their capabilities.
Materials and methods
Genome-scale, constraint-based metabolic models
In this study we used the P. putida KT2440 genome-scale metabolic models iJN746
[5] and iJP962 [7].
GSM simulations
iJN746 and iJP962 were analysed using Flux Balance Analysis (FBA) in the CobraPy
toolbox [14, 19]. Growth predictions were performed by setting biomass production
as maximization objective in FBA. The minimal glucose medium conditions were
set by allowing ’unlimited’ uptake (up to 1000 mmol gdw−1 h−1, gdw: grams dry
weight) of copper, cobalt, iron, protons, water, sodium, nickel, ammonia, phosphate,
sulphate, and nitrate. In addition, the glucose uptake rate was set to be maximally
6.14 mmol gdw−1 h−1, based on experimentally measured uptake rates [20]. The
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in silicomedium composition closely resembles the composition of DeBont minimal
medium which was used for the in vivo experiments.
Rich medium conditions were set by allowing unlimited uptake (up to
1000 mmol gdw−1 h−1) of all compounds (except oxygen) for which exchange re-
actions are present in the GSM. Under oxic conditions, the O2 uptake rate was set to
maximally 18.5 mmol gdw−1h−1. Reactions for previous designs or to complement
newly identified reactions were added using the CobraPy ’addReaction’ function.
Genome annotation
We selected six genomes of facultative anaerobic strains from the Pseudomonas genus
(P. aeruginosa PAO1 and M18, P. stutzeri DSM10701 and A1501, P. denitrificans
ATCC13867 and P. fluorescens F113) and six genomes of obligate aerobic P. putida
strains (KT2440, F1, S16, W619, GB1, and BIRD1). All genomes were obtained
from the EnsemblBacteria repository in March 2015 [21]. Genomes were annotated
in SAPP [22, 23] using Prodigal for gene prediction (version 2.6) [24], 2010] and
with InterProScan version 5.4-47.0 [25] for functional annotation, with the selected
applications: TIGRFAM, ProDom, SMART, PROSITE Pattern, PfamA, PRINTS, SU-
PERFAMILY, Coils, Gene3d.
Bacterial strains and cultivation conditions
Bacterial strains used in this study can be found in [26]. E. coli CC118λpir was
used for cloning procedures and plasmid maintenance, and was routinely culti-
vated at 37◦C under oxic conditions in LB medium (containing 10 g/l tryptone,
10 g/l NaCl and 5 g/l yeast extract), optionally containing antibiotics for selection
(50 µg/ml kanamycin as indicated). For solid medium, 15 g/l agar was added to
the medium. P. putida KT2440 was routinely cultivated under oxic conditions at
30◦C in LB medium. Growth and fluorescence experiments were performed in De
Bont minimal medium (DBG) [27] (3.88 g/l K2HPO4, 1.63 g/l NaH2PO4 · 2H2O,
2.00 g/l (NH4)2SO4, 0.1 g/l MgCl2 ·6H2O, 10 mg/l EDTA, 2 mg/l ZnSO4 · 7H2O,
1 mg/l CaCl2 · 2H2O, 5 mg/l FeSO4 · 7H2O, 0.2 mg/l Na2MoO4 ·2H2O, 0.2 mg/l
CuSO4 ·5H2O, 0.4 mg/l CoCl2 ·6H2O, 1 mg/l MnCl2 ·2H2O), with 4.5 g/l glucose as
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the sole carbon source. The medium was supplemented with 50 µg/ml kanamycin
as indicated. Pre-cultures were prepared by picking and transferring a single colony
from solid LB medium with the appropriate antibiotic selection into culture flasks
for oxic overnight cultivation at 200 rpm at indicated cultivation temperatures.
Construction of Plasmids
Plasmids used in this study are described in [26]. DNA segments were amplified
from the indicated template by colony-PCR using Phire Hot Start II DNA Poly-
merase (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufactur-
ers’ protocol (Primers are listed in [26]). Restriction enzymes were obtained from
NEB (New England BioLabs®inc, Ipswich, MA USA). L-aspartate oxidase was iso-
lated from both E. coli BW25113 or P. putidaKT2440. Both genes were designed with
NdeI and BamHI restriction sites on the 5’- and 3’-ends, respectively. DNA frag-
ments were purified from agarose gel using the KG Gel Purification Kit (Machery-
Nagel GmbH and Co. Düren, Germany) and ligated into the pSEVA638 backbone
(Standardized SEVA plasmid system [28, 29]) using T4 DNA Ligase (Roche Ap-
plied Science, Indianapolis, IN USA). Acetate kinase (ackA) was isolated from E. coli,
the two-subunit gene cluster class I dihydroorotate hydrogenase (pyrK-pyrD B) and
the two-subunit gene cluster class III ribonucleotide triphosphate reductase (nrdD-
nrdG) were ordered using the gene from L. lactis as a template but codon-optimized
for P. putida KT2440. The genes were designed with PacI and SpeI restriction sites
on the 5’- and 3’-ends, respectively. Similarly purified DNA segments were ligated
into the pSEVA2213 backbone (Standardized SEVA plasmid system [28, 29]). Each
construct additional carries the fluorescent protein EcFbFP [30] which does not de-
pend on oxygen to check if the genes are transcribed and in roughly what amount
the proteins are present. The empty plasmid control only carries EcFbFP.
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Micro-oxic experiments
Oxygen gradients are based on Bailey and Scott’s Diagnostic Microbiology [31]. Oxy-
gen gradients were set up in sterile 10 ml glass test tubes capped with loosely fitting
caps and filled halfway with LB medium. After autoclaving, the medium was sup-
plemented with sterile components: antibiotics as indicated, 5 g/l L-cysteine and
0.5 g/l sodium thioglycollate to remove O2 from the medium, 1 mg/l resazurin to
indicate O2 presence and 4 g/l agarose to stabilize the gradients. After heating the
medium to just below boiling point for 10 min to expel O2, the tubes were cooled to
room temperature. 24 Hours after preparation, the tubes were inoculated drop-wise
with 10µl of a pre-culture.
Strain performance in oxygen gradients was tested while oxygen gradient test
tubes were slanted at a 45◦ angle or upright. Multiple agar or agarose concentrations
and variants were tested [26]. Micro-oxic conditions within the gradient were veri-
fied with a micro-electrode (similar set-up as described in [32, 33]). The resazurin
colour change from pink to colourless coincides with a dissolved oxygen concentra-
tion around the micro-electrode detection limit of 0.01 mg/l [26]. Growth of the
strains through the oxygen gradient was monitored via a Mirazoom MZ-902 time-
lapse camera (OOWL tech, Kowloon, Hong Kong) set-up in a well-lit non-shaking
30◦C incubator. Time-lapse movies were analysed using Fiji 1.51p (ImageJ 1.51p,
Rasband, National institutes of Health, Bethesda, MA USA) [26]. Growth in the oxy-
gen gradients started from the surface of the medium (high in oxygen) downwards
(gradually lower in oxygen), and was measured in mm. Sampling of bacteria was
done by selecting the bacteria growing at the lowest oxygen concentration with a
3 ml syringe (Thermo Fisher Scientific, Waltham, MA USA) and 1.5” needle (BD
Microlance, Switzerland).
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Anoxic cultivation
Anoxic cultivation of E. coli JW2558was performed in 50ml glass 20mm aluminium
crimp cap vials with rubber stoppers (Glasgerätebau Ochs laborfachhandel e.K.) in
30 ml DBG medium supplemented with 0.75 g/l L-cysteine, 1 mg/l resazurin and
with 50 µg/ml gentamycin as selectionmarker. Before inoculation, the vials were gas
exchanged with CO2/N2. Inoculation was done with aerobically precultured bacte-
rial sample, with a starting OD of ca. 0.03. Samples were taken using CO2 flushed
1.5” needles (BD Microlance) and 3-5 ml syringes (ThermoFisher) avoiding O2 ex-
posure. Anoxic conditions were ensured as in samples taken the resazurin turned
from colourless to bright pink within seconds. Growth rates were determined by
OD600 measurements. Medium only served as a blank control.
Statistical analysis
All reported experiments were independently repeated three times, testing biolog-
ical triplicates. Figures represent the mean values of corresponding biological trip-
licates and the standard deviation. The level of significance of the differences when
comparing results was evaluated by means of analysis of variance (ANOVA), with
α=0.05.
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Results
Model evaluation confirms the strict aerobic nature of P. putida KT2440
Previous designs of anaerobically surviving P. putida strains were conceptually
based on insufficient anaerobic ATP generation and redox balancing [6, 15–18]. Im-
plementation of acetate kinase resulted in prolonged survival times under anoxic
conditions [6, 15, 16]. Therefore, we first re-evaluated these designs in the context
of the P. putida KT2440 models iJP962 [7] and iJN746 [5]. GSMs iJP962 and iJN746
describe the known metabolism of P. putida KT2440 as well as its requirements for
survival and growth. When analysed with Flux Balance Analysis (FBA) [14], these
GSMs can predict whether or not P. putida grows under various conditions [5, 7].
The analysis of the two GSMs led to similar results and hereafter we will specifically
report those obtained with iJP962.
iJP962 Was first confirmed to correctly predict the obligate aerobic nature of
wild-type P. putida KT2440. It predicted the maximal achievable growth rate under
anoxic conditions in both rich and minimal medium to be zero, which is in line with
the obligate aerobic nature of P. putida. iJP962 Was then used to contextualize the
anaerobic P. putida designs referred to above. The GSMwas expanded with reactions
corresponding to the expressed heterologous genes from previous experimental de-
signs [6, 15–17]. These expanded GSMs still predicted that anaerobic growth was
not possible in neither minimal nor rich medium. These predictions are consis-
tent with the experimental observations that none of the previous designs enabled
P. putida KT2440 to grow anaerobically. In addition, these predictions imply that
iJP962 captures previously undescribed limitations to anaerobic growth in P. putida
KT2440.
Limited energy supply and inability to generate biomass inhibit
P. putida to survive under anoxic conditions
The model allows identification of reactions which indirectly use oxygen, thereby
resulting in limited survival under micro-oxic conditions. To identify additional
limitations, we performed two independent in silico analyses: GSM simulations and
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domainome, comparative genomic analysis. The GSM simulation approach focused
on identifying essential O2-dependent metabolic reactions in iJP962, whereas the
comparative genomics approach focused on pinpointing the genetic differences be-
tween obligate aerobic P. putida strains and other facultative anaerobic Pseudomonas
species (Figure 4.1). To identify reactions in the GSM that involve O2 and are essen-
tial for growth, we first set the growth medium to a minimal glucose medium under
oxic conditions. Then, we iteratively deleted each reaction that involves O2 one at
a time and predicted whether or not growth was possible. Growth was no longer
possible upon the deletion of either (i) protoporphyrinogen oxidase, (ii) L-aspartate
oxidase, or (iii) dihydroorotate dehydrogenase. These enzymes are required for the
biosynthesis of heme, NAD+/NADP+, and pyrimidines, respectively (Figure 4.2).
Next, we evaluated whether the lack of anaerobic alternatives to these three re-
actions is the only limitation to in silico anaerobic growth. We expanded iJP962 with
anaerobic alternatives for L-aspartate oxidase, dihydroorotate dehydrogenase and
protoporphyrinogen oxidase and again simulated growth. iJP962 now predicted
anaerobic growth of the modified P. putida on glucose minimal medium, suggesting
that the lack of anaerobic alternatives to the aforementioned three reactions is the
only limitation to anaerobic growth.
The predicted anaerobic growth rate with the three aforementioned metabolic
alternatives was, however, very low (0.007 h-1) compared to the aerobic growth rate
using the unamended model (0.450 h-1). Although low, this does suggest that ac-
cording to the GSM the modified P. putida is capable of producing all biomass con-
stituents necessary for growth. The comparatively low growth rate suggests a lack
of resources or an inefficient conversion thereof.
The limiting factor was identified to be ATP formation. Under anoxic conditions,
most ATP required for biomass formation is in silico generated by oxygen-dependent
cytochrome reactions. Therefore, we further expanded iJP962 with reactions corre-
sponding to the previous anaerobic P. putida designs that dealt with anaerobic ATP
generation [6, 15–17]. The addition of acetate kinase to the model doubled the pre-
dicted growth rate to 0.014 h−1, while addition of the nitrate respiration machinery
increased the predicted growth rate to 0.171 h−1. Based on the modelling results,
we hypothesized that the anaerobic ATP generation is insufficient.
Anaerobic Fermentation
4
73
Figure 4.1: Overview of in silico approaches to identify limitations to anaerobic growth in P. putida.
(A) Summary of genome-scale GSM predictions using iJP962 [7] given an aerobic environment
(left) and expansions with indicated reaction sets given an anaerobic environment (right). The
colours indicate no growth (orange), poor growth (purple) and growth (green) (B) Comparative
genomics workflow. Genomes of the P. putida group and the anaerobic Pseudomonas group were
systematically annotated using SAPP [22, 23], the protein domains were extracted, and the domains
common to all anaerobic Pseudomonas species (the core domains) were selected. Predictions from
both methods were combined to obtain a final design.
Although the GSM-based approach successfully identified several limitations to
anaerobic growth in P. putida, this identification is restricted to metabolism as de-
scribed in iJP962. Other cellular processes that may rely on O2 are not described.
Therefore, we also used comparative genomics to perform an analysis of protein
domain content and pinpoint genetic differences between select groups of obligate
aerobic P. putida strains and facultative anaerobic Pseudomonads. The P. putida group
consisted of the following strains: KT2440, F1, S16, W619, GB1, and BIRD1. The
facultative anaerobic Pseudomonas group consisted of P. aeruginosa PAO1 and M18,
P. stutzeriDSM10701 and A1501, P. denitrificansATCC13867 and P. fluorescens F113.
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All genomes were de novo annotated to avoid artefacts from differences in the an-
notation procedures. Annotated protein domains were extracted from each genome
to compare the presence of functional protein domains. The domains from the
anaerobic Pseudomonas group were then further filtered to select only those domains
that are shared by all members of the group: core domains. These core domains
were compared to the domains present in the P. putida strains to identify domains
common to all selected anaerobic Pseudomonas species and absent from all selected
P. putida strains. This resulted in a shortlist of 47 anaerobic-only protein domains
(Figure 4.1, [26]).
These domains thus identify the genetic makeup of the anaerobic lifestyle and
can be divided in three main categories: i) Domains functional in ATP generation
(16), ii) Domains of unknown function (13), and iii) Other domains (18).
Category i) comprises nitrate respiration, and acetate kinase (IPR000890). Fur-
thermore, two domains that are related to ribonucleotide-triphosphate reductase
(IPR012833, IPR012840) have been identified which are crucial for this work, as dis-
cussed further below. Category ii), domains of unknown function, must be excluded
from the design as nothing can be said about them with the current knowledge.
For the majority of the remaining domains belonging to category iii) it is not
clear how they would contribute to the desired anaerobic lifestyle. For example, sev-
eral domains associated with siderophore transport (IPR003538) and pilus assembly
(IPR008707, IPR013362, IPR013374, IPR025746) are found. While they have been
related to virulence in P. aeruginosa [34, 35], which is part of its pathogenic lifestyle,
they do not appear to be linked to anaerobicity. Other domains may be beneficial but
not essential for anaerobic growth. The identified iron-sulfur clusters (IPR007202,
IPR018298) for example were absent in the investigated aerobic species. Typically
these clusters are oxygen sensitive, which may explain their absence. The iron sul-
fur clusters have a regulatory role [36, 37] and are implicated as intracellular sensors
and in electron transport. Hence, these clusters do not appear essential for a conver-
sion from an aerobic to an anaerobic lifestyle.
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Design of anaerotolerant P. putida
Together, the in silico approaches provide a holistic view on the metabolic
processes required to enable designing a P. putida strain capable of anaerobic
growth by fermentation. The main bottlenecks found include L-aspartate oxi-
dase (NadB), dihydroorotate dehydrogenase (PyrD), protoporphyrinogen oxidase
(HemY), ribonucleotide-triphosphate reductase (RNRs), and anaerobic energy gen-
eration. We address these below.
L-aspartate oxidase (NadB) catalyses the conversion of L-aspartate to iminoas-
partate, a precursor in NAD(P)+ biosynthesis. In iJP962 this conversion requires
O2 as electron acceptor. However, in E. coli L-aspartate oxidase is known to use ei-
ther O2 or fumarate as electron acceptors [38]. The necessity of exchanging nadB in
P. putida KT2440 must be checked experimentally. This was done by constructing a
plasmid with either nadB from P. putida KT2440 or nadB from E. coli BW25113 and
transforming it into nadB knock-out strain E. coli JW2558. The growth dynamics of
the resulting recombinant E. coli strains were compared under anoxic conditions.
Dihydroorotate dehydrogenase (PyrD) catalyzes the production of orotate,
which is required for pyrimidine biosynthesis, and ultimately for the synthesis of
RNA and DNA. In iJP962 this enzyme interacts directly with O2, but in reality
P. putida pyrD encodes a membrane-bound class II dihydroorotate dehydrogenase
[39], which interacts with quinones rather than directly with O2 [40]. The re-
oxidation of the quinones requires the flow of electrons towards the terminal elec-
tron acceptor O2. Thus, P. putida pyrD is indirectly dependent on O2 via the electron
transfer chain. To circumvent the need for the electron transfer chain, a biochemi-
cally characterised class I dihydroorotate dehydrogenase that uses fumarate, FAD+,
or NAD+ [40] could be obtained from the non-pathogenic Lactobacillus lactis [41]
and introduced in P. putida KT2440.
Protoporphyrinogen oxidase (HemY) converts protoporphyrinogen IX to pro-
toporphyrin IX, which is further converted to heme. Heme is involved in many cel-
lular processes–including respiration–and is essential for most organisms, exclud-
ing some specific species capable of fermentation under anoxic conditions [42, 43].
It is unclear whether heme is essential for an anaerobically fermenting P. putida
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strain, but it is most likely required for anaerobic respiration. There are two alter-
native protoporphyrinogen oxidases in gram negative bacteria: HemG and HemJ.
The protein HemG is quinone-dependent instead of O2-dependent, but is not found
in any Pseudomonas species. The protein HemJ is found in Pseudomonads, including
P. aeruginosa [44] and P. putida, but it is unknown whether or not it relies on O2 [42].
We have thus not included an alternative biosynthesis gene for the heme precursor
protoporphyrin IX, as it is likely that protoporphyrin IX can be synthesized by the
endogenous P. putida HemJ.
Ribonucleotide-triphosphate reductases (RNRs) are required for the biosyn-
thesis of deoxynucleotides (dNTPs). There are three classes of RNRs: Class I is
strictly aerobic, class II is O2-independent, and class III is O2 sensitive [45, 46].
P. putida only has a class I RNRs and is not able to produce DNA under anoxic
conditions. In contrast, P. aeruginosa contains RNR of all three classes [46]. RNR
knockout experiments in P. aeruginosa revealed that the class II enzyme contributes
most to anaerobic dNTP production [46], and that the class II RNRs are reported
to be essential for anaerobic growth in P. aeruginosa [47]. Therefore, a class II RNR
seems the most promising candidate to enable anaerobic nucleotide production in
P. putida.
The identified limitations and alternative options found using the in silicometh-
ods were combined into a consolidated design of a P. putida KT2440 strain capable
of in-silico growth under anoxic conditions through anaerobic fermentation. The
predicted lack of ATP was resolved by acetate production, based on the previously
successfully expressed acetate kinase for fermentation [6, 15]. The newly proposed
design includes (i) a quinone-independent gene cluster class I dihydroorotate de-
hydrogenase (pyrK-pyrD B) which was taken from the non-pathogenic L. lactis [48],
(ii) the class III ribonucleotide-triphosphate reductase (nrdD-nrdG) which was taken
from the non-pathogenic L. lactis, (iii) acetate kinase (ackA) which was taken from
E. coli, and possibly (iv) L-aspartate oxidase (nadB) from E. coli (Figure 4.2).
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Figure 4.2: Final design of P. putida KT2440 capable of growth under anoxic conditions through
anaerobic fermentation. QH2: quinol, Q: quinone; T-(SH)2: reduced thioredoxin, T-S2 oxidized
thioredoxin NTP: nucleoside triphosphate, dNTP: deoxynucleoside triphosphate, UMP: uridine
monophosphate.
The P. putida L-aspartate oxidase can function without oxygen as electron
acceptor
To determine the need to replace the nadB gene to facilitate anaerobic survival of
P. putida, plasmids carrying either nadB from E. coli (p638 nadBEco) or the nadB
gene from P. putida (p638 nadBPpu) were inserted into the E. coli nadB knockout
strain JW2558. The strains were cultured anaerobically, monitoring growth through
sampling. Both strains grow similarly under anoxic conditions, proving that the
endogenous L-aspartate oxidase of P. putida does not need oxygen as an electron
acceptor and therefore does not have to be replaced (Figure 4.3).
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Figure 4.3: Testing of P. putida L-aspartate oxidase under anoxic conditions. A) Schematic overview
of constructs for E. coli JW2558: p638 - (empty plasmid control) (purple), p638 nadBEco (green)
and p638 nadBPpu (orange). B) Anaerobic growth analysis of all strains.
Expression of acetate kinase, dihydroorotate dehydrogenase and
ribonucleotide triphosphate reductase in P. putida does not alter aerobic
growth
To verify the in silico analysis, recombinant strains were constructed carrying ackA,
pyrK-pyrD B, nrdD-nrdG, or all three (ackA-(pyrK-pyrD B)–(nrdD-nrdG)) (Figure
4.4A). The genes of interest were placed in the same SEVA pS2213 backbone, with
an RK2 origin of replication and an EcFbFP gene included directly behind the gene
of interest. In the empty plasmid, only the fluorescence gene is present.
A 64-hour growth experiment under oxic conditions in a platereader was per-
formed, measuring the OD600 and fluorescence (Figure 4.4B-D). The similar growth
curves of the different recombinant strains show no difference in plasmid burden,
while plasmid sizes vary between 4 kb (empty plasmid) and 10 kb (pS2213 ackA-
(pyrK-pyrD B)-(nrdD-nrdG)) (Figure 4.4B).
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Figure 4.4: Building the design of P. putida KT2440 capable of growth under anoxic conditions and
testing under oxic conditions. A) Schematic overview of constructs for P. putida KT2440: 2213F -
(empty plasmid control), pS2213 ackA, pS2213 pyrK-pyrD B, pS2213 nrdD-nrdG and pS2213
ackA-(pyrK-pyrD B)-(nrdD-nrdG). The symbols in front of the strain names function as the legend
for the graphs. B) Aerobic growth analysis of all strains. C) Aerobic fluorescence assay of all strains
at excitation of 450 and emission of 495. D) Fluorescence relative to cell density. Measurements for
B, C and D were taken every 30 min for 64 hours at 30◦C. Cultures were shaken continuously.
All recombinant strains carrying plasmids emit significantly more fluorescence
than the wild-type counterpart (Figure 4.4C, D). There are large differences in flu-
orescence between those strains. In 12 hours, the relative fluorescence of the strain
carrying the empty plasmid was 2.3 to 1.4 times as high as the recombinant strains.
At that point, the fluorescence intensity of strain KT2440 pS2213nrdD-nrdG exceeds
all other strains by a factor 1.6 (Figure 4.4D). Remarkably, strain KT2440 pS2213
ackA-(pyrK-pyrD B)-(nrdD-nrdG) and strain KT2440 pS2213 pyrK-pyrD B emitted
similar amounts of fluorescence. In spite of the size of the two-subunit gene clus-
ter class III ribonucleotide triphosphate reductase, relatively more fluorescence was
recorded in P. putida KT2440 pS2213 nrdD-nrdG than when solely acetate kinase
is expressed. In this context, the differences in fluorescence between strains can
be used as a rough indication of difference in gene transcription, as the genes were
placed in the same backbone under de same promoter and with equal copy numbers.
These data show that under oxic conditions all plasmids pose an equal burden,
but the level of gene transcription varies significantly between strains.
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Additional ATP generation results in growth of P. putida KT2440 under
micro-oxic conditions
The recombinant strains were exposed to micro-oxic conditions in an adaptive labo-
ratory evolution set-up using an oxygen gradient first for two days, followed by two
four-day cycles. Strain performance was continually monitored using a time-lapse
camera, taking a picture every 20 seconds. The end of one round was marked by ei-
ther stagnation of growth and visible cell-death, or the ability of the strains to grow
under micro-oxic conditions, defined as below the micro-electrode detection limit.
Recombinant strains were passed three times over oxygen gradients to adapt the
strains to micro-oxic conditions (Figure 4.5A). Since KT2440 pS2213 pyrK-pyrD B
underperformed in preliminary oxygen gradient experiments, this strain was ex-
cluded (data not shown). KT2440 pS2213 - (negative control), KT2440 pS2213 ackA,
KT2440 pS2213 nrdD-nrdG and KT2440 pS2213 ackA-(pyrK-pyrD B)-(nrdD-nrdG)
were monitored for three consecutive rounds of culturing in the oxygen gradients.
Medium was used as a blank control.
Over multiple consecutive rounds, all recombinant strains except the empty
plasmid control showed improved performance under micro-oxic conditions (Fig-
ure 4.5B). This is reflected by the difference in progress towards a dissolved oxygen
concentration of <0.01 mg/l along the consecutive passages over the oxygen gra-
dients. In contrast to the other transformant strains, no growth beyond detectable
oxygen levels was achieved with the empty plasmid between passage 2 and 3. To en-
sure that there was no growth possible beyond the detection limit, we deliberately
tested the empty plasmid in further cycles. The results show that the empty plasmid
control only adapts to the limit of detectable oxygen levels over multiple passages,
but does not surpass it (Figure S6).
After a period of four days the strains progressed to areas with <0.01 mg/l oxy-
gen (Figure 4.5, Supplementary data). While in the set-up, time-wise, the first pas-
sage (T1, two days) is different from the following cycles (T2 and T3, four days),
presently it is unclear what causes the sudden increase in performance from T2 to
T3 observed in strains carrying either pS2213 -, pS2213 nrdD-nrdG or pS2213 ackA-
(pyrK-pyrD B)-(nrdD-nrdG) (Figure 4.5B). When solely acetate kinase is expressed,
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strain performance in micro-oxic conditions is directly improved. The differences
between the strains with pS2213 ackA and pS2213 ackA-(pyrK-pyrD B)-(nrdD-nrdG)
could either be explained by the additional metabolic load caused by gene expres-
sion under micro-oxic conditions (which in itself imposes a burden), or by the effect
of acetate kinase held back by the additional expression of pyrK-pyrD B and nrdD-
nrdG. When analysing the overall daily progress of the strains (Figure 4.5C) it again
becomes apparent that overall the strain expressing acetate kinase performs signifi-
cantly better. Extra energy generation is therewith proven to be a vital requisite for
P. putida to accommodate micro-aerobic growth.
The results of the O2-gradients show that after multiple rounds over the oxygen
gradient expression of nrdD-nrdG alone in P. putida KT2440 result in growth under
micro-oxic conditions (Figure 4.5).
Figure 4.5: Testing of transformed strains under micro-oxic conditions. A) Screening assay using
an adaptive laboratory evolution method with oxygen gradients. Recombinant strains were passed
three times over oxygen gradients to adapt the strains to micro-oxic conditions in LB medium. B)
Ingrowth in oxygen gradients over consecutive rounds. The first adaptation round was monitored
over two days, followed by two four-day cycles. Strain performance of P. putida KT2440 pS2213 -,
KT2440 pS2213 ackA, KT2440 pS2213 nrdD-nrdG and KT2440 pS2213 ackA-(pyrK-pyrD B)-
(nrdD-nrdG) throughout the experiment was monitored continuously with a time-lapse camera
set-up, and was depicted as ingrowth in mm from the surface of the growth medium down. Above
the purple dashed line the oxygen concentration is <0.01 mg/L. Non-inoculated medium was taken
as control. C) The average progression of the recombinant strains in the oxygen gradients over time,
depicted in mm/day.
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Discussion
We discuss below the work described along four major lines:
1) The integrated computational analysis herein described provided a coher-
ent, systems-wide basis to understand the factors underlying the aerobic nature of
P. putida. By enabling to explain previous unsuccessful experimental efforts aiming
at making P. putida grow under anoxic conditions, this endeavour emphasised the
value of applying an a priori systems, model-driven design perspective to metabolic
engineering, as opposed to the common practice of designing experiments based on
fractional knowledge of parts of the system. Also, the combination of GSM simu-
lations and comparative genomics can be of widespread use as they are inherently
complementary. GSMs, already available for many organisms [7, 9], describe an or-
ganism in high detail; whereas comparative genomics pinpoints the genetic basis
underlying the differences between organisms.
2) According to the understanding of P. putida KT2440 metabolism as repre-
sented in iJP962, the adjustments we found through comparative genomics and pro-
tein domain content analysis should enable anaerobic growth. However, it must be
noted that although this metabolic model offers a clear and direct insight into the
known metabolism of P. putida KT2440, it is far from complete. Due to necessity,
metabolic models represent a significantly simplified metabolism. Not enough ex-
perimental data is available to describe redox balances and regulatory pathways in a
model in full detail, especially considering that much remains unknown about reg-
ulatory pathways and protein domain functions. The model contains all reactions
known regardless if they are active or not, which means that pathways or reactions
that are unlikely to be active under certain conditions are active in the model. The
metabolic model therefore offers a good starting point, but should not be consid-
ered to provide a perfect design to the ambitious goals we set out. Hence, we rather
see the model predictions regarding anaerobic growth as a guide towards achieving
micro-oxic robustness.
3) When testing the fermentative design of P. putida KT2440 as detailed in Fig-
ure 4.5, we used adaptive laboratory evolution methods combined with insertion of
the genes/gene clusters that enabled the strain to grow under micro-oxic conditions.
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The oxygen gradient analysis proved a robust and reliable way to follow the progress
of recombinant strains versus control strains under micro-oxic conditions within
two to four days’ time over multiple passages. Under oxic conditions, fluorescence
levels (Figure 4.4) indicate that acetate kinase concentrations in P. putida KT2440
pS2213 ackA are higher than in KT2440 pS2213 ackA-(pyrK-pyrD B)-(nrdD-nrdG).
Under micro-oxic conditions KT2440 pS2213 ackA outperforms all other strains,
including KT2440 pS2213 ackA-(pyrK-pyrD B)-(nrdD-nrdG). This suggests that ac-
etate kinase directly leads to improved performance under micro-oxic conditions:
the more acetate kinase, the larger the ATP availability, the better the strain perfor-
mance under micro-oxic conditions. However, the accumulation of acetate due to
AckA activity could lower the pH to a growth-inhibiting environment. The produc-
tion of acetate (yielding ATP) could also reduce carbon flow towards the product of
interest, lowering the yield. Yet, acetate is just one way to increase the ATP pool.
Other options include growing cells on more energy-ready carbon sources such as
gluconic acid, knocking out energy demanding pathways [12], applying a different
terminal electron acceptor by offering an anode in combination with phenazines or
electron mediators in a bioelectrochemical system [17, 18] or switching to anaerobic
respiration [16]. The use of genetic switches at the level of acetyl-CoA could also
be used to alleviate the potential toxicity exerted by acetate [49]. The experimental
set-up with overall improved strain performance in micro-oxic conditions over mul-
tiple oxygen gradient passages shows the value of an adaptation set-up in relation
to GSM predictions. GSM predictions regarding growth rates and fluxes typically
relate better to strains already having undergone adaptive laboratory evolution [50,
51]. Hence, improvement of strain performances under micro-oxic conditions is
expected upon further adaptive laboratory evolution.
4) After multiple rounds over the oxygen gradients, dihydroorotate dehydroge-
nase and ribonucleotide triphosphate reductase had an added benefit in this assay.
The ability of growing under micro-oxic conditions of KT2440 pS2213 nrdD-nrdG
and KT2440 pS2213 ackA-(pyrK-pyrD B)-(nrdD-nrdG) after three passages over oxy-
gen gradients, as opposed to P. putida KT2440 pS2213 –, indicate the added value
of these genes. However, pyrK-pyrD B and nrdD-nrdG are expected to be only of
value under anoxic conditions, since aerobic endogenous versions of these genes are
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present in the KT2440 genome. We expect that a switch to anoxic conditions will
result in the exclusive use of the anaerobic versions of the proteins.
These four items represent as well the core elements of the Design-Build-Test-
Learn (DBTL) engineering cycle of Synthetic Biology [52]. This integrated, highly
iterative workflow illustrates how such strategies can efficiently assist lifestyle engi-
neering of industrial traits and provide the means to enable a new era in tailored,
agile biomanufacturing.
Conclusions
The obligate aerobic metabolism of P. putida is a major obstacle for the breakthrough
of this bacterium to be widely used as a biotechnological host. The integrated com-
putational analysis herein described provided a coherent, solid basis to understand
the factors underlying the aerobic nature of P. putida. The model-driven redesign of
an obligate aerobe into a strain tolerant to low-oxygen concentrations constitutes an
important fundamental step in the rational engineering of such biological systems.
The initial design addressed five metabolic bottlenecks: protoporphyrinogen
oxidase (hemY), L-aspartate oxidase (nadB), dihydroorotate dehydrogenase (pyrD),
ribonucleotide-triphosphate reductase (RNRs) and anaerobic energy conservation
(through substrate-level phosphorylation by acetate kinase, ackA). This design could
be brought back to the addition of five genes upon further evaluation. Introduction
of hemY was determined not to be essential as the endogenous HemJ can possibly
fulfil its role and P. putidaNadBwas experimentally proven to function under anoxic
conditions.
Upon testing the final design under micro-oxic conditions, the increased avail-
ability of ATP through the synthesis of acetate in P. putida KT2440 pS2213 acka re-
sults in growth, unlike the wild-type strain. The importance of ATP availability un-
der anoxic conditions was demonstrated earlier [6, 15]. Moreover, an increased ATP
pool may also have beneficial effects on other processes, including thermo-tolerance
[12, 53]. This work thus confirms that insufficient ATP generation is a main bottle-
neck for cell growth under oxygen-limiting conditions.
The final design included three enzymes. The two newly introduced gene sets,
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pyrK-pyrD B encoding for class I dihydroorotate dehydrogenase and nrdD-nrdG en-
coding for class III ribonucleotide triphosphate reductase, recognized through the
in silico approach, proved effective upon introduction after multiple rounds of adap-
tive laboratory evolution pressure. This not only highlights the value of the in silico
approach, but also demonstrates the importance of design testing under micro-oxic
conditions to allow for strain adaptation. Together, these enzymes make up the
anaerobic version of the pathway for dNTP production, an essential pathway for
strain performance under anoxic conditions.
Combined they achieve the highest impact, although sole introduction of nrdD-
nrdG also enabled improved micro-oxic performance on its own. This suggests that
nrdD-nrdG is the main bottleneck of the two metabolic activities. The impact so far
does not compare to the implementation of ackA, since the aerobic homologs are still
present and functional. We believe that these newly recognized genes will prove to
be essential under fully anoxic conditions.
Altogether, this work provides insights into the non-linear process of transform-
ing a strict aerobic species into a facultative anaerobic bacterium.
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Pseudomonas putida KT2440 is a metabolically versatile, HV1-certified, genetically accessible,
and thus interesting microbial chassis for biotechnological applications. However, its obligate
aerobic nature hampers production of oxygen sensitive products and drives up costs in large
scale fermentation. The inability to perform anaerobic fermentation has been attributed to
insufficient ATP production and an inability to produce pyrimidines under these conditions.
Addressing these bottlenecks enabled growth under micro-oxic conditions, but does not lead
to growth or survival under anoxic conditions.
Here, a data-driven approach was used to develop a rational design for a P. putida KT2440
derivative strain capable of anaerobic respiration. To come to the design, data derived from a
genome comparison of 1628 Pseudomonas strains was combined with genome-scale metabolic
modelling simulations and a transcriptome dataset of 47 samples representing 14 environmen-
tal conditions from the facultative anaerobe Pseudomonas aeruginosa.
The results indicate that the implementation of anaerobic respiration in this species would re-
quire at least 61 additional genes of known function, 3 externally added vitamins, and through
guilt by association, 8 genes encoding proteins of unknown function.
Abstract
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Introduction
Pseudomonas putida KT2440 is a HV1-certified [1], genetically accessible [2–7] and
metabolically versatile [8–10] species, which makes it an interesting adaptable in-
dustrial workhorse. However, its strict aerobic lifestyle is an industrial disadvan-
tage [4, 11–14] as the strict requirement for dissolved O2 results in increasing costs
of large-scale cultivation and may lead to unstable production rates due to inade-
quate local oxygen supply due to oxygen fluctuations. Its strict aerobic nature also
excludes production of O2 sensitive enzymes and pathway intermediates as well as
the production of O2-sensitive products.
Most Pseudomonas species are facultative anaerobes and can use an inorganic
compound such as nitrate as alternate electron receptor. This includes species that
are closely related to the P. putida KT2440 strain, such as P. fluorescens and P. deni-
trificans. Only one Pseudomonas species is capable of anaerobic fermentation: Pseu-
domonas aeruginosa [15–18]. P. aeruginosa is capable of arginine fermentation and
pyruvate fermentation, although the latter only leads to prolonged survival under
anoxic conditions, not to growth [16–18].
The relatively short evolutionary distance between P. putida KT2440 and fac-
ultative anaerobic Pseudomonas species suggests that through the implementation
of a rational engineering cycle, this strain can be adapted to a facultative anaer-
obic lifestyle. In earlier work a Design, Build, Test, Learn engineering cycle [19]
was performed in an attempt to obtain an anaerobic fermentative P. putida KT2440
strain. Using genome metabolic models (GSMs) iJP962 and iJP746 combined with a
protein domain comparison analysis (PCA) between six aerobic Pseudomonas putida
strains including KT2440 and six facultative anaerobic Pseudomonas strains, three
key enzymes were selected and included in the final design: acetate kinase (encoded
by ackA), dihydroororotate dehydrogenase (nrdD-nrdG) and ribonucleotide triphos-
phate reductase class II (pyrK-pyrD B). This design was built and the resulting re-
combinant strain showed growth under micro-oxic conditions (Chapter 4, [20]). Ear-
lier work already described an increase in survival rates upon introduction of solely
acetate kinase [4, 12], and since the model predictions used in the design can only
consider either full oxic or full anoxic conditions, survival rates of the recombinant
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strains under anoxic conditions needs to be tested.
Here, we (i) analysed the survival rate of the recombinant strains under anoxic
conditions, (ii) identified limitations for anaerobic growth through respiration and,
(iii) composed a new design for a recombinant P. putida KT2440 capable of anaer-
obic respiration. In pursuit of this goal we expanded upon earlier work using the
current wealth of genome data available on P. putida and other Pseudomonas species
by inclusion of 1628 strains in an extensive comparative genome and domainome
analysis [21]. Transcriptome data of 151 clinical isolates of the facultative anaero-
bic Pseudomonas aeruginosa cultures grown in 14 different conditions [22] was also
taken into account and integrated with previous and newly obtained GSM simula-
tion results [4, 20].
Materials and methods
Bacterial strains and cultivation conditions
Bacterial strains and plasmids used can be found in Table S1. For plasmid construc-
tion see previous work [20]. E. coli CC118λpir was used for cloning procedures and
plasmid maintenance, and was routinely cultivated at 37◦C in aerated conditions in
LBmedium (containing 10 g/l tryptone, 10 g/l NaCl and 5 g/l yeast extract), option-
ally containing antibiotics for selection (50 µg/ml kanamycin or 50 µg/ml ampicillin
as indicated). For solid medium, 15 g/l agar was added to the medium. P. putida
KT2440 was routinely cultivated under oxic conditions at 30◦C in LB medium.
Experiments were performed in De Bont minimal medium (DBGA) [23] (3.88 g/l
K2HPO4, 1.63 g/l NaH2PO4 · 2H2O, 2.00 g/l (NH4)2SO4, 0.1 g/l MgCl2 ·6H2O, 10
mg/l EDTA, 2 mg/l ZnSO4 · 7H2O, 1 mg/l CaCl2 · 2H2O, 5 mg/l FeSO4 · 7H2O,
0.2 mg/l Na2MoO4 ·2H2O, 0.2 mg/l CuSO4 ·5H2O, 0.4 mg/l CoCl2 ·6H2O, 1 mg/l
MnCl2 ·2H2O), with 20 g/l gluconic acid as the sole carbon source. In previous
work, different carbon sources were tested for optimal performance [20]. Gluconic
acid was used for optimal growth by eliminating ATP consumption for substrate up-
take due to passive membrane transport. The medium was supplemented with 50
µg/ml kanamycin when indicated. Precultures were prepared aerobically overnight
(o/n) at 200 rpm at 30◦C.
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Anoxic survival experiment
Oxygen gradients served to allow the recombinant strains to grow in micro-oxic
conditions [20]. Anoxic cultivation of P. putida KT2440 recombinants unpassed or
passed over oxygen gradients was performed at 30◦C in 50 ml glass 20 mm alu-
minium crimp cap vials with rubber stoppers (Glasgerätebau Ochs laborfachhandel
e.K.) in 30 ml DeBont GA with 1 mg/l resazurin and with 50 µg/ml kanamycin
as selection marker for recombinant strains. Were indicated, a 1000x diluted vi-
tamin mix (vitmix) was added (0.02 g/l biotin, 0.2 g/l nicotinamide, 0.1 g/l p-
aminobenzoic acid, 0.2 g/l thiamin, 0.1 g/l panthotenic acid, 0.5 g/l pyridoxamine,
0.1 g/l cyanocobalamine, 0.1 g/l riboflavine). Before inoculation, the vials were gas
exchanged with CO2/N2. Inoculation was done with aerobically pre-cultured bacte-
rial sample at an OD600 of 0.05. Approx. 8 h after inoculation, the resazurin became
completely colourless, indicating full anaerobic conditions. Samples were taken us-
ing sterile CO2 flushed 1.5” Needles (BD Microlance) and 3-5 ml syringes (Ther-
moFisher) to avoid O2 exposure. Anoxic conditions were ensured as the resazurin
turned from colourless to bright pink within seconds in extracted samples. Survival
rates were analysed by colony forming units (CFU) determination. A dilution se-
ries was made and five drops of 10 µl per dilution were applied onto LB-agar plates
without selection marker, which were incubated o/n at 30◦C. Colonies were counted
manually, and photos were taken of the plates. Gram-staining was performed to
ensure culture purity, according to manufacturers’ instructions (gram-staining kit
Machery-Nagel, Germany).
Statistical analysis
The reported experiments were independently repeated six times with biological
triplicates in each separate experiment. Figures represent the mean values of corre-
sponding biological triplicates and the standard deviation. The level of significance
of the differences when comparing results was evaluated by means of analysis of
variance (ANOVA), with α=0.05.
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Genome annotation
The information of 16989 different Pseudomonas strains was obtained via the Gold
database [24]. Per species, extensive literature research was performed to elucidate
their aerobicity (Data S5). 1628 Different genomes of facultative anaerobic and strict
anaerobic strains from the Pseudomonas genus (Data S5) were obtained from the
EnsemblBacteria repository in March 2015 [25]. Metadata for all genomes obtained
are present in the GOLD database repository as of March 2018 [24] and were de-
novo annotated in SAPP [26] using Prodigal for gene prediction (version 2.6) [27],
2010] and with InterProScan version 5.4-47.0 [28] for functional annotation using
Pfam. A similar analysis was performed on earlier work in [21].
Protein domain architecture-based clustering
The positions (start and end on the protein sequence) of domains having InterPro/P-
fam [28] identifiers were used to extract domain architectures (i.e. combinations of
protein domains). Protein domains were retrieved for each protein individually [21].
Persistence and essentiality analysis
The persistence of a gene in a taxonomic group or group of genomes can be defined
as
Persistence =
N (orth)
N
where N (orth) is the number of genomes carrying a given ortholog and N is the
number of genomes considered [21]. For the set of 1628 considered genomes. Or-
thologous genes were identify through identity of protein domain architectures tak-
ing into account copy number. Resulting protein domain contents were analysed
through protein domain comparison (PDC).
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Feature selection using random forest
The random forest classification algorithm was used to classify the genome se-
quences in aerobic and facultative anaerobic species with the goal to identify the
domains (features) responsible for the separation in these two groups (feature selec-
tion). Three hundred randomly selected genomes from aerobic or anaerobic Pseu-
domonas species were selected to train random forest models. The process was re-
peated one hundred times. The resulting 100 different models were used to weigh
5831 protein domains from both aerobic and anaerobic Pseudomonas species. Vari-
able selection was used to identify the most influential domains for classification in
aerobic and facultative anaerobic strains, yielding 100 Gini coefficients, represent-
ing the importance of a protein domain for separation per domain. Gini coefficients
were combined into a cumulative Gini. The resulting protein domains were sepa-
rated into aerobic/anaerobic specific protein domains before further analysis.
Transcriptome data analysis
A publicly available P. aeruginosa transcriptome data set was retrieved from GEO
database (accession number GSE55197) [22]. This dataset contains 47 samples cor-
responding to 14 environmental conditions, including changes in growth temper-
ature, growth stage, osmolarity, concentration of ions in the media, and surface
attachment and anaerobic respiration. For every gene the log2 fold change of its
expression values was calculated in comparing every possible conditions with anaer-
obic respiration. Missing or infinity values arising from genes with very low counts
in some condition(s) were imputed to 0 or ± 4, according to the significance of the
differential expression (False discovery rate, fdr < 0.05). Normalization, fold change
computations and differential expression analysis were performed using the R pack-
age DESeq [29].
Genome-scale metabolic models
In this study we used the P. putida genome-scale metabolic models (GSMs) iJP962,
iJN746 and iJN1411 [3, 5, 30]. iJN1411 was obtained directly from the authors [30].
GSM simulations were performed as in [20].
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Results
Insertion of acetate kinase in P. putida KT2440 does not lead to extended
strain survival under anoxic conditions
Designs to obtain P. putida strains surviving anoxic conditions were conceptually
based on a lack of energy conservation and redox balancing [4, 11–14]. Expression
of the acetate kinase gene from P. aeruginosa and E. coli was reported to result in
extended survival under anoxic conditions [4, 12]. Expression of the acetate kinase
gene (ackA) from E. coli combined with class I dihydroorotate hydrogenase (pyrK-
pyrD B) and class III ribonucleotide triphosphate reductase (nrdD-nrdG) from L. lac-
tis successfully led to growth under micro-oxic conditions (Chapter 4, [20]).
To determine the tolerance of a P. putida KT2440 negative control carrying an
empty plasmid and the recombinant strain enriched with ackA, pyrK-pyrD B and
nrdD-nrdG to anoxic conditions and to analyse the effect of adaptation over oxy-
gen gradients performed earlier [20], a survival experiment of 18 days was per-
formed. After inoculation at a standardized cell density under oxic conditions,
the cultures were incubated overnight in capped gas-exchanged vials in oxygen-
depleted medium (see Materials and Methods). The survival rate was determined
by performing colony forming unit (CFU) counts at set time points over a period
of 18 days, with T0 being the start of the experiment in anoxic conditions (Figure
5.1, Figure 5.4). The results showed that in anoxic conditions there is no significant
difference in survival rates between the negative control and any of the recombinant
strains tested. Under these conditions, only the positive control, E. coli BW25113
harbouring an empty plasmid, survived.
A rational design of P. putida KT2440 capable of anaerobic respiration
The failure of the fermentative design [20] (Chapter 4) to grow under anoxic con-
ditions could be explained by the heavy reliance on the two state of art genome-
scale models (GSMs) used in this design, which currently do not include an accu-
rate representation of the complete redox balance and its intricate involvement in
the metabolism. Additionally, the analysis was performed using only a few strains
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Figure 5.1: Survival experiment of P. putida KT2440 under anoxic conditions Survival under
anoxic conditions was determined by comparing the number of colony forming units (CFU) over
time with the number of CFU at T0. Escherichia coli BW25113 was used as positive control.
Pseudomonas putida KT2440 with an empty plasmid (pS2213 -) was used as a negative control.
The tested strains were Pseudomonas putida KT2440 with acetate kinase (pS2213 ackA) unpassed
(p+0) or passed three consecutive times over oxygen gradients (p+3), and Pseudomonas putida
KT2440 with acetate kinase, dihydroororotate dehydrogenase and ribonucleotide triphosphate re-
ductase type II (pS2213 ackA-(pyrK-pyrD B)-(nrdD-nrdG) unpassed (p+0) or passed three consec-
utive times over oxygen gradients (p+3). Results were processed with a level significance evaluated
by analysis of variance (ANOVA), with α=0.05
while the protein domain comparison performed showed apparent differences be-
tween aerobic and anaerobic strains in availability of protein domains.
Many facultative anaerobic Pseudomonas species are incapable of anaerobic
fermentation, but rather perform anaerobic respiration. The close phylogenetic
distances between some of these facultative anaerobic Pseudomonas species and
P. putida KT2440 may suggest that acquiring a facultative anaerobic lifestyle via
anaerobic respiration would require less genetic changes. To come to a rational de-
sign of P. putida KT2440 capable of anaerobic respiration, the previous methods
were thus expanded upon by i) using significantly more facultative anaerobic and
aerobic Pseudomonas strains for domain analysis, ii) inclusion of iJN1411, a manu-
ally curated metabolic reconstruction of P. putida KT2440 [30] and iii) incorporation
of an elaborate transcriptome analysis of anaerobic respiration of 115 isolates of
P. aeruginosa grown under anoxic conditions compared to P. aeruginosa grown un-
der 13 other conditions [22]. Inclusion of transcriptome data shows gene regulation,
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Figure 5.2: Principal component analysis of 1628 Pseudomonas strains. Blue indicates facultative
anaerobic strains capable of respiration, red indicates aerobic species. (A) 2D Plot of PCA analy-
sis. (B) Complete dendrogram derived from PCA analysis. (C) Specific cluster from dendrogram
including P. putida KT2440, marked with black arrow. (D) Enlarged cluster containing P. putida
KT2440, indicated in purple and with a black arrow.
improving the design by complementing the genome based methods.
For the protein domain comparison genomic data from 1628 Pseudomonas
species was used. For each species oxygen requirements were determined via lit-
erature analysis. A principal component analysis was performed, creating a den-
drogram based the binary distance (gene domain presence/absence) of the principal
component analysis plot (Figure 5.2).
We assumed that domains essential for anaerobic respiration are highly persis-
tent in facultative anaerobic strains, but show a lower persistence in obligate aerobic
strains. The strategy to obtain this protein domain core is outlined in Figure 5.3. A
"long list" of anaerobic protein domains was generated by comparing domain per-
sistence between aerobic versus anaerobic strains. First a 95% persistence threshold
was applied, to obtain a "domain core" of present in at least 95% of the genomes of
"aerobic" strains and in the "anaerobic" strains analysed. These aerobic and anaero-
bic domain cores were used as input for subsequent comparative analysis and first
list split into "shared between aerobic and anaerobic species" (Shared domain core),
"specific for aerobic species" (Aerobe specific domain core) and "specific for anaer-
obic species" (Anaerobe specific domain core creating a long list of 427 anaerobe
specific protein domains. A second long list was created by the same input but
searching for the reverse, a separation based on domains with a very low persis-
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tency in aerobic or anaerobic strains. For this threshold of no more than 1% was
applied creating the second long list of 167 anaerobe specific protein domains. This
process was repeated with a 90% and a 1% persistence threshold for a "restricted
list", based on the early branch split between a large group of exclusively anaero-
bic Pseudomonas strains and a mixed group, including P. putida KT2440, containing
138 facultative anaerobic and 87 obligatory aerobic Pseudomonas strains (Figure 5.2
panel C).
The four different lists enriched in protein domains essential for anaerobic
growth were compared to each other and manually further annotated. Results are
summarized in Table 5.1 and Figure 5.3. The Random Forest analysis as described in
the Materials and Methods section was used to add weight to the generated protein
domain lists.
The transcriptomics data obtained [22] from 115 samples of P. aeruginosa grown
under 14 different conditions was filtered based on extreme (up- or downregulation
of ≥4 times in at least 3 of the conditions tested with all other conditions similarly
regulated) differential gene regulation in all conditions when compared to anoxic
growth. Differential regulation through all conditions versus all other conditions
was performed to identify a general stress response. Genome-scale models were
used to identify any reactions that could either directly or indirectly not function
without the presence of oxygen [20].
All results were annotated by hand and filtered based on function and associa-
tion. Domains of unknown function (DUFs) were filtered out unless an indirect link
with anaerobic respiration could be made through guilt by association. A compari-
son was made between all different lists obtained from the metabolic models, pro-
tein domains analysis, transcriptomics data and previous efforts [4, 11, 12, 20] (Table
5.1) towards a design for anaerobic respiration, resulting in an extensive overview
of the many hurdles that need to be overcome towards an P. putida KT2440 strain
capable of anaerobic respiration (Figure 5.3).
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Table 5.1: Number of unique protein domains obtained from each separate in
silico method
Method # Unique protein domains
Genome domain comparisons
Input aerobic domain core 1029
Input anaerobic domain core 1182
Long list, 1628 strains [95% threshold]
Shared domain core 755
Aerobe specific domain core 274
Anaerobe specific domain core 427
Long list [1% threshold]
Shared domain core 1015
Aerobe specific domain core 14
Anaerobe specific domain core 167
Restricted list, 225 strains [90% threshold]
Shared domain core 1012
Aerobe specific domain core 17
Anaerobe specific domain core 170
Restricted list [1% threshold]
Shared domain core 934
Aerobe specific domain core 95
Anaerobe specific domain core 248
Transcriptome analyses 175
GSM simulations 18
RandomForest [input] 5831
Domains with an accumulative influence ≥20 360
Domains with an accumulative influence ≥100 5
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Design Considerations
The protein domain analysis of 1628 genomes yielded 1012 protein domains present
only in anaerobic respiring Pseudomonas species (Figure 5.2, ES Data S6). Transcrip-
tion data [22] of 5831 genes tested in 15 different conditions (including anaerobic
respiration) yielded 87 upregulated genes and 85 downregulated genes (Figure 5.5,
ES Data S7). GSM simulations yielded 18 metabolic reactions directly or indirectly
requiring oxygen (ES Data S8) [20]. Lists were compared by evaluating the function
of each gene starting with the encoded domain annotation, checking for domain
co-existence in operonic structures and operon associated non-listed genes, compar-
ing metabolic functions with GSM data, and with gene regulation. The weight of
each protein domain was determined using the random forest analysis (Data S9). In
this way the list could be brought back to 69 genes and a supplement of 3 vitamins
to the medium that are deemed essential for P. putida KT2440 to enable anaerobic
respiration.
The selected genes can be separated into various categories based on their func-
tions: Nitrogen metabolism (49 domains in 37 genes), Hydrogenases (18 domains
in 16 genes), Cytochrome C (3 domains in 3 genes), Pyrimidine and amino acid
biosynthesis (4 domains in 2 genes, 3 vitamins added), ATP production (3 domains
in 3 genes), and Domains of Unknown Function (indirectly associated with anaero-
bic respiration) (8 domains).
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Nitrogen metabolism
Of the 61 known genes found vital for anaerobic respiration, 37 are either directly
or indirectly involved in nitrogen metabolism. With nitrate as the final electron
acceptor in anaerobic respiration, the largest amount of energy can be conserved as
opposed to other final electron acceptors such as sulfate, iron(III), manganese(II), or
selenate [31]. P. putida KT2440 lacks the nitrate/nitrite respiration pathway, which
was resolved in earlier studies [11] by inserting either a Nir-Nar or Nor plasmid.
This resulted in extended survival under anoxic conditions, but not growth. Our
transcriptomics and protein domain analysis indicated that the combination of both
the Nir-Nar and the Nor operon are required (Table 5.2). The operons include genes
required for energy conservation, cofactor biosynthesis, amino acid biosynthesis,
nitrogenmetabolism, nitrate, nitrite and nitrogen transporters, nitrate, nitrite, nitric
oxide and nitrous oxide reductases and several regulatory proteins (Table S3). Of
the 49 protein domains or 37 genes we identified within this category, only 15 genes
were previously found (narK1, narK2, narG, narH, NarJ, narI narX, narL, nirF, nirQ,
nirM, nirS, nirJ, nirL within Nir-Nar operon, norC, norB, norD, nosR within the Nor
operon) [11].
Previously unidentified genes include many transporters, and mechanisms to
tap indirect sources of nitrate or nitrite. Pseudomonas species capable of anaerobic
respiration apply these when nitrate or nitrite is scarce. Depending on the indus-
trial process, it might be interesting if the recombinant Pseudomonas putida KT2440
could tap from different nitrogen sources or even use electron acceptors besides ni-
trate and nitrite, such as sulfate. Numerous genes could aid in alternative nitrogen
sourcing. Only the genes which were found uniformly present in species capable of
anearobic respiration and strongly associated with those of the nitrogen metabolism
were included in the design.
Allantoicase (or allantoate amidinohydrolase) participates in purinemetabolism,
and facilitates the use of purines as secondary nitrogen sources under nitrogen-
limiting conditions, which results in the production of ammonia and carbon dioxide
using the uricolytic pathway, which is absent in P. putida [32]. A second example
of an enzyme required for sourcing secondary nitrogen sources is methylaspartate
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ammonia-lyase. This enzyme catalyses the second step of glutamate fermentation,
a process in which L-threo-3methylaspartate is converted to mesaconate and am-
monia. Ureohydrolases facilitate the ammonia to urea conversion, with urea as the
principle product of nitrogen excretion.
Table 5.2: Respiratory design of facultative anaerobic P. putida KT2440.
Genes to add for a P. putida KT2440 capable of anaerobic respiration
InterPro PFAM Name Abbreviation Function Source
Nitrogen metabolism (37)
PF00491 Ureohydrolases
Ammonia to urea conversion (principal
product of nitrogen excretion)
PDC
PF00491 Arginase ArgI
L-arginine + H2O
↔ L-ornithine + urea
PDC
PF00491 Agmatinase SpeB
Agmatine + H2O
↔ putrescine + urea
PDC
PF00491 Formimidoylglutaminase HutG
N-formimidoyl-L-glutamate + H2O
↔ L-glutamate + formamide
PDC
Proclavaminate
amidinohydrolase
Pah
Amidinoproclavaminate + H2O
↔ proclavaminate + urea
PDC
IPR015908 PF03561
allantoate + H2O↔
(S)-ureidoglycolate + urea
PDC, T
IPR015868 PF04960 Glutaminase
Glutamine + H2O
→ Glutamate + NH3
PDC, T
IPR000292 PF01226 Formate/nitrite transporter Transport of Formate/Nitrite PDC, T
IPR025736 PF13556
PucR C-terminal
helix-turn-helix domain
PucR-like transcriptional regulators PDC, T
IPR022665 PF05034
Methylaspartate ammonia-lyase
N-terminus
L-threo-3-methylaspartate
→mesaconate + NH3
PDC, T
IPR022662 PF07476
Methylaspartate ammonia-lyase
C-terminus
L-threo-3-methylaspartate
→mesaconate + NH3
PDC, T
IPR000825 PF01458
Uncharacterized
protein family (UPF0051)
Chaperone proteins for nitrogenase
production
PDC, T
NifS Metallocluster formation nitrogenase PDC, T
NifU Metallocluster formation nitrogenase PDC, T
IPR005346 PF03658 Ubiquitin RnfH family Electron transport PDC, T
PF02508 Rnf-Nqr subunit,
Nitrogen fixation
membrane protein
PDC, T
PF03116 Nqr2 family Nitrogen fixation PDC, T
RnfD family Nitrogen fixation PDC, T
RnfE family Nitrogen fixation PDC, T
PF03060 Nitronate monooxygenase Nitrogen metabolism PDC, T
IPR010349 PF06089 L-asparaginase II
L-asparagine + H2O
→ L-aspartate + NH3
PDC, T
PA3862 PF02423 DauB
NAD(P)H-dependent anabolic
L-arginine dehydrogenase
PDC, T, [11]
PA3863 PF01266 DauA DauBAR operon PDC, T, [11]
PA3864 PF08348 DauR
Transcriptional regulator
of the dauBAR operon
PDC, T, [11]
PF13309 PDC, T, [11]
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Table 5.2: Respiratory design of facultative anaerobic P. putida KT2440.
Genes to add for a P. putida KT2440 capable of anaerobic respiration
InterPro PFAM Name Abbreviation Function Source
PA14_13750 PF07690
Nitrite extrusion
protein (putative)
NarK2
Membrane proteins
Transport of small molecules
PDC, T, [11]
PA14_13770 PF07690 Nitrite extrusion protein NarK1
Membrane proteins
Transport of small molecules
PDC, T, [11]
PA3875 PF14710 NarG ATP generation PDC, T, [11]
PF00384 PDC, T, [11]
PF01568 PDC, T, [11]
PA14_13800 PF13247 Nitrate reductase NarH β-subunit, ATP generation PDC, T, [11]
PF14711 PDC, T, [11]
PA14_13810 PF02613 Nitrate reductase NarJ λ-chain, ATP generation PDC, T, [11]
PA14_13830 PF02665 Nitrate reductase NarI γ-chain, ATP generation PDC, T, [11]
PA3878 PF02518 Two-component sensor NarX Nitrogen metabolism PDC, T, [11]
PF00672 PDC, T, [11]
PF07730 PDC, T, [11]
PF13675 PDC, T, [11]
PA3879 PF00072 Response regulator NarL Two-component response regulator PDC, T, [11]
PF00196 PDC, T, [11]
PA14_13850 PF04055 Heme d1 biosynthesis protein NirJ Heme d1 biosynthesis PDC, T, [11]
PA0516 PF02239 Heme d1 biosynthesis protein NirF Heme d1 biosynthesis PDC, T, [11]
PA0514 Heme d1 biosynthesis protein NirL Heme d1 biosynthesis PDC, T, [11]
PA0520 PF07728 NirQ Regulatory protein PDC, T, [11]
PF08406 CbbQ
Post-translational activation
of Rubisco – photosynthesis
PDC, T, [11]
NorQ,
Post-translational activation
of Rubisco – photosynthesis
PA14_06750 PF13442 Nitrite reductase precursor NirM
Biosynthesis of cofactors, prosthetic
groups and carriers
PDC, T, [11]
PA3870 PF00994
Molybdopterin
biosynthetic protein A1
MoaA1
Biosynthesis of cofactors, prosthetic
groups and carriers
PDC, [11]
PF03453 PDC, [11]
PF03454 PDC, [11]
PA14_13260 PF00994
Molybdopterin
biosynthetic protein B1
MoaB1
Biosynthesis of cofactors, prosthetic
groups and carriers
PDC
PF00394 Multicopper oxidase PDC, T
PA0519 PF13442 Nitrate reductase NirS ATP generation PDC, T, [11]
Nitrate reductase NirS ATP generation PDC, T, [11]
PF02239 Nitrate reductase NirS ATP generation PDC, T, [11]
PF05940 NnrS protein PDC, T
NirK Reduction of nitrite to nitrous oxide PDC, T
Nor Reduction of nitrite to nitrous oxide PDC, T
PA14_06810 PF00034 Nitric-oxide reductase NorB-NorC Subunit B, C PDC, T, [11]
PA14_06830 PF00115 Nitric-oxide reductase NorB-NorC Subunit B, C PDC, T, [11]
PA14_06840 PF00092 NorD Putative dinitrification protein PDC, T, [11]
PA14_20230 PF04205 NosR Regulatory protein for N2O reductase PDC, T
T, Trancriptomics; PDC, Protein Domain Comparisons; GSM, Genome Scale Modelling; [27, 28]
Anaerobic Respiration
5
109
Hydrogenases
Included in the list are 16 hydrogenases. The redox state of the cell and the avail-
ability of O2 are regulatory signals in facultative anaerobic species [33]. [FeFe]- and
[NiFe]-hydrogenases are widely distributed under anaerobic species. These hydro-
genases are only produced under anoxic conditions, and most [NiFe]-hydrogenases
are inactivated by oxygen, only to be re-activated under reducing conditions [34].
Hydrogenases catalyse the reversible oxidation of molecular hydrogen, and thus
play a regulatory role and balance the redox state. Hydrogen oxidation is coupled to
the reduction of electron acceptors (such as oxygen, nitrate, sulphate, carbon diox-
ide and fumarate). P. putida KT2440 lack hydrogenases necessary for the reduction
of nitrogen compounds, and the necessary hydrogenase chaperones, assembly, mat-
uration and formation proteins (Table 5.3).
Of the 16 proteins vital for maintaining the redox balance in anaerobic condi-
tions only 2 have been found in previous work [11].
Table 5.3: Respiratory design of facultative anaerobic P. putida KT2440.
Genes to add for a P. putida KT2440 capable of anaerobic respiration
InterPro PFAM Name Abbreviation Function Source
Hydrogenases (16)
IPR027394 PF14720
NiFe/NiFeSe hydrogenase small subunit
C-terminal
Oxidation of molecular hydrogen PDC
IPR001501 PF00374 Nickel-dependent hydrogenase activation of hydrogen PDC
IPR006894 PF04809 Hydrogenase expression protein HupH
Hydrogenase synthesis,
C-terminal conserved region
PDC
IPR000671 PF01750 Hydrogenase maturation protease Hydrogenase maturation PDC
IPR002780 PF01924 Hydrogenase formation hypA family HypA-HypF Hydrogenase formation PDC, [34]
IPR000688 PF01155
Hydrogenase/urease
nickel incorporation
HypA
[Ni,Fe]-Hydrogenase and
urease metallochaperone
PDC, [34]
IPR010893 PF07449 Hydrogenase-1 expression protein HyaE Hydrogenase assembly PDC
IPR023994 PF11939
[NiFe]-Hydrogenase
assembly chaperone
HybE
[NiFe] Hydrogenases assembly
chaperones
PDC
PF13237 4Fe-4S dicluster domain Mediate electron transfer PDC
IPR007038 PF04955 HupE / UreJ protein
Hydrogenase / urease
accessory proteins.
PDC
PA0527 PF00027 Transcriptional regulator DNR Transcriptional regulators [11]
PF13545 [11]
T, Trancriptomics; PDC, Protein Domain Comparisons; GSM, Genome Scale Modelling; [27, 28]
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Cytochrome C
Included in the list are 3 C-type cytochromes. C-type cytochromes account for a
vital step in ATP bio-generation via the proton motive force (Table 5.4). Aero-
bically, the cytochrome BC1 complex requires oxygen as electron acceptor, yield-
ing H2O. Anaerobically, cytochrome C 551 (NirN), C 552 and cytochrome C oxi-
dase CBB 3 transfer electrons to nitrate reductase (NirS) and nitric-oxide reductase
(NorB-NorC). The importance of NirN andNirC (the precursor of NirN) was demon-
strated in [11]. In addition, cobalamin-independent methionine synthase is impor-
tant. This methionine synthase is a precursor of C 551 that can be produced without
using vitamin B12. This might be a key component for anaerobic growth, since both
the protein domain analysis and the GSM iJN1411 [30] predict that, amongst other
vitamins, the active form of vitamin B12 can only be bio-generated in the presence
of oxygen in P. putida KT2440.
The protein domain comparison analysis also indicates the need for cytochrome
C 552, and for cytochrome C oxidase CBB 3 and its maturation protein. The en-
zyme cytochrome C nitrite reductase (C 552) catalyses the six-electron reduction
of nitrite to nitrogen as one of the key steps in denitrification, Nitrogen is then re-
duced to ammonium in the nitrogen fixation pathway, where it participates in the
anaerobic energy metabolism of dissimilatory nitrate ammonification. If P. putida
KT2440 would be enriched with both the denitrification pathway and the nitrogen
fixation pathway it could reduce nitrate or nitrite to ammonium, which can then be
assimilated to organic compounds, transforming P. putida KT2440 in a diazotroph
of agronomical importance. Expression of cytochrome CBB 3 oxidase allows agro-
nomically important diazotrophs to sustain anaerobic respiration [35].
Table 5.4: Respiratory design of facultative anaerobic P. putida KT2440.
Genes to add for a P. putida KT2440 capable of anaerobic respiration
InterPro PFAM Name Abbreviation Function Source
Cytochrome-C (3)
IPR003321 PF02335 Cytochrome C 552
Proton motive force
cytochrome C
oxidase biogenesis
PDC
PA0517 PF13442 Probable C-type cytochrome precursor NirC Cofactor biosynthesis PDC, T, [11]
PA0521 PF00510 Probable cytochrome C oxidase subunit Proton motive force PDC, [11]
T, Trancriptomics; PDC, Protein Domain Comparisons; GSM, Genome Scale Modelling; [27, 28]
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Pyrimidine and amino acid biosynthesis
Included in the list are 2 genes involved in pyrimidine and amino acid synthesis,
and additional bottlenecks that can be solved by adding 3 vitamins to the medium.
Earlier GSM simulations with iJP962 indicated that alternate genes must be inserted
for dihydroorotate dehydrogenase and ribonucleotide triphosphate reductase type II
for pyrimidine and ultimately DNA and RNA biosynthesis [20]. Both the protein do-
main analysis and GSM simulations using the iJN1411 metabolic model predict that
cobalamin (vitamin B12), pyridoxal-5-phosphate (vitamin B6) and menaquinone
(vitamin K2) cannot be produced under anoxic conditions.
Crespo et al. showed that class II RNRs depend on adenosylcobalamin or vitamin
B12 (cobalamin) to generate its radical independently of oxygen [36]. Cobalamin is
an complex essential cofactor for many enzymes mediating methylation, reduction
and intramolecular rearrangements, and for methionine synthase. There is a recog-
nised distinction between aerobic and anaerobic generation of cobalamin [37, 38].
The routes differ in terms of cobalt chelation (via CobNST complex in the aerobic
pathway, via precorrin-2 with CbiK in the anaerobic pathway) and oxygen require-
ments. The enzymes CobI, CobG, CobJ, CobM, CobF, CobK, CobL, CobH, CobB
and CobNST form the aerobic pathway. CbiK, CbiL, CbiH, CbiF, CbiG, CbiD, CbiJ,
CbiET, CbiC and CbiA form the anaerobic route [28, 37, 39]. Surprisingly, the pro-
tein domain comparison yielded none of the enzymes of the anaerobic pathway for
Vitamin B12 synthesis, but instead CobT and CbtB, both described important for the
aerobic pathway. According to the extensive analysis, these specific protein domains
linked to these genes are not present in aerobic species analysed but only in anaero-
bic species. It was found that in the anaerobic bacterium E. limosum, CobT functions
as an activator for a range of lower ligand substrates including DMB, determining
cobamide diversity. The specific function of CbtB is unknown [37, 38].
Vitamin B6 is required for a wide variety of processes [40]. There are many
vitamin B6-dependent proteins involved in amino acid biosynthesis, amino acid
catabolism, antibacterial functions, ironmetabolism, carbonmetabolism, nucleotide
utilization, cofactors for biotin, folate and heme, NAD biosynthesis, cell wall
metabolism, tRNA modification, regulate gene expression and biofilm formation.
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Vitamin K2 is responsible for electron transport during anaerobic respiration.
However, knock-out experiments in E. coli showed that upon loss of menaquinone
and vitamin K1 only 3% of theorethical yield was obtained, but this was instantly
revived to 44% upon supplementing of vitamin K1 or vitamin K2 [41], indicating
vitamin K1 can partially make up for the loss of vitamin K2.
Rather than inserting all missing genes, in a minimal design setup, these vita-
mins can be supplemented to the medium (indicated in Table 5.5 with ∗). To de-
termine any immediate effect on growth or survival rates, vitamin supplementation
through the medium was tested, monitoring performance of all recombinant strains
under anoxic conditions. This was done parallel to a survival experiment without
vitamin mix added. No difference in growth rates or survival rates was found (Fig-
ure S4, Figure S5, Data S10, Data S11).
Table 5.5: Respiratory design of facultative anaerobic P. putida KT2440.
Genes to add for a P. putida KT2440 capable of anaerobic respiration
InterPro PFAM Name Abbreviation Function Source
Pyrimidine and amino acid synthesis (2)
IPR002751 PF01891
Cobalt uptake substrate-specific
transmembrane region
Vitamin B12 ∗ VitB12 biosynthesis PDC
IPR006538 PF06213 Cobalamin biosynthesis protein CobT VitB12 biosynthesis PDC
PF09489 Probable cobalt transporter subunit CbtB VitB12 biosynthesis PDC
PF10531 SLBB domain Vitamin B12 Vit B12 uptake PDC
Adenosylcobalamin Vitamin B12 Cofactor for enzymes and proteins GSM
PF02621 Menaquinone Vitamin K2 ∗ Electron transport PDC, [41]
Pyridoxal 5 phosphate Vitamin B6 ∗ Cofactor for proteins and enzymes GSM, [40]
Dihydroorotate dehydrogenase PyrK-PyrD B Pyrimidine biosynthesis GSM, [20]
Ribonucleotide triphosphate reductase
type II
NrdD-NrdG Pyrimidine biosynthesis GSM, [20]
T, Trancriptomics; PDC, Protein Domain Comparisons; GSM, Genome Scale Modelling; ∗ can be added as vitamin to medium; [27, 28]
ATP Generation
Of the 61 genes known genes required for anaerobic respiration, 3 are involved
in ATP generation. Both the protein domain analysis, transcriptomics data and
metabolic modelling with iJP962 and iJN1411 indicate that ATP production remains
one of the main bottlenecks to tackle. Earlier work has come to the same conclusion
and tackled this by insertion of genes for acetate production or ethanol production
[4, 12]. Our protein domain analysis has elucidated specific ATPases that only occur
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in anaerobic strains, providing an alternative to ATP production by fermentation
(Table 5.6).
Table 5.6: Respiratory design of facultative anaerobic P. putida KT2440.
Genes to add for a P. putida KT2440 capable of anaerobic respiration
InterPro PFAM Name Abbreviation Function Source
ATP Generation (3)
IPR002736 PF01874
ATP:dephospho-CoA
triphosphoribosyl transferase
Triphosphoribosyl-
dephospho-CoA production
GSM
IPR017557 PF10620
Phosphoribosyl-
dephospho-CoA transferase
MdcG
Triphosphoribosyl-
dephospho-CoA production
GSM
Acetate kinase AckA
ADP to ATP conversion by acetate
production
PDC, GSM, [20]
T, Trancriptomics; PDC, Protein Domain Comparisons; GSM, Genome Scale Modelling; [27, 28]
Domains of Unknown Function
The protein domains analysis resulted in 270 unique protein domains of unknown
function occurring in the genomes of anaerobic strains but not in aerobic strains.
Based on contextual information, 8 were identified as important for anaerobic respi-
ration. These were included in the design (Table 5.7). Similarly, 28 protein domains
of unknown function were associated with virology factors or immunity, and could
be excluded from the design. This leaves 244 protein domains of which the function
is unknown and which can thus not be completely excluded from this design.
Table 5.7: Respiratory design of facultative anaerobic P. putida KT2440.
Genes to add for a P. putida KT2440 capable of anaerobic respiration
InterPro PFAM Name Abbreviation Function Source
Domains of Unknown Function (8)
PF09086 Domain of unknown function DUF1924 PDC
IPR013039 PF07627 Domain of unknown function DUF1588 PDC
IPR013036 PF07626 Domain of unknown function DUF1587 PDC
IPR013042 PF07631 Domain of unknown function DUF1592 PDC
IPR013043 PF07637 Domain of unknown function DUF1595 PDC
IPR011727 PF09601 Domain of unknown function DUF2459 PDC
PF12981 Domain of unknown function DUF3865 PDC
PF02026 Domain of unknown function RyR domain PDC
T, Trancriptomics; PDC, Protein Domain Comparisons; GSM, Genome Scale Modelling; [27, 28]
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Discussion
No extended survival under anoxic conditions after acetate kinase
integration
The first rational design that was proposed [20] (Chapter 4) was based on two
genome-scale models and genome domain comparison analysis of six anaerobic
Pseudomonas species compared to six aerobic Pseudomonas putida species. Under
micro-oxic conditions, the addition of acetate kinase, dihydroorotate dehydrogenase
and class II ribonucleotide triphosphate reductase lead to growth. However, we did
not find that P. putida KT2440 could survive anoxic conditions when introducing
acetate kinase via a plasmid. The lack of improvement in survival rates can easily
be explained when contemplating the novel design assembled in this research, as
numerous factors such as an alternative electron acceptor or an anaerobically active
cytochrome-C is missing. However, earlier research did report an increase in sur-
vival rate in Pseudomonas putida under anoxic conditions upon plasmid integration
of acetate kinase alone [4, 12].
Sohn and colleagues tested P. putida with or without a plasmid carrying ackA.
They used conical vials with medium purged with nitrogen and kept under anaer-
obic conditions 2 days prior to incubation. The cells added were from an aerobic
overnight culture washed twice and transferred to the anaerobic chamber for incu-
bation. The bottles were sealed from gas exchange with nitrogen, which only re-
moves oxygen from the headspace, before incubation at 30◦C. They then performed
sampling with sterile needles every two days over a period of 8 days. Each sampling
was followed by recharging the bottles with nitrogen [4]. No additives were used to
remove oxygen from the medium, and oxygen concentrations in the medium were
not checked. No blanks or positive controls were reported.
Nikel and colleagues tested P. putida KT2440 with or without ackA or pdc-AdhB
[12]. They describe the use of modifiedM9mediumwith K2SO4 instead of NaCl and
yeast extract to supply additional vitamins. An oxic preculture was prepared up to
mid-exponential growth phase, after which the cells were washed and incubated
at 30◦C in Hungate tubes, filled up to 75%. Resazurin was added to monitor oxy-
gen levels only in the medium. Separate tubes were used for each sampling point to
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avoid oxygen leakage during sampling. Anoxic biotransformation experiments were
performed in separate commercial glass vials with teflon-stoppered metallic screw
caps. In screw-cap vials, headspace chromatography was used to verify anoxic con-
ditions only in the headspace. No blanks or positive controls were reported.
In our experiments, we have seen that both the medium and the headspace con-
tain much oxygen. Both must be treated to remove oxygen for anaerobic conditions
from the start of the experiment. If only one is treated, oxygen depletion takes up
to 12h. The medium can be prepared with L-cysteine or sodium thioglycollate to
remove oxygen and counter oxygen leakage. Medium without any supplements is
very easily oxygenated in case of an oxygen leak [20]. The headspace must be gas-
exchanged to remove oxygen. Resazurin staining indicates when levels drop below
a detectable level (determined with micro-electrode at 0.01 g/l dissolved oxygen, as
seen in previous work [20], chapter 4), but does not indicate micro-oxic levels of
oxygen. Using screw-caps on anaerobic vials, even though a wide applied method,
risks oxygen leakage. Oxygen leakage is clearly apparent in anaerobic experiments
as CFU count suddenly increases compared to the sampling time before. Addition-
ally, we flushed the sterile syringes used for sampling prior to sampling, to counter
oxygen leakage there. Repeating this method of testing six times over a longer period
of time (minimally 9 to maximally 31 days). None of the work mentioned applied a
blank or a positive control to verify their method.
We showed no extended survival of the strains upon introduction of ackA. Even
though only Sohn and colleagues and Nikel and colleagues performed this same
experiment, anoxic conditions prove so exact that to consider extended survival un-
der anoxic conditions all previous work should be re-evaluated. This proves it is
extremely challenging to acquire anoxic conditions.
The importance of the redox balance alone is shown when using bio-electrical
systems [13, 14, 42, 43], resulting in sustained metabolic activity and growth upon
the introduction of an external redox mediator under oxygen limiting conditions.
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Technical difficulties in building a design
Previous designs included between 3 and 24 genes that should be incorporated in
the P. putida KT2440 genome to enable an anaerobic lifestyle [4, 11, 12, 20], but
our in silico methods shows this to be almost at least three times that. Novel meth-
ods developed specifically for integration of large operons or multiple genes like
yTREX [44] allow incorporation of approximately 14 genes at one time in P. putida,
which are all incorporated in the Tn5 or Tn7 sites in the genome. The 65 genes
in our design are excluding 244 unknown genes, which complicate the task even
further. Considering the short evolutionary distance between the anaerobic and aer-
obic Pseudomonas species, this research shows that the evolutionary gap is larger
than expected.
The new design compared to previous designs
We elucidated that for anaerobic growth both Nir-Nor and Nar operons are vital.
Comparing this to the experimental work of Steen and colleagues [11], where the
nitrate operon or the nitrite operon was implemented. There do exist Pseudomonas
species that naturally have but one of these operons and are capable of nitrate to ni-
trite transformation, but these belong to the category “Aerobic nitrogen respiration”:
they are shown to be incapable of growth in anoxic conditions [45, 46]. Another el-
ement that has not been addressed before is cytochrome C552, identified as specific
for anaerobic respiration. Since it is well-known that energy production is already
a bottleneck in anaerobic growth [4, 11, 12], this might be one of the key proteins
missing from previous designs.
The most prevalent anaerobic dissimilatory nitrate respiration regulator DNR is
one of the key hydrogenases obtained from the protein domain comparison. In the
facultative anaerobic E. coli, knock-out mutants for dnr ortholog, fnr, were unable to
grow under anoxic conditions. By DNA microarray technology it was shown that in
E. coli 49% of the genes which differ in expression under anoxic and oxic conditions
are regulated by FNR [33]. The two-component aerobic respiratory control system
(ArcA and ArcB) control gene transcription in E. coli under anoxic conditions. Mu-
tations in this system are known to affect expression of over 30 operons. Most of
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these are repressed under anoxic conditions, but cytochrome d oxidase and pyru-
vate formate lyase are activated. In E. coli, ArcA and FNR are deemed essential for
anaerobic activation [47]. In an anaerobic respiratory design of P. putida KT2440,
it is debatable whether regulatory genes are required. We deem this advisable, in
order to maintain optimal functionality of this strain under oxic conditions next to
gaining the anaerobic respiration treat. These genes are thus included in the final
design.
We argue that for a lifestyle shift from a strict aerobic lifestyle in P. putida
KT2440 to an anaerobic respirative one, all these genes are required. However, an
increase of strain performance under micro-oxic conditions or prolonged survival
rates under anoxic conditions significantly improves strain robustness in large scale
bioreactors with fluctuating oxygen levels. Hence, each step towards an anaerobic
lifestyle may substantially ease processes in large scale bioreactors. For enhanced
performance under micro-oxic conditions, it was demonstrated that increasing ATP
production alone through acetate production is enough [20]. For prolonged survival
rates, however, these key elements include both Nir-Nar and Nor operons for den-
itrification and nitrogen fixation, cytochrome C 552, and external supplementation
of the lacking vitamins. This conclusion is supported by previous findings that en-
ergy supply and redox balancing are the main bottlenecks in an anaerobic lifestyle
[4, 11–14, 20].
The role of metals
Many of the genes found in the design are closely linked to metal transport, in-
cluding many hydrogenases and genes for pyrimidine and amino acid biosynthesis.
Before oxygen arose in the Earth’s atmosphere, oceans were saturated with metal
ions like manganese (Mn2+) and molybdenum (Mo6+), with soluble iron (Fe2+) be-
ing the most common. However, oxygen reacted with soluble Fe2+ to form insoluble
iron oxides as Fe3+, causing a drop in the bioavailability of Fe2+. The reverse oc-
curred with copper, which upon reacting with oxygen passed from insoluble Cu+ to
soluble Cu2+. In microorganisms, this change is still visible. Since early (anaerobic)
life was constrained to the use of Fe2+ in an anoxic environment, these bacteria have
had to adapt to avoid, adapt, detoxify or use Fe3+ or Cu2+ in a different way than
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aerobic bacteria, leading to main differences between an aerobic and an anaerobic
lifestyle. This is extensively reviewed [48]. This adaptation has had a substantial
impact on the regulation of the aerobic and anaerobic redox balance. Metal toxicity
is mainly caused by Cu2+, which is more toxic than Fe3+. Reasons for this can be
summarized as (i) Cu2+ has a higher capacity compared to Fe3+ to non-specifically
bind biomolecules and thus provokes higher oxidative damages, (ii) Cu2+ can cat-
alyze the conversion of Fe2+ to the more toxic Fe3+, and (iii) through a series of reac-
tions, Cu2+ causes the production of large quantities of radical OH. As strict aerobic
species are completely wired to resolve these toxicity problems and mainly use Cu2+
in their metabolism, a switch to anoxic conditions–and thus a switch to the bioavail-
ability of Fe2+ instead of Cu2+–poses serious problems, which so far have not been
addressed in an attempt to change the strict aerobic lifestyle to a facultative anaero-
bic one [4, 11, 12, 20]. Promising results obtained using electrode systems highlight
the importance of redox balancing under anoxic conditions [13, 14, 42].
Domains of unknown function are unexplored territory
A major bottleneck of the respiratory anaerobic respiration design could be hid-
den within the 270 DUFs resulting from the genome domain comparison. Without
knowing their exact function, these genes cannot entirely be excluded from the de-
sign. Eight of these are somehow associated with survival and/or growth in anoxic
conditions [28]. The possible importance of unknown genes was earlier found by
Hutchison and colleagues [49], who in their attempt to make a minimal bacterial
genome, unexpectedly found 149 genes with unknown biological function to be es-
sential for their cell to grow. However, of over 1000 unique genes of known function
initially deemed necessary for anaerobic respiration based on the combined in silico
methods, only 53 genes (roughly 6%)made it to the final selection based on function,
annotation and literature, so we can be confident that not all of the 270 unknown
DUFs will be vital for anaerobic growth. Future efforts could include more in silico
research of the DUFs found followed by systematically knocking out the DUFs in
anaerobic species to see if it hampers anaerobic respiration, proving their impor-
tance for the design.
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Conclusion
Increased ATP generation by insertion of acetate kinase via a plasmid does not lead
to prolonged survival rates of Pseudomonas putida KT2440 under anoxic conditions.
This proves that increased performance under micro-oxic conditions does not guar-
antee prolonged survival under anoxic conditions. A P. putida KT2440 strain capa-
ble of anaerobic respiration would require the insertion of at least 69 genes into the
genome and a supplement of 3 vitamins to the medium. The conversion of a strict
aerobic species to a facultative anaerobic lifestyle by anaerobic respiration is a much
more elaborate process than was thought before. The function of DUFs and their
role in anaerobic respiration must be researched.
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Supplementary data
Figure 5.4: Survival experiment of P. putida KT2440 under anoxic conditions. The CFU determi-
nation of Pseudomonas putida KT2440 with an empty plasmid (pS2213 -), acetate kinase (pS2213
ackA) or acetate kinase, dihydroororotate dehydrogenase and ribonucleotide triphosphate reduc-
tase type II (pS2213 ackA-(pyrK-pyrD B)-(nrdD-nrdG) unpassed (p+0) or passed three consecutive
times over oxygen gradients (p+3) survival under anoxic conditions. The experiment was repeated
independently six times. All figures share the same legend. (A) Experiment 1 (B) Experiment 2 (C)
Experiment 3 (D) Experiment 4
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Figure 5.5: Transcriptomics of Pseudomonas aeruginosa PA01 in 15 different conditions. (A)
Heatmap of up- (green) or downregulation (red) of all genes per condition. (B) All upregulated
genes per condition. (C) All downregulated genes per condition.
Figure 5.6: Survival experiment of P. putida KT2440 under anoxic conditions. The CFU determi-
nation of Pseudomonas putida KT2440 with an empty plasmid (pS2213 -), acetate kinase (pS2213
ackA) or acetate kinase, dihydroororotate dehydrogenase and ribonucleotide triphosphate reduc-
tase type II (pS2213 ackA-(pyrK-pyrD B)-(nrdD-nrdG) unpassed (p+0) or passed three consecutive
times over oxygen gradients (p+3) with or without vitamin mix.
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Figure 5.7: Growth experiment of P. putida KT2440 under anoxic conditions. The OD600 determi-
nation of Pseudomonas putida KT2440 with an empty plasmid (pS2213 -), acetate kinase (pS2213
ackA) or acetate kinase, dihydroororotate dehydrogenase and ribonucleotide triphosphate reduc-
tase type II (pS2213 ackA-(pyrK-pyrD B)-(nrdD-nrdG) unpassed (p+0) or passed three consecutive
times over oxygen gradients (p+3) with vitamin mix.
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The universally applied essential redox factor NAD+ is involved in internal signalling, defense,
detoxification, circadian regulation, chromosome segregation, aerotaxis, sporulation, biofilm
formation and dispersal. The redox homeostasis is often the first affected by internal and
environmental changes.
Previous work described the thermal stability of thermophilic L-aspartate oxidase; the main
bottleneck in the aspartate pathway for NAD+ biosynthesis.
We determined the effect of exchanging the L-aspartate oxidase gene in different mesophiles
for a thermophilic ortholog. In E. coli, the exchange results in a 10 times shorter lag phase
compared to a negative control when the growth temperature is shifted to 44◦C. In P. putida
the exponential growth phase becomes twice as steep compared to a positive control when the
growth temperature was shifted to 40◦C.
To determine how widespread the connection between NAD+ availability and thermo-
tolerance is, the mesophilic or thermophilic aspartate pathway was implemented in yeast,
which normally generates NAD+ via the kynurenine pathway. Not only was S. cerevisiae able to
use the aspartate pathway for NAD+ generation, but supplemented with the bacterial pathway
the strain proved more robust when grown at 41◦C.
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Introduction
Figure 6.1: Overview of different de novo
biosynthesis pathways of NAD+. Nicotinate-
nucleotide dephosphorylase (Bna6, eukaryotic)
or decarboxylating quinolinate phosphoribosyl-
transferase (nadC, prokaryotic), nicotinamide/ni-
cotinic acid mononucleotide adenylyltransferase
(Nma1,2, eukaryotic) or nicotinamide mononu-
cleotide synthetase (nadD, prokaryotic), and
NAD+ synthetase (Qns1, eukaryotic or nadE,
prokaryotic) overlap in function between eu- and
prokaryotes, respectively. In eukaryotes, NAD+ is
synthesizes in the mitochondria [1].
The redox homeostasis is universally
recognised as highly important in all
living organisms [2]. In response to
donor or acceptor availability, microor-
ganisms adjust their metabolism to bal-
ance their redox state. Alterations in
redox state often act as a primary sig-
nal for developmental or behavioural
changes, thus facilitating the survival
of the organism. Severe fluctuations in
the redox potential, both internally or
environmentally, are generally consid-
ered as stressors as they bring about
major shifts in gene expression, affect-
ing the metabolism and growth cycle,
in either the organism itself or the en-
tire population. Recent work in di-
verse microorganisms reveals that more
subtle changes act as signals, elicit-
ing responses in defence and detoxifi-
cation. Moreover, the redox balance has
a large influence on the circadian reg-
ulation and chromosome segregation,
aerotaxis, sporulation and social be-
haviours, including biofilm formation
and dispersal [3–5]. In redox homeosta-
sis, the widely available redox factor nicotinamide adenine dinucleotide, or NAD+,
plays a major role. NAD+ is an essential molecule in all living organisms. It func-
tions as an electron carrier or cofactor in redox reactions, and serves as a substrate
for the synthesis of cyclic ADP ribose or nicotinic acid adenine dinucleotide phos-
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phate.
NAD+ is generated de novo through the complex kynurenine pathway or the as-
partate pathway (Figure 6.1). In addition, NAD+ can be generated through salvage
pathways [1, 3, 4, 6–13]. Eukaryotes generate NAD+ mainly through the kynure-
nine pathway [14, 15], while most prokaryotes generate NAD+ through the aspar-
tate pathway [16, 17]. The kynurenine pathway and the aspartate pathway converge
in the last three steps, to make NAD+ from quinolinate.
This research will focus on the aspartate pathway (Figure 6.1). De novo biosyn-
thesis of NAD+ through the aspartate pathway proceeds through the condensation
reaction between L-aspartate and dihydroxyacetone phosphate, catalysed by the
quinolinate synthase system [18]. This proposed complex is composed of two en-
zymes: L-aspartate oxidase (NadB) which catalyses the oxidation of L-aspartate to
iminoaspartate using O2 as an electron receptor releasing H2O2 [19], and quinoli-
nate synthase, which condenses iminoaspartate with dihydroxyacetone phosphate
to produce quinolinate [20]. Despite the important role played by these enzymes in
NAD+ biogeneration, many of their biochemical and structural properties are still
largely unknown (Table 6.1). As the rate limiting step in this pathway, NadB will be
the focus of this research.
Table 6.1: Enzymes from the Aspartate pathway
Enzyme Full name Size Km Kcat Source
NadA Quinolinate synthase 38.24 kDa 0.08 mM 0.12 s−1 [20]
NadB L-aspartate oxidase 60 kDa 4.1 mM 32 min−1 [17]
NadC Quinolinic acid phosphoribosyltransferase 36 kDa 6.4 µM 0.6 s−1 [17]
NadD Nicotinic acid mononucleotide adenylyltransferase 24.5 kDa 1.5 mM 15 min−1 [17, 21]
NadE NAD synthase 30.24 kDa 0.6 mM 1.8 min−1 [17]
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We set out to elucidate the effect of aspartate oxidase in relation to NAD+ avail-
ability and external stress. As a stress factor, shifts in growth temperature were used.
The nadB from Escherichia coli, Pseudomonas putida, thermophilic Bacillus smithii or
mesophilic psychrophile Trichococcus flocculiformis were isolated and expressed via
a plasmid system in nadB knock-out strains of E. coli and P. putida. Growth exper-
iments were performed to test strain performance throughout temperature shifts
both in oxic and anoxic conditions and diauxic shifts. The bacterial aspartate path-
way of either P. putida, B. smithii or T. flocculiformis was also placed in the eukaryote
Saccharomyces cerevisiae to determine if growth was affected by a temperature shift.
Materials and methods
Strains, cultivation conditions and media
Bacterial strains used are listed in Table 6.2. E. coli DH5α was used for cloning pro-
cedures and plasmid maintenance, and was routinely cultivated at 37◦C under oxic
conditions in LB medium (containing 10 g/l tryptone, 10 g/l NaCl and 5 g/l yeast
extract), optionally containing antibiotics for selection (10 µg/ml chloramphenicol,
100 µg/ml ampicillin, 50 µg/ml kanamycin or 10 µg/ml gentamycin as indicated).
For solid medium, 15 g/l agar was added to the medium. E. coli BW25113 and KEIO
library strains JW2558, JW0733 and JW0105 were used for experiments. Experi-
ments with E. coli strains were performed in LB medium or in M9 minimal medium
(5x m9 minimal salts, 1MMgSO4, 1M CaCl2, Thiamin and 100x trace elements con-
taining (NH4)2SO4, 0.1 g/l MgCl2 ·6H2O, 10 mg/l EDTA, 2 mg/l ZnSO4 · 7H2O,
1 mg/l CaCl2 · 2H2O, 5 mg/l FeSO4 · 7H2O, 0.2 mg/l Na2MoO4 ·2H2O, 0.2 mg/l
CuSO4 ·5H2O, 0.4 mg/l CoCl2 ·6H2O, 1 mg/l MnCl2 ·2H2O), with 20 g/l glucose,
4 g/l L-asparate, or 10 g/l glycerol as sole carbon source as indicated. P. putida
KT2440 was routinely cultivated under oxic conditions at 30◦C in LB medium. Ex-
periments were performed in LB medium or in De Bont (DB) minimal medium [22]
(3.88 g/l K2HPO4, 1.63 g/l NaH2PO4 · 2H2O, 100x trace elements), with 20 g/l glu-
cose, 20 g/l acetate, 4 g/l L-aspartate, or 10 g/l glycerol as sole carbon source as
indicated. The medium was supplemented with 10 µg/ml gentamycin when indi-
cated. The optical cell density was analyzed photometrically at 600 nm (OD600).
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Precultures were prepared overnight at 200 rpm at 30◦C under oxic conditions.
Saccharomyces cerevisiae BY4741 was routinely cultivated under oxic conditions at
30◦C in YPD medium (10 g/l yeast extract, 20 g/l peptone and 20 g/l glucose). For
solid medium, 15 g/l agar was added to the medium. Experiments with S. cerevisiae
strains were performed in YNB medium (6.7 g/l Yeast Nitrogen Base w/o amino
acids, 30 mg/l leucine, 20 mg/l methionine and 20 mg/l histidine, 20 mg/l uracil
was added when wild type strain BY4741 without any plasmid needed to be culti-
vated). For solid medium, 20 g/l agar was added to the medium.
Table 6.2: Strains used in this study
Bacterial strains Relevant characteristics Optimal growth temperature Growth temperature range Source
Escherichia coli Gram-negative mesophile 37◦C 27− 44◦C
DH5α Cloning host; φ80lacZ∆M15 recA1
endA1 gyrA96 thi-1 hsdR17() supE44
relA1 deoR ∆(lacZYA-argF)U169
[11]
BW25113 lacIq rrNAT14 ∆lacZWJ16 hsdR514
∆araBADAH33 ∆rhaBADLD78
[12]–[14]
JW2558 BW25113 ∆nadB [23]
Pseudomonas putida Gram-negative mesophile 30◦C 25− 40◦C
KT2440 Wild-type strain, spontaneous restriction-
deficient derivative of strain mt-2 cured
of the TOL-plasmid pWW0
[24]
KT2440 ∆nadB KT2440 with a knocked out nadB gene This study
Bacillus smithii Gram-Positive motile, spore-forming, rod-
shaped, facultative anaerobic,
facultative thermophile
55◦C 25− 65◦C
DSM 4216T Wild type strain [25]
Trichococcus flocculiformis Gram-Positive cocci, facultatively anaerobic,
mesophilic psychrophile
25− 30◦C 4− 40◦C
Echt (DSM 2094) Wild type strain [26]
Yeast strain
Saccharomyces cerevisiae Mesophile 33◦C 3− 45◦C [27]
BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 [27]
Construction and transformation of plasmids
Plasmids used in this study are detailed in Table 6.2. For plasmids used in bacterial
strains, the SEVA plasmid collection was used [28]. DNA segments were amplified
by colony PCR using the Phire Green Hot Start II DNA Polymerase kit (Thermo
Fisher Scientific, Waltham, MA, USA), according to the manufacturers protocol.
Clones were regularly checked by colony PCR and sequencing. All primer oligonu-
cleotides used were purchased from Sigma-Aldrich Co. (ES Table 1). Restriction
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enzymes were obtained from NEB (New England BioLabs inc.). Using the Stan-
dardized SEVA plasmid system [28], the cargo was designed with BamHI and EcoRI
restriction sites on the 5’ end and 3’ end, respectively. DNA fragments were puri-
fied from agarose gel using the Machery-Nagel GmbH & Co. KG Gel Purification Kit
(Machery-Nagel GmbH & Co. Düren, Germany). Plasmid inserts were verified by
gel electrophoresis or DNA sequencing via Lightrun sequencing at GATC Biotech.
T4 DNA Ligase (Roche Applied Science Indianapolis, IN USA) was used to ligate the
isolated DNA fragments in the pSEVA 638 backbone.
The three plasmids constructed for use in yeast strains, pRV156, pRV157 and
pRV178 (ES Table S1, ES Data S2), were constructed using the Yeast ToolKit de-
scribed by Lee et al. [29], which is based on Golden Gate cloning. In short, the
nadABC genes from both P. putida and B. smithii were amplified from gDNA us-
ing the oligos indicated (ES Table S1). After cloning the individual genes in the
entry vector YTK001 with restriction enzyme BsmBI, gene cassette vectors were
constructed with restriction enzyme BsaI in which each gene was combined with
a promoter and terminator, both taken from the Yeast ToolKit. Each NadA gene was
cloned downstream of promoter pHHF2 and upstream of terminator tADH1, each
NadB gene was cloned downstream of promoter pTEF1 and upstream of termina-
tor tPGK1, each NadC gene was cloned upstream of promoter pTEF2 and upstream
of terminator tENO2. Finally, plasmids pRV156 containing NadABC (with their re-
spective promoters and terminators) from B. smithii and and pRV157 containing
NadABC (with their respective promoters and terminators) from P. putida were con-
structed by cloning them into a level 2 backbone plasmid with restriction enzyme
BsmBI. pRV178 was contructed by cloning a 44-bp spacer (CTCTAGAGTCGACCT-
GCAGGCATGCAAGCTTAGGAGGAAAAACA) into the same backbone as pRV156
and pRV157. All three plasmids were transformed to electrocompetent S. cerevisiae
BY4741 according to the method of Suga and colleagues [30, 31].
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Table 6.3: Plasmids used in this study
Plasmids for bacterial strains Characteristics Source
pGNW * Derivative of vector pEMG carrying p14g −→ msfGFP [32]
pSEVA 6213S * Helper plasmid; oriV(RK2), PEM7 −→ I-SceI, GmR [32]
pSEVA 638 * Expression vector, pBBR1, xylS-Pm, GmR [28, 33]
pSEVA 638 nadBEco * pSEVA 638 nadB E. coli BW25113 This study
pSEVA 638 nadBPpu * pSEVA 638 nadB P. putida KT2440 This study
pSEVA 638 nadBBsm * pSEVA 638 nadB B. smithii DSM 4216T This study
pSEVA 638 nadBTfl * pSEVA 638 nadB T. flocculiformis DSM 2094 This study
Plasmids for yeast strain
pRV178 URA3, 2-micron ori, 44 bp spacer This study
pRV156 pRV178 nadABC B. smithii DSM 4216T This study
pRV157 pRV178 nadABC P. putida KT2440 This study
* Plasmids that belong to the SEVA (Standard European Vector Architecture) collection [28, 33]
Knock-out generation
For E. coli knock-outs, the KEIO library strains were used and verified via genome se-
quencing. To generate P. putida KT2440 knock-out strains, the accelerated genome
engineering protocol from Wirth et al. was used [32]. The AMUSER tool was ap-
plied to design primers for amplification of ∼100 bp upstream and downstream of
the gene of interest. Via USER cloning, the homologous regions were amplified from
P. putida KT2440 gDNA and assembled into pGNW. The resulting plasmid was ac-
cumulated with DH5α-λpir cells before delivery in P. putida KT2440. Successful
co-integration of the pGNW plasmid was determined by fluorescence. The resulting
recombinant cells were transformed with pS6213S. Knock-out of the gene of interest
was determined by loss of fluorescence, PCR analysis and genome sequencing.
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Growth experiments
Plate-reader experiments were performed to monitor growth through cell den-
sity (OD600) at varying temperatures, in different types of media and in oxic or
anoxic conditions closely over periods of 24-72h. Recombinant E. coli or recom-
binant P. putida strains were precultured at 30◦C under oxic conditions on the same
medium as applied in the experiment. 96 Wells-plates were inoculated at a start-
ing OD of 0.05. As a control, wells were prepared with un-inoculated medium. The
plates were taped on the short sides to prevent condensation at higher temperatures.
Growth experiments with S. cerevisiae strains were conducted in glass test tubes
with a loose fitting cap to ensure presence of sufficient oxygen. Biological triplicates
of wild type and recombinant yeast strains were precultured at 30◦C with shaking
at 250 rpm in YNB medium. Glass test tubes with 3 ml medium were inoculated to
a cell density of 0.2 at 600 nm. Each replicate of each strain was inoculated in YNB
medium with and without 30 mg/ml aspartate. Cultures with both media were
inoculated at 30◦C and 41◦C with shaking at 250 rpm. Cell density was measured
every hour during the first 12 hours of incubation and then once 24 hours after start
of experiment.
Transcriptomics
Cultures of P. putida KT2440 wild type (positive control), P. putida KT2440 ∆nadB
P. putidaKT2440 ∆nadB p638 empty (negative control), and P. putidaKT2440 ∆nadB
p638 nadB from B. smithii were harvested at mid-exponential growth phase when
grown at 30◦C and at 40◦C. Harvested samples were washed with 0.9 % saline solu-
tion before they were flash-frozen at −80◦C. RNA Isolation was performed using a
Promega Maxwell machine, using the Maxwell 16 LEV SimplyRNA Purification tis-
sue kit, according to the manufacturer’s protocol. Quality control of isolated RNA
was done by gelelectrophoresis, and Qsep analysis. Concentration was determined
using a NoVix Fluorometer Spectrophotometer. Isolated RNA of high quality was
sent to Novogene for sequencing.
Illumina reads were trimmed for low quality and adapters with fastp (v0.20.0)
[34] using default settings. rRNA Sequences were removed with BBDuk(v38.35) [35]
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using the following parameters k=31 and ref=riboKmers.fa.gz. Transcripts from the
reference strain of Pseudomonas putida KT2440 (GCF_000007565.2_ASM756v2)
were quantified with Kallisto (v0.46.0)[36] with a bootstrap value of 100. In R [37]
transcript abundances were imported using the Bioconductor package tximportp
[38] for differential expression analysis. Differential expression analysis was per-
formed with DESeq2 [39] using the biological replicates for each condition. The sta-
tistical significance of gene expression differences was evaluated using an adjusted
P-value < 0.05 and log2 (fold change)| ≥ log2 (1.5) as a threshold. Graphs were made
using Microsoft Excel.
Statistical analysis
The plate-reader experiments were done using biological and technical triplicates.
Other growth experiments were conducted with biological triplicates. Figures rep-
resent the mean values of corresponding biological and, if applicable, technical trip-
licates and the standard deviation. Data was normalized by dividing all OD values
by OD at T0. The level of significance of the differences when comparing results was
evaluated by means of analysis of variance (ANOVA), with α=0.05. The growth rate
µ in the exponential phase between T4 and T7 in the yeast growth experiments was
calculated as
µ =
ln2
G
(6.1)
where
Generation time G =
7− 4
n
(6.2)
and
Number of generations n =
log10OD600T7 − log10OD600T4
log102
(6.3)
138
Results
Expression of thermophilic nadB increases the resilience to high
temperatures in mesophilic bacteria
A possible link between biogeneration of NAD+ through the aspartate pathway and
external stress was determined by focusing on the main pathway bottleneck, L-
aspartate oxidase (nadB), and exchanging this gene in mesophiles for the heterol-
ogous gene of thermophile B. smithii or psychrophile T. flocculiformis. Then, growth
was monitored through a shift in growth temperature to determine strain thermo-
tolerance. Thermo-tolerance is here defined as the temperature range at which a
micro-organism sustains normal growth.
To this end, a pSEVA 638 plasmid carrying either the L-aspartate oxidase gene
(nadB) from P. putida KT2440, E. coli BW25113, B. smithii DSM4216 or T. flocculi-
formis DSM 2094 was introduced in a P. putida KT2440 ∆nadB strain. A transfor-
mant with an empty plasmid was used as a negative control. The pSEVA 638 plas-
mid contains an inducible XylS-Pm promoter system, which when not induced with
3-methyl benzoate (3MB) results in basal expression levels of the genes (Figure 6.2),
and a high expression level when induced with 3MB (Figure 6.3). The performance
of the recombinant strains was monitored through a temperature shift from 30◦C to
40◦C. After grown overnight at 40◦C, performance was determined at 41◦C (Figure
6.2).
Overexpression of the recombinant genes by XylS-Pm induction with 3MB did
not improve strain performance at any temperature tested. When looking at basal
expression levels the replacement of the homologous gene with that of a bacterial
species with a higher optimum growth temperature, either mesophilic E. coli or ther-
mophilic B. smithii, caused the maximum growth rate to increase by a factor 2 when
shifting the growth temperature from 30◦C to 40◦C. From 0.0453 to 0.0943 (E. coli)
or 0.0922 (B. smithii). Isolation of the growing strains and increasing the temper-
ature by 1◦C to 41◦C also resulted in growth in the recombinant strains carrying
thermophilic nadB, as opposed to the positive control.
NAD+ Availability and Thermo-Tolerance
6
139
Figure 6.2: Growth experiment of P. putida at 40◦C (left) and 41◦C (right). Depicted are P. putida
KT2440 ∆nadB pS638 - (Purple circle), nadBPpu (Blue diamond), nadBEco (Green triangle),
nadBBsm (Orange circle), nadBTfl (Red square). Growth in wells was monitored over 21 hours
in a platereader. Blank wells with un-inoculated medium were used to correct for background emis-
sion.
Figure 6.3: Induction experiment. Recombinant strain performance of P. putida KT2440 ∆nadB
without induction (left) and with induction using 3-methyl benzoate (right). Depicted are P. putida
KT2440 ∆nadB pS638 - (Purple circle), nadBPpu (Blue diamond), nadBEco (Green triangle),
nadBBsm (Orange circle), nadBTfl (Red square). Growth in wells was monitored over 21 hours
in a platereader. Blank wells with un-inoculated medium were used to correct for background emis-
sion.
An overview of differentially expressed genes by thermophilic nadB
The assumption is that strains harbouring a thermophilic nadB gene exert their ef-
fect through an increased NAD+ availability. To find out which processes could
profit from the thermo-tolerance effect, duplicate samples of P. putida KT2440 wild
type, P. putida KT2440 ∆nadB p638 empty and P. putida KT2440 ∆nadB nadBBsm
were grown at either 30◦C or 40◦C and harvested mid-exponential phase. RNA was
isolated and used for RNA sequencing. An extensive comparative analysis was per-
formed (Figure 6.4).
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Figure 6.4: Schematic overview of comparisons made in the transcriptomics data. As a standard,
P. putida KT2440 wild type grown at its optimum growth temperature of 30◦C or P. putida KT2440
wild type grown at 40◦C was used. P. putida KT2440 ∆nadB served as the negative control, indi-
cating the genes whose expression was affected by nadB. In purple, the comparisons in expression
patterns made to determine gene expression affected by temperature is shown. In green, the compar-
isons in expression patterns made to determine gene expression affected by the recombinant ther-
mophilic nadB gene are indicated. A final list of all these comparisons was composed, after which
all similarly differentially expressed surrounding genes were sought out and sorted into operons.
All gene expression patterns were compared both against P. putida KT2440 wild
type grown at its optimum growth temperature of 30◦C, and at 40◦C. Of all 5565
predicted genes, 3304 had a significantly different expression (2log fold change
>0.5). Of these, 2854 genes encoded domains of unknown function, leaving 450
genes of known function with a significantly different expression pattern for further
analysis. First, genes whose expression were affected by nadB were filtered out by
comparing the gene expression patterns of P. putida KT2440 wild type and P. putida
KT2440 ∆nadB pS638 nadBBsm, both grown at 30◦C and at 40◦C, with P. putida
KT2440 ∆nadB. Next, the wild type gene expression pattern was compared to the
recombinant strain grown at the same temperature. This shows which genes are
affected by the change of nadB for that of the thermophilic gene from B. smithii.
Finally, all genes surrounding the genes of interest which were similarly regulated
were sorted into operons (Figure 6.4).
NAD+ Availability and Thermo-Tolerance
6
141
When analysing comparative transcription levels of the strain carrying the nadB
gene of thermophile Bacillus smithii versus P. putida KT2440 wild type grown at
30◦C or 40◦C, 90 genes of interest were found. Differential gene expression as a re-
sponse to the effects caused by the introduction of nadB from B. smithii compared to
the homogenous nadB can be divided into few categories. First, genes can be divided
to be upregulated (19), downregulated (34) or regulated according to temperature
(37) as a response to the effects caused by the recombinant nadB introduction, in-
creased temperature, or both. Second, the genes per main category can be placed
in functional categories: Electron transfer and redox balance (18), Catalytic activ-
ity (28), Regulatory (7), Transporters (14), Translation and transcription machinery
(8), Structural proteins (11), Amino acid degradation (2), and Arsenic resistance (2)
(Table 6.4).
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Figure 6.5: Schematic overview of significant differences in gene regulation between P. putida
KT2440 WT and P. putida KT2440 ∆nadB p638 nadBBsm, both grown at 30◦C (purple) or 40◦C
(orange). From top to bottom: genes regulated by NadB of Bacillus smithii specifically, regulated by
NadB in general, genes responding to temperature and genes responding to stress. Right shows the
difference in expression of nadB and nadB Bsm.
Function analysis of genes differentially expressed by thermophilic nadB
An extensive literature search was performed to elucidate the function of each gene
or operon of interest. Of the 90 genes of interest, 20 genes were identified as be-
ing of highest importance in gene regulation, caused specifically by the insertion of
nadB from Bacillus smithii and the expected resulting increase in the NAD+-pool. Of
these, 5 were downregulated, 4 were upregulated, and 11 were regulated accord-
ing to growth temperature. Out of the 20, 8 genes are part of 8 different operons.
The function of the genes of interest and the effect of their differential regulation is
outlined below.
NAD+ Availability and Thermo-Tolerance
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Electron transfer and redox balance
NAD-specific glutamate dehydrogenase (GdhB) is part of the arginine catabolism
pathway. Arginine is an important nutrient to P. putida [40]. This protein is reported
to be allosterically activated by NADP+, but is downregulated in the recombinant
strain. This could indicate a minor shift in the redox balance towards NAD+.
Highest upregulated is the iscU gene, part of the isc-operon. This operon regu-
lates the biological assembly of Fe-S clusters and their insertion into apo-proteins.
These clusters are important in electron transfer, redox and non-redox catalysis and
gene regulation [41]. IscU specifically functions as a scaffold for the assembly of an
Fe-S cluster prior to its delivery to apo-proteins. Additionally, two iron-storage cy-
tochrome systems, bacterioferritin (previously identified as cytochrome B1) and the
cycH/cmmABCDEFG operon (cytochrome C and protoheme), are downregulated;
the first at higher temperatures, the latter consistently. Release of cytochrome C is a
typical biochemical characteristic of apoptosis [42, 43]. The lesser degree of expres-
sion in the modified strains thus imply that there is less oxidative stress due to the
larger redox capacity.
Catalytic activity
The enzymes beta-ketothiolase (BktB), acetoacetyl-CoA reductase (Aacs) and PHA
synthase (PhaC) make up the metabolic pathway for polyhydroxyalkanoates (PHA)
synthesis. PHAs function for energy storage [44, 45]. In the recombinant strain, this
pathway is downregulated compared to the control strains, indicating more energy
is fuelled into survival and growth than in storage.
Quorum sensing is the intrabacterial communication system to determine pop-
ulation density via the secretion of small diffusible signal molecules called auto-
inducers. Interference with this system is an anti-bacterial defense mechanism,
also applied by non-quorum sensing strains. The protein QuiP degrades long-chain
auto-inducers, using them as growth substrate instead, and thereby quenches quo-
rum sensing [46]. In the recombinant strain, this gene is downregulated at 30◦C but
upregulated at 40◦C. This seems to indicate that bacterial defense mechanisms are
also upregulated at higher temperatures.
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Regulatory proteins
Analysing the genes that were affected by an increased NAD+ availability in general,
most remarkable was the upregulated expression of the small heat shock protein
IbpA, which adds to the explanation of the thermo-tolerance effect observed.
The RibC operon and the THI operon for riboflavin (vitamin B2) and thiamine
pyrophosphate (vitamin B1) synthesis respectively, [47, 48], are upregulated upon
B. smithii nadB expression. Increased production of these important regulators and
growth factors also adds to the explanation for improved growth of the modified
strains under increased stress levels.
Transport
Genes from the Dpp operon, encoding for binding-protein-dependent ABC trans-
porters for dipeptides were downregulated upon expression of nadB from B.smithii.
This superfamily of transporters mediate the overall nutrient uptake capacity [49].
Overall, at higher temperatures (and thus higher stress levels), these genes are up-
regulated, which could mean the cells increase expression of transporters since they
require more nutrients for more energy to deal with stress.
Transcription and translation machinery
Multiple genes required for the transcription and translationmachinery were upreg-
ulated in the recombinant strain at higher temperatures. These genes include RNA
polymerase RpoE, nucleotide biosynthesis operon Pur (PurM, PurL), translation-
dependent operon regulators YoeB toxin-YefM antitoxin system for cleavage of
translated mRNA, and ligases proline-tRNA ligase ProS and methionine-tRNA lig-
ase metG to generate amino acid specific tRNAs [50, 51]. Another gene related to
cell division is dacA coding for D-alanyl-D-alanine carboxypeptidase, which is re-
quired for trimming D-alanyl residues from the carboxy terminal of peptidoglycan
pentapeptides [45]. Expression of this particular gene is upregulated in the recom-
binant P. putida strain at 40◦C but repressed at low temperatures (30◦C), indicating
a more active cell division machinery at raised temperatures. Similarly regulated
is the trans-membrane transporter of α-ketoglutarate and protons, α-ketoglutarate
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permease (kgtP) [52]. α-Ketoglutarate is a source of glutamate and glutamine in the
Krebs cycle that stimulates protein synthesis and inhibits protein degradation.
Structural proteins
There are many structural components specifically reacting to the expression of
nadB from B. smithii. Solvent tolerance protein TrgI was downregulated. TrgI
was found to be downregulated in response to solvent stress induced with toluene
[53]. When TrgI is knocked out, solvent tolerance is significantly increased in
P. putida S12. Although its exact function is unknown, the results obtained by Volk-
ers et al. indicate that TrgI positively affects membrane stability, which is an im-
portant trait in temperature resistance [53]. Membrane stability proteins from the
Tol operon are upregulated, which explains the increased robustness of the strain
to external stress. Similarly, the acyl carrier protein AcpP is upregulated in the re-
combinant strain. AcpP is a key component for fatty acid biosynthesis, required for
the formation of membranes. This component carries fatty acyl intermediates by
different enzyme active sites [54].
Similarly, genes from the FLI operon for flagelli bioformation are downregulated
in the recombinant strain compared to the wild type. This indicates a shift from
energy sources; the 31-gene large operon for flagelli biogenesis is energy expensive,
and this energy is redirected towardsmaintenance, growth and stress-tolerance. Ad-
ditionally, flagelli influence the membrane integrity of a cell. Less flagelli could
indicate a more stable membrane.
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The universal link between NAD+ availability and thermo-tolerance
To see if the observed effect of increased thermo-tolerance at higher temperatures
caused by exchange of nadB for a thermophilic heterolog is not specific for Pseu-
domonas putida, a nadB knock-out of E. coli JW2558 was tested using the same plas-
mids and methods as P. putida KT2440 ∆nadB. This was done by reinserting a ther-
mophilic nadB gene from B. smithii DSM 4216 via pSEVA plasmid 638 into a nadB
knock-out strain of the E. coli KEIO library, E. coli JW2558. As a control, an empty
pSEVA 638
Figure 6.6: Growth experiment under anoxic conditions at 37◦C, in LB medium (left) or DBG
minimal medium (right). Depicted are E. coli BW25113 WT, (Lilac stripe) E. coli JW2558 ∆nadB
pS638 - (Purple circle), nadBPpu (Blue diamond), nadBEco (Green triangle), nadBBsm (Yellow
circle), nadBTfl (Orange circle). Growth in a platereader was monitored over 13 hours. Blank wells
with uninoculated medium were used to correct for background emission.
plasmid or pSEVA 638 with endogenous nadB from E. coli BW25113, and nadB
from the mesophile P. putida KT2440 were tested in the E. coli knock-out strain.
Growth rates of recombinant strains through temperature shifts were monitored by
platereader experiments monitoring the increase in cell density over time. Already
at ideal growth temperature 37◦C, a benefit can be observed from the nadB from
B. smithii (Figure 6.6). When grown under anoxic conditions, this benefit is lost: no
significant difference between strains can be observed. When shifting the growth
temperature from 37◦C to 44◦C, the replacement of the inherent gene by the ther-
mophilic B. smithii nadB in E. coli results in a 10 times shorter lag phase compared
to a wild type positive control (Figure 6.7).
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Figure 6.7: Growth experiment of E. coli JW2558 at 44◦C (left) and 45◦C (right). Depicted are
E. coli BW25113 WT (Light Purple), E. coli JW2558 ∆nadB pS638 - (Dark Purple), nadBPpu
(Blue), nadBEco (Green), nadBBsm (Orange). Growth in flasks was monitored over 60 hours and
30 hours, respectively. Blank wells with uninoculated medium were used to correct for background
emission.
A larger NAD+ pool in yeast increases thermo-tolerance
So far, the thermo-tolerance effect has been observed in prokaryotes which have
the aspartate pathway for NAD+ biogeneration. Eukaryotic Saccharomyces cere-
visiae generates NAD+ through the kynurenine pathway. If the increase in thermo-
tolerance in bacteria is indeed caused by the resolution of the main bottleneck
(nadB), resulting in an increased availability of NAD+, this effect should also oc-
cur in an organism that has the kynurenine pathway. To this end, the prokaryotic
biosynthesis genes were expressed on a plasmid in S. cerevisiae BY4741. This re-
sulted in a yeast strain expressing both its inherent kynurenine pathway and the
bacterial aspartate pathway for NAD+ biogeneration (Figure 6.1).
Growth of the wildtype strain and three strains harbouring either NadABC from
P. putida or B. smithii or an empty plasmid was monitored at 30◦C and 41◦C in YNB
minimal medium, YNB supplemented with aspartate, which is the substrate of the
prokaryotic NAD+ biosynthesis pathway, or YNB supplemented with tryptophan,
which is the substrate of the native yeast NAD+ biosynthesis pathway (Figures 6.8
and 6.9, Data S1).
While the growth rates of the wild type strain and the empty plasmid strain
(pRV178) are similar, the pRV178 strain grows to a higher cell density from 7 hours
onwards at 30◦C (Figure 6.8 left and Suppl Data). This effect is most likely caused by
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the difference between the concentration of uracil in the medium that the wild type
grows in and the amount of uracil that is produced by the pRV178 strain through
the URA3 gene that is present on the plasmid. Culturing in YNB medium supple-
mented with aspartate leads to a higher cell density in pRV157 than in wildtype or
pRV156, compared to culturing in YNB medium and YNB medium supplemented
with aspartate (Figure 6.8 middle and right). In medium with tryptophan, pRV156
ends with a higher cell density then pRV157 or wild type.
At 41◦C in YNB medium all three strains with plasmids perform better with re-
spect to cell density and growth rate than the wild type, especially pRV157 (NadABC
from P. putida) and pRV178 (Figure 6.9 left). This is most likely caused by the effect
of uracil that is also seen in the empty plasmid strain at 30◦C. Supplementation with
either aspartate or tryptophan does not influence growth of the wild type strain at
41◦C (Figure 6.9 middle and right).
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Figure 6.8: Saccharomyces cerevisiae at 30◦C. From left to right YNB medium, YNB + Aspartate
medium and YNB + Tryptophan medium. Depicted are S. cerevisiae BY4741WT (Orange triangle),
pRV156 empty plasmid (Yellow circle), pRV156 nadABC Bsm (Green square), pRV157 nadABC
Ppu (Blue diamond). Growth in glass test tubes was monitored for 24 hours. Test tubes with
uninoculated medium were used to correct for background emission.
Figure 6.9: Saccharomyces cerevisiae at 41◦C. From left to right YNB medium, YNB + Aspartate
medium and YNB + Tryptophan medium. Depicted are S. cerevisiae BY4741WT (Orange triangle),
pRV156 empty plasmid (Yellow circle), pRV156 nadABC Bsm (Green square), pRV157 nadABC
Ppu (Blue diamond). Growth in glass test tubes was monitored for 24 hours. Test tubes with
uninoculated medium were used to correct for background emission.
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Remarkably, yeast expressing NadABC from either B. smithii or P. putida cul-
tured in the presence of aspartate or tryptophan (both strains) or YNB (P. putida
genes) performed the best at the high temperature of 41◦C, compared to the empty
plasmid strain. This indicates that indeed a higher availability of NAD+ at elevated
temperatures causes thermo-tolerance in yeast. The NadABC genes from P. putida
perform better in yeast than the genes from B. smithii, since they do not need sup-
plementation of aspartate in order to have an effect on growth.
All plasmid-bearing strains grow to higher cell densities in asparate and trypto-
phan medium than the wildtype. Next to that, it seems that supplementation of the
medium with tryptophan negatively influences cell density and in some cases also
growth rate, in all strains except strain pRV156, compared to YNB.
Discussion
A link between NAD+ availability and thermo-tolerance
The focus of this work was NAD+ biogeneration through the aspartate pathway.
In general, bacteria have the aspartate pathway, and complex eukaryotes generate
NAD+ through the kynurenine pathway. However, this is not universally correct:
there are both bacterial species which apply the kynurenine pathway and eukaryotic
species which apply the aspartate pathway. In this research, the aspartate pathway
was enhanced and added in yeast which inherently uses the kynurenine pathway to
determine if the effect observed between NAD+ availability and thermo-tolerance is
universal. Although the effect does indeed occur in both bacteria which apply the
aspartate pathway and in yeast which is forced to employ the kynurenine pathway
or the aspartate pathway, the explanation for this effect may vary between pathways
and species.
It was briefly mentioned that the link between NAD+ availability and ROS ac-
cumulation in temperature stress is considered the main cause for this effect. This
hypothesis is supported by the observation that the thermo-tolerance effect does not
occur when the experiment is performed under anoxic conditions. It also explains
that upon testing this effect in prokaryotes through the aspartate pathway and in eu-
karyotes via both an inserted aspartate pathway and the inherent kynurenine path-
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way, the thermo-tolerance effect is maintained. Other methods to enlarge NAD(P)+
availability are thus expected to have a similar effect on the thermo-tolerance of a
species.
Does thermophilic L-aspartate oxidase increase the NAD+ pool?
In this study, a connection was determined between the exchange ofmesophilic nadB
for thermophilic nadB and thermo-tolerance. The extent and limitations of this ef-
fect were examined.
All genes were expressed via the pSEVA 638 plasmid, carrying a XylS-Pm in-
ducible promoter system. Only when not induced with 3-methyl benzoate (3MB),
thermo-tolerance was improved in recombinant P. putida or E. coli strains (Figures
6.2, 6.3). Induction with 3MB did not improve strain performance at any temper-
ature tested. The lack of thermo-tolerance upon promoter induction suggests that
there is a balance present between the benefit obtained through transcription of
nadB and the plasmid burden. In other words: the NAD+/ATP balance is precari-
ous. Due to the low basal expression of the XylS-Pm promoter compared to other
inducible systems, this system has been applied extensively in both applied and fun-
damental research. Basal expression dramatically increases with the copy number
if the regulatory elements are plasmid-borne, ranging from ∼10-fold in a medium
copy plasmid to ∼100-fold low copy plasmid in E. coli with oriV (RK2), and 20 ±10
with oriV (RK2) or 30 ±7 with oriV pBBR1 in P. putida [55–59]. In this case, the un-
induced XylS-Pm system appears to offer basal expression levels, which transcribe
exactly the right amount of nadB to improve the NAD+ biogeneration pathway.
The recombinant P. putida KT2440 strain carrying nadB from B. smithii via the
pSEVA 638 plasmid was able to grow at 41◦C. However, this growth was only mi-
nor. This indicates that although the thermo-tolerance of the recombinant P. putida
KT2440 is improved at higher temperature, 41◦C is a hard physiological constraint.
Similarly, in the recombinant S. cerevisiae strains 42◦C proved a physiological con-
straint (Suppl Data). This suggests that nadB and the presumed NAD+ availability
linked to it is the main bottleneck towards growth at high temperatures, but as ex-
pected, not the only one.
The improvement of thermo-tolerance in yeast upon introduction of the aspar-
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tate pathway in addition to its kynurenine pathway for NAD+ biogeneration sup-
ports the claim that in eukaryotes thermophilic nadB increases the NAD+ pool which
causes the thermo-tolerance. The yeast strain harbouring nadABC from P. putida
grows better at 41◦C in all media and at 30◦C in medium with aspartate. This sug-
gests that the P. putida KT2440 genes function well in yeast compared to those of
B. smithii DSM 4216T and that they are very well able to convert aspartate into
NAD+ promoting growth.
What should be considered is that the kynurenine pathway and the aspartate
pathway converge at quinolinate phosphoribosyl transferase: NadC in the aspartate
pathway, Bna6 in the kynurenine pathway. Some level of cross-functionality can
not be excluded. However, since NadC and Bna6 both are no bottlenecks in their
respective pathways (Table 6.1), [17, 60], any effect of cross-functionality would be
unexpected.
The addition of tryptophan in the yeast strain had a negative effect on growth
rates at higher temperatures. This could be explained by results obtained in earlier
research by Jarolim et al. [61], who found improved survival of S. cerevisiae through
heat shocks in the absence of tryptophan. This might indicate that the presence of
tryptophan suppresses the heat shock resistance or stress survival response in yeast.
When the recombinant yeast strain has the aspartate pathway of B. smithii, either
aspartate or tryptophan are required to improve growth over the empty plasmid
control, while this is not required when the pathway of P. putida is implemented.
Reasons for this are unknown, but it is expected that the B. smithii pathway does
not function as well in yeast due to structural differences of the proteins. Additional
substrate feeding into the pathway (either aspartate for the aspartate pathway or
tryptophan for the inherent kynurenine pathway) supposedly increases the NAD+
pool insofar the plasmid burden can be overcome.
Based on the assumption that due to the thermophilic nadB there is an increase
in NAD+ at higher temperatures, the loss of effect under anoxic conditions can also
be explained. The availability of NAD+ combats the formation of reactive oxygen
species (ROS). In plants, a close association has been discerned between ROS and the
heat stress-response signal transduction pathways and defense mechanisms [62]. In
fact, several studies have linked heat shock transcription factors with ROS sensing
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[63, 64]. The growth experiments under anoxic conditions prove that the thermo-
tolerance effect that occurs upon introduction of a thermophilic nadB is lost when
repeating the temperature shift without oxygen presence. This could mean that,
similarly to seen in plants, an indirect increase of the NAD+ upon better perfor-
mance of nadB inhibits the buildup of ROS due to temperature stress.
To determine what exactly causes the thermo-tolerance, RNA sequencing was
performed. When looking at gene expression patterns, we found that 90 genes
were differentially expressed due to the effects caused by the exchange of nadB from
B. smithii for the homogeneous nadB. The genes most influenced by this exchange
are involved in iron cluster assembly. Iron is essential to maintain the redox balance
during the growth of animals, plants and most microorganisms. However, when
grown aerobically, iron can pose problems of bioavailability and cytotoxicity. Iron
reacts with oxygen, generating toxic free radical. In its oxidised state, it is relatively
insoluble. Bacteria overcame this problem with specific mechanisms for iron uptake
mechanisms and creating iron storage, which allow growth in an iron-deficient en-
vironment [65]. Downregulation of the storage mechanism but upregulation of the
uptake mechanism as a response to the effects caused by introduction of nadB from
B. smithii at higher temperatures is thus closely linked to oxidative stress, although
its specific role remains controversial.
An overall upregulation of a heat shock protein was observed when NAD+ avail-
ability is increased. Furthermore, the nadB gene from B. smithii appears to have
a strong regulatory effect from rerouting energy from demanding processes such
as flagelli biosynthesis and energy storage to stimulate cellular growth, to regu-
lating important factors affecting the redox balance. All together, 19 genes were
linked to the specific presence of nadB from B. smithii, and all help explain the
thermo-tolerance effect observed. It is difficult to indicate which genes are cause
and which are effect of the thermo-tolerance in this complex system. Are the genes
for the transcription/translation machinery upregulated because it grows better, or
do they cause it to grow better? More research could aid towards pinpointing the
exact pipeline of cause and effect.
Alternative pathways to generate NAD+ are via the salvage pathway, or the pro-
duction of lactate. Through these alternative pathways, the nadB knock-out negative
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control strain is still viable. Metabolic increase in use in these pathways would be
recognisable by an upregulation of vital enzymes of these pathways, such as nicoti-
nate phosphoribosyltransferase (PncB) for the salvage pathway [66] or lactate dehy-
drogenase (ldhA) for lactate production. Transcriptomics data does not reflect any
upregulation of these genes, including in the negative control, which reflects the
poor growth observed in this strain overall.
As the rate limiting step in the aspartate pathway for de novo NAD+ synthesis
(Table 6.1, [17, 20, 21]), the large impact gained by replacement of nadB can be
explained. Noteably, however, multiple adaptive laboratory evolution (ALE) exper-
iments based on temperature tolerance have not resulted in the adaptation of this
single gene [67]. In fact: nadB has never before been identified in thermo-tolerance.
Conclusion
An increased thermo-tolerance is a widely sought-after goal in industry. In microor-
ganisms, more stability at higher temperatures means less costs during fermentation
due to less need for cooling, a higher product yield since the micro-organism can
better handle temperature fluctuations occurring at large scales, and it opens up the
possibility to apply thermophilic enzymes in mesophilic species.
The NAD+ biogeneration pathway is one of the main bottlenecks for thermosta-
bility. Prokaryotes and eukaryotes can gain a higher thermo-tolerance upon enlarg-
ing the NAD+ pool, either by the introduction of additional pathways to overpro-
duce NAD+ or by introduction of thermophilic enzymes which function better at
higher temperatures.
The connection between NAD+ availability and thermo-tolerance could be ex-
plained upon transcriptomics analysis, which showed that upon a larger availability
the heat shock protein IbpA is upregulated. Furthermore, specifically upon expres-
sion of nadB from B. smithii, it was observed that this L-aspartate oxidase enzyme
has a regulatory role, as it redirects energy from demanding non-essential purposes
like flagelli biogeneration towards cellular growth by activating the transcription
and translation machinery, it works to stabilize the cellular membrane and it largely
affects the redox balance. This finding was patented (Appendix).
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Appendix: PCT/EP2019/080645 Microbial Hosts engineered for
Increased Tolerance to Temperature Shifts
Linde F. C. Kampers, Rita J. M. Volkers
Peter J. Schaap, Vitor A. P. Martins dos Santos
The presented invention relates to the field of molecular microbiology, metabolic
engineering, and fermentation technology. In particular, the invention relates to mi-
crobial host cells that have been engineered for increased tolerance to temperature
shifts, for increased performance at temperatures different from themicroorganisms
optimal temperature and/or for changing at least one of the microorganisms cardi-
nal temperatures by replacing an endogenous NAD+ biosynthesis gene by a heterol-
ogous gene encoding a corresponding enzyme with another temperature profile.
Introduction
Mesophiles are the preferred organisms for industry. They are genetically accessible,
easy to culture, and have established methods to adapt the metabolism for produc-
tion optimization. However, it is often beneficial to use bacteria which are robust
against a broad temperature range. Fermentation at high temperature offers several
advantages not common with mesophilic microorganisms, including higher growth
and metabolic rates, lower cellular growth yield, increased physicochemical stabil-
ity of enzymes and organisms and facilitated reactant activity and product recovery
[1, 2]. Downsides to use thermophiles include the genetic inaccessibility, but also
the high costs that are associated to culturing only at such high temperatures. To
adapt a mesophile to have more resilience to higher temperatures would provide
the benefits of both. This would open up many different applications for mesophilic
industrial workhorses, including increasing the production yield, robustness of the
production process, the possibility of inducement with temperature shifts, or apply-
ing thermophilic new enzymes that are much more stable than their counterparts
from mesophiles [3, 4].
Nicotinamide Adenine Dinucleotide (NAD+) is a cofactor essential for survival
in all living organisms, by balancing the redox balance. In prokaryotes, de novo
biosynthesis of NAD+ proceeds via a condensation reaction of L-aspartate and di-
166
hydroxyacetone phosphate, catalysed by the quinolinate synthase system [5]. This
proposed complex is composed of two enzymes: L-aspartate oxidase (NadB) which
catalyses the oxidation of L-aspartate to iminoaspartate using O2 as an electron re-
ceptor, releasing H2O2, and quinolinate synthase, which condenses iminoaspartate
with dihydroxyacetone phosphate to produce quinolinate.
It is an object of the present invention to provide formicrobial host cells that have
been engineered for increased tolerance to temperature shifts and/or for increased
performance at temperatures different from their strain specific optimal tempera-
ture.
Summary of the invention
In a first aspect, the invention pertains to a microbial host cell comprising a nu-
cleotide sequence encoding a heterologous NAD+ biosynthesis enzyme, wherein at
least one of:
1. The heterologous NAD+ biosynthesis enzyme is from amicrobial donor organ-
ism with an optimum growth temperature that is different from the optimum
growth temperature of the microbial host cell, or from a microbial donor or-
ganism that has a wider range of growth temperatures than the microbial host
cell.
2. The heterologous NAD+ biosynthesis enzyme has a higher activity than the
corresponding endogenous NAD+ biosynthesis enzyme of the host cell at a
temperature that differs from the optimum growth temperature of the host
cell, as determined in an assay for activity of the NAD+ biosynthesis enzyme
wherein the activity of the endogenous and heterologous NAD+ biosynthesis
enzymes is determined over a period of time of at least 10 minutes.
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Preferably, the heterologous NAD+ biosynthesis enzyme encoded by the nu-
cleotide sequence comprised in the microbial host cell is selected from the
group consisting of L-aspartate oxidase, quinolinate synthase and quinolinate
phosphoribosyl-transferase, and wherein preferably the microbial host cell com-
prises nucleotide sequences encoding two or all three of the NAD+ biosynthesis
enzyme from the group consisting of L-aspartate oxidase, quinolinate synthase and
quinolinate phosphoribosyl-transferase. A preferred microbial host cell according
to the invention is a host cell wherein the temperature difference in at least one of a)
and b) above, is at least 2◦C. More preferably, a microbial host cell according to the
invention is a host cell, wherein at least one of:
1. The heterologous NAD+ biosynthesis enzyme has a higher activity than the
corresponding endogenous NAD+ biosynthesis enzyme in the host cell at a
temperature that is higher than the optimum growth temperature of the host
cell.
2. The heterologous NAD+ biosynthesis enzyme is from amicrobial donor organ-
ism with an optimum growth temperature that is higher than the optimum
growth temperature of the microbial host cell.
In one embodiment, a microbial host cell according to the invention com-
prises a genetic modification that reduces or eliminates the specific activity of
an endogenous NAD+ biosynthesis enzyme that corresponds to the heterologous
NAD+ biosynthesis enzyme encoded by the nucleotide sequence comprised in
the host cell, wherein preferably, the nucleotide sequence encoding a heterol-
ogous NAD+ biosynthesis enzyme replaces the endogenous nucleotide sequence
encoding the corresponding endogenous NAD+ biosynthesis enzyme. A micro-
bial host cell according to the invention preferably is a yeast, a filamentous fun-
gus, a eubacterium or an archaebacterium, more preferably the host cell is a
Gram-positive or a Gram negative bacterium. A microbial host cell according to
the invention can e.g. be a host cell of a genus selected from the group con-
sisting of: Escherichia, Anabaena, Actinomyces, Acetobacter, Caulobacter, Clostrid-
ium, Gluconobacter, Gluconacetobacter, Rhodobacter, Pseudomonas, Paracoccus, Bacil-
lus, Brevibacterium, Corynebacterium, Rhizobium Sinorhizobium, Flavobacterium, Kleb-
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siella, Enterobacter, Lactobacillus, Lactococcus, Streptococcus, Oenococcus, Leuconos-
toc, Pediococcus, Carnobacterium, Propionibacterium, Enterococcus, Bifidobacterium,
Methylobacterium, Micrococcus, Staphylococcus, Streptomyces. Zymomonas, Strepto-
coccus, Bacteroides, Selenomonas, Megasphaera, Burkholderia, Cupriavidus, Ralstonia,
Methylobacterium, Methylovorus, Rhodopseudomonas, Acidiphilium, Dinoroseobacter,
Agrobacterium, Sulfolobus, Sphingomonas, Acremonium, Aspergillus, Aureobasidium,
Cryptococcus, Filibasidium, Fusarium, Humicola, Magnaporthe, Mucor, Mycelioph-
thora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Piromyces, Schizophyl-
lum, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trichoderma, Ustilago, Sac-
charomyces, Kluyveromyces, Candida, Pichia, Schizosaccharomyces, Hansenula, Kloeck-
era, Schwanniomyces, Yarrowia, Cryptococcus, Debaromyces, Saccharomycecopsis, Sac-
charomycodes, Wickerhamia, Debayomyces, Hanseniaspora, Ogataea, Kuraishia, Koma-
gataella, Metschnikowia, Williopsis, Nakazawaea, Torulaspora, Bullera, Rhodotorula,
and Sporobolomyces.
The heterologous NAD+ biosynthesis enzyme encoded by the nucleotide se-
quence that is comprised in a microbial host cell of the invention, preferably is an
NAD+ biosynthesis enzyme that is obtained or obtainable from a microbial donor
organism, which is a psychrophilic, a psychrotrophic or a thermophilic organism.
In a preferred embodiment, the microbial host cell is a mesophile.
In one embodiment of a microbial host cell according to the invention, the het-
erologous NAD+ biosynthesis enzyme is a modified version of an enzyme that is
endogenous to the host cell, which modified version enzyme comprises at least one
modification in its amino acid sequence as compared to the endogenous enzyme, and
wherein the modified version has a higher activity than the endogenous enzyme at
a temperature that differs from the optimum growth temperature of the host cell,
in an assay for activity of the NAD+ biosynthesis enzyme wherein the activity of
the endogenous and the modified enzymes is determined over a period of time of at
least 10 minutes.
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The heterologous NAD+ biosynthesis enzyme encoded by the nucleotide se-
quence that is comprised in a microbial host cell of the invention, preferably is an
NAD+ biosynthesis enzyme comprising an amino acid sequence selected from the
group consisting of:
1. An amino acid sequence that is at least 45% identical to NadB Bacillus smithii.
2. An amino acid sequence that is at least 45% identical to NadB Trichococcus
flocculiformis.
3. an amino acid sequence that is at least 45% identical to NadB Pseudomonas
putida.
4. An amino acid sequence that is at least 45% identical to NadB Escherichia coli.
5. An amino acid sequence that is at least 45% identical to NadA Bacillus smithii.
6. An amino acid sequence that is at least 45% identical to NadA Trichococcus
flocculiformis.
7. An amino acid sequence that is at least 45% identical to NadA Pseudomonas
putida.
8. An amino acid sequence that is at least 45% identical to NadA Escherichia coli.
9. An amino acid sequence that is at least 45% identical to NadC Bacillus smithii.
10. An amino acid sequence that is at least 45% identical to NadC Trichococcus
flocculiformis.
11. An amino acid sequence that is at least 45% identical to NadC Pseudomonas
putida.
12. An amino acid sequence that is at least 45% identical to NadC Escherichia coli.
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In a second aspect, the invention relates to a process for producing a fermentation
product, the process comprises the steps of:
1. Culturing a microbial host cell of the invention in a medium, whereby the host
cell converts nutrients in the medium to the fermentation product.
2. Optionally, recovery of the fermentation product.
Preferably, the process comprises a shift in temperature, wherein preferably the shift
in temperature is a shift of at least 2, 5, 7 or 10◦C. In a third aspect, the invention
relates to the use of a nucleotide sequence encoding a NAD+ biosynthesis enzyme
that is heterologous to a microbial host cell, wherein the nucleotide sequence is used
for at least one of:
1. Changing at least one of the minimum, maximum and optimum growth tem-
perature of the microbial host cell.
2. Improving resistance of the microbial host cell to a shift in temperature,
wherein preferably the resistance of themicrobial host cell to a shift to a higher
temperature is improved.
Preferably, in the use of a nucleotide sequence encoding a NAD+ biosynthesis
enzyme that is heterologous to a microbial host cell, at least one of the microbial
host cell and the nucleotide sequence encoding a heterologous NAD+ biosynthesis
enzyme is as defined herein. Preferably in this aspect, at least one of:
1. At least one of the minimum, maximum and optimum growth temperature of
the microbial host cell is changed by at least 1◦C.
2. The lag phase of the microbial host cell upon a shift in temperature of at least
2◦C, is reduced by at least a factor 1.1.
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Fluctuations in temperature due to overheating of large-scale industrial set-ups pose a chal-
lenge for stable microbial production. Strain robustness in this respect is highly appreciated,
but difficult to establish on a laboratory scale. The here developed millifluidics device en-
ables for testing such fluctuations on a small scale, mimicking industrial conditions during the
research phase. In previous work, the universal link between NAD+ availability and thermo-
tolerance was elucidated. Recombinant P. putida KT2440 ∆nadB was enriched with either the
homologous, a psychrophilic or a thermophilic L-aspartate oxidase (nadB) gene. Growth was
monitored at 40◦C and 41◦C. Equipped with the thermophilic nadB, thermo-tolerance of the
strains increased significantly.
Presently, we analyse the recombinant strains performance through temperature fluctuations
that occur in large scale bioreactors. A down-scaled millifluidics system was built to this pur-
pose which at room temperature can expose the cells to near instantaneous temperature fluc-
tuations ranging from 30◦C to 50◦C. The system was applied to monitor the effect of such
fluctuations on the performance of the recombinant P. putida strains.
When exposed to stochastic temperature fluctuations ranging up to 50◦C, P. putida KT2440
∆nadB carrying a plasmid with Bacillus smithii nadB performed equally to the unburdened wild
type, and significantly better then a positive control with the inherent nadB supplied through
a plasmid or a negative control with an empty plasmid. Tolerance to (near) instantaneous
temperature fluctuations is a desired industrial trait. The results show that this trait is directly
linked to the nadB gene, and can be transferred between species, substantially improving strain
robustness in an industrial set-up.
Abstract
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Introduction
Transition costs from laboratory scale to manufacturing scale, including pilot and
demo scales, can run up to $100 million to $1 billion US dollars [1]. Even though it
was estimated that it takes over 10 000 experiments for a single bioprocess develop-
ment project from primary screening to pilot-scale trials [2, 3], this far exceeds the
costs of the microbial development and lab-scale testing combined.
Generally, microbial research is performed at relatively perfect conditions com-
pared to industrial production scale: the small scale allows for homogeneous distri-
bution of nutrients, dissolved oxygen, microorganisms and temperature. The scale-
up process that follows the research and development phase is considered challeng-
ing at best for industrial applications [1, 4–6]. Poor scaling up results in low yields
during fermentation, which is often themost expensive step. Scale-up issues include
maintaining optimum and homogeneous reaction conditions, minimizing microbial
stress and enhancing metabolic accuracy [4]. A literature study by Geisler and col-
leagues indicated that the broad range of technical correlations used to build large-
scale setups is based on data obtained at laboratory scale [7], which leads to discrep-
ancies in the scaling up process. Scaling up any process quickly encounters both
practical and theoretical conflicts. When considering important factors like temper-
ature input, equipment shape, and stirring power, choices must be made on what
to maintain most true to form [1]. The biological properties of the micro-organism
used combined with the fluid properties of the medium and the inconsistencies dur-
ing the scale up render all laboratory predictions on production yield and stability
poorly inconsistent [4, 7].
An alternative to perfecting the manufacturing scale to try to remove fluctua-
tions that occur is to try to mimic them at a laboratory scale to offers more reliability
for industrial set-ups. This is referred to as down-scaling, which was indicated as
a vital necessity for successful scale-up [1, 2, 5]. It was shown that microfluidics
can be used to mimic industrial scale fluctuations. Zanzotto and colleagues built
a microbioreactor with a volume of mere micro-litres, with well defined dissolved
oxygen and pH conditions. When comparing the microbioreactor with a 500 mL
bench-scale bioreactor, similarity were found in growth conditions, dissolved oxy-
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gen profile within the vessel over time, pH profile over time, the final number of
cells and the cell morphology [8]. They proved that microbioreactors can success-
fully scale-up to at least laboratory scale.
Microfluidics and millifluidics thus offer a cheap and easy solution during the
development stage to mimic the imperfections that occur at industrial scale [9–12].
Micro-reactors can be used to simulate the industrial process in small channels using
continuous-flow processes.
In this research, we focus on temperature fluctuations within large-scale systems,
and mimic them on a millifluidic scale. Variations in temperature in large scale sys-
tems are mainly caused by uneven cooling and heat produced during fermentation
by microorganisms [13], and deviate as much as 10◦C [14, 15]. Using embedded
scaffold removing open technology, or ESCARGOT, a 3D printed acrylonitrile buta-
diene styrene (ABS) scaffold can be applied to make a micro or milli-channel device
in a single block of polydimethylsiloxane (PDMS). PDMS is transparent, gas perme-
able and heat resistant, with low thermal conductivity (0.15 W m−1 K−1).
Combined with heating elements such as nichrome wire [16] or Peltier elements,
thermal zones can be created in the device. the elasticity of the PDMS allows for ad-
ditional use of pumps, valves and thermistors directly in the device [9]. Such micro
or millifluidic devices pave the way for a straight-forward and consistent scale-up
pathway, clearly highlighting instability in the production process at the earliest
stage possible.
In Chapter 6 [17], the universal link between NAD+ availability and thermo-
tolerance is described in P. putida KT2440, where the L-aspartate oxidase (nadB)
gene was replaced with either the homologous, a psychrophilic or a thermophilic
nadB gene. Growth was monitored at 40◦C and 45◦C, respectively. Equipped with
the thermophilic nadB, strain thermo-tolerance increased significantly [17] (Chap-
ter 6). It was hypothesized that this increase in thermo-tolerance would aid produc-
tion process stabilization on an industrial scale.
Presently, the thermo-tolerance effect of the previously developed recombinant
strains was tested through temperature fluctuations that occur in industrial scale
bioreactors, to analyse the recombinant strain value as opposed to the wild-type for
large scale application. A unique down-scaled millifluidics system was designed
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and built for this purpose. The system was applied to monitor recombinant strain
performance through high temperature fluctuations long term.
Materials and methods
Millifluidics
To mimic the temperature fluctuations that occur in a large scale bioreactor, a mil-
lifluidics down-scaled system was designed and built. Via the ESCARGOT method
[9], a 21 by 6 cm PDMS construct with straight embedded acrylonitrile butadiene
styrene (ABS) cylindrical scaffolds with a diameter of 2.85 mm was first cured at
70◦C for 4 hours and then and treated with acetone to remove the ABS, creating
eight millifluidic channels in one system. Based on a diameter of 2.85 mm and a
length of 21 cm the channels each have an effective volume of ' 5 mL. Via a reser-
voir, rubber tubing and a Schenchen LabV1.6 YZ1515X peristaltic pump, bacteria
are looped through the system at various speed rates. At a flow speed of 0.5 mL/min
the bacteria remain in the channel for 10 minutes (Figure 7.1).
Temperature fluctuations are regulated at will in the millifluidic channels.
Peltier elements with attached dissipators were placed on either side of the mil-
lifluidic device. The top side is equipped with fans and used for quick cooling of the
system, the bottom side is used for heating the system. Copper plating on both sides
evenly distributes the temperature over the length of the millifluidics. A thermistor
is applied inside one micro-channel to monitor the temperature at the start and end
of the channels. The thermistor is linked to an Arduino Uno micro-controller board
[18] which was programmed to regulate the temperature of the microchannels using
the Peltier elements. A wiring schematic can be found in Figure 7.2. A 3D printed
holder was designed to apply accurate contact between the Peltier elements, the
copper plate and the millifluidic devices, stabilizing the system.
The schematics for the electronics and the components needed for the Arduino
Flow-reactor as well as the code used can be found in the supplementary informa-
tion. Schematics were drawn using Fritzing 4 and licensed under CC Attribution-
ShareALike [19].
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Bacterial strains and cultivation conditions
Bacterial strains and plasmids used in this study can be found in Table 7.1. P. putida
KT2440 was routinely cultivated under oxic conditions at 30◦C in LB medium
(containing 10 g/l tryptone, 10 g/l NaCl and 5 g/l yeast extract). For solid
medium, 15 g/l agar was added to the medium. Experiments were performed
in De Bont minimal medium (DBG) [20] (3.88 g/l K2HPO4, 1.63 g/l NaH2PO4 ·
2H2O, 100x trace elements consisting of NH4)2SO4, 0.1 g/l MgCl2 ·6H2O, 10 mg/l
EDTA, 2 mg/l ZnSO4 · 7H2O, 1 mg/l CaCl2 · 2H2O, 5 mg/l FeSO4 · 7H2O,
0.2 mg/l Na2MoO4 ·2H2O, 0.2 mg/l CuSO4 ·5H2O, 0.4 mg/l CoCl2 ·6H2O, 1 mg/l
MnCl2 ·2H2O), with 20 g/l glucose as the sole carbon source. Medium was supple-
mented with 10 µg/mL gentamycin to maintain the plasmids. The cell density prior
to the experiment was determined photometrically at 600 nm (OD600). Optical cell
densities in the system were monitored automatically, using a 600 nm LED light and
a light-to-frequency sensor positioned opposite the LED source. A standard curve
was made to translate frequencies to cell density. The frequencies obtained were cor-
rected using no-light measurements and calibrated using cultures of known OD600.
The data was fitted via a non-linear fitting procedure in MATLAB 2018b (The Math-
Works, Natick, MA, USA), with a 95% confidence interval.
Table 7.1: Strains and plasmids used in this study
Strains Characteristics Optimal growth temperature Growth temperature range Source
Pseudomonas putida Gram-negative mesophile 30◦C 25− 40◦C
KT2440 Wild-type strain, spontaneous restriction-
deficient derivative of strain mt-2 cured
of the TOL-plasmid pWW0
[21]
KT2440 ∆nadB KT2440 with a knocked out nadB gene [17]
Plasmids for bacterial strains
pSEVA 638 nadBEco pSEVA 638 nadB E. coli BW25113 [17]
pSEVA 638 nadBPpu pSEVA 638 nadB P. putida KT2440 [17]
pSEVA 638 nadBBsm pSEVA 638 nadB B. smithii DSM 4216T [17]
pSEVA 638 nadBTfl pSEVA 638 nadB T. flocculiformis DSM 2094 [17]
All plasmids belong to the SEVA (Standard European Vector Architecture) collection [22, 23]
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Statistical analysis
Experiments were independently repeated three times. Figures represent the mean
values of corresponding biological triplicates and the standard deviation. The level
of significance of the differences when comparing results was evaluated by means of
analysis of variance (ANOVA), with α=0.05.
Results
The millifluidics device
As bacterial cultures suffer stochastic temperature fluctuations in an industrial scale
bioreactor, a millifluidics device was designed to expose a random subsampling of
bacterial culture to near instantaneous temperature fluctuations (Figure 7.1).
The system is designed to flow a loop of bacteria culture through the channels
during fermentation. An external culture reservoir, kept at optimal growth temper-
ature, is pumped through the heated (or cooled) millifluidic channel for a certain
amount of time depending on the pump speed, and then flowed back into the reser-
voir. The external sample is kept in a open 50 mL syringe using the tip of the syringe
as inlet for the millifluidics and the open top for flowing back the culture, so that
over time, all sample will have gone through the device. A peristaltic pump is used
to pump round the same sample so that the effect of the temperature fluctuations
can be seen over a long time-span. The peristaltic pump alsomakes the system easily
adaptable: by changing the flow speed, the temperature fluctuation exposure can be
prolonged or decreased. The double row of Peltier elements were used for efficient
and fast heating and cooling. Copper plating between the Peltiers and the PDMS
was used for an even temperature distribution over the length of the millifluidic
device. Multiple channels allow for strains to be tested in parallel.
The Arduino Uno micro-controller board regulates the temperature or the dif-
ferent temperatures in time by adjusting the current flown in the heating and cool-
ing Peltier elements. A thermistor was used directly at the end of one channel in
the millifluidic device in such a way that the temperature of the fluid is measured
at the outlet. With all wiring and programming in place, the device was tested
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Figure 7.1: Schematic overview of millifluidics device A) depicts the millifluidics device, 1. the
PDMS gel through which eight microchannels run. 2. Top Peltier elements, in charge of cooling
the system. The fans are placed on top for heat dispersion. 3. Bottom Peltier elements, for heating
the system. 4. Thermistor for temperature registration, which via the Arduino Uno is then used to
regulate the Peltier elements, placed within the bacterial sample where the PDMS meets the tubing.
5. Peristaltic pump. 6. External bacterial sample in a 50 mL syringe. B) shows a side view of the
device, C) shows a picture of the actual device.
for its ability to regulate the temperature when medium is pumped through the
channels, and the stability of that temperature (Figure 7.3). A solution containing a
thermochromic dye was used to measure the temperature synchronisation and hys-
teresis of each millifluidic channel (supplementary information). Thermistor data is
directly fed into the Arduino Uno, which is programmed to either keep one stable
temperature or any time/temperature fluctuation desired. A schematic of the wiring
can be found in Figure 7.2.
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Figure 7.2: Schematic overview of Arduino Uno wiring. The electrical routing of the device.
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The side view shows the temperature of media being pumped through four chan-
nels (visible as circles within the PDMS) when the Peltier elements are set to heat
to 45◦C. The temperature reached approximately 40◦C, indicating a fluctuation of
5◦C between the Peltier and the actual cells. The top view shows that the medium
actually reaches this temperature at two-thirds of the PDMS. Due to this hysteresis,
cells are exposed to the programmed maximal and minimal temperature for 3.33
minutes per round with a flow speed of 0.5 mL/min.
The temperature determination using the thermistor located at the output of
the gel (Figure 7.3 C, D) shows good stability of the device, although temperatures
nearing room temperature (21◦C) are more difficult to maintain.
For a monitoring of the culture, an automatic OD measurement was integrated
at the outlet of the eight channels, before the culture is flown back to the reservoir.
The OD measurement work on a 600 nm LED light and a light-to-frequency sen-
sor positioned at 180 degrees from the LED source. The LED and the sensors are
connected to the same Arduino UNO which records the OD data for the 8 channels
every 10 minutes. To translate frequencies obtained from the light-to-frequency
sensor to cell density, a standard curve was made. An overnight culture of P. putida
KT2440 wild type was prepared and diluted to a cell density measured with the
spectrophotometer ranging from OD600 0.1 to 2.6. Blank medium was used to cor-
rect for background. A standard curve was determined for each separate sensor
(Figure 7.4).
The device should mimic the irregularities within large bioreactors, which are
also not maintained at perfect temperature for long periods of time. With the exter-
nal sample placed at 30◦C, and the device set at room temperature with a flow speed
of 50 µL/min, the millifluidics device can stably expose the bacteria to temperatures
fluctuations between 25◦C and 50◦C for 3.33 minutes per 10 minutes. This milliflu-
idic device thus is capable, via an Arduino microprocessor, to control and monitor
the temperature of the bacteria culture flown into the device, monitor the OD of the
culture and record the outcome of the experiment over long periods of time.
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Figure 7.3: Temperature stability within the millifluidics device A) Thermal camera image of the
side view of the millifluidics channel. B) Thermal camera image of the top view of the millifluidics
channel. C) Temperature in channel as determined with the thermistor at output when the temper-
ature is set at 50◦C. D) Channel temperature as determined with the thermistor at output when the
temperature regulation is set to a loop of 30− 40− 30− 23◦C.
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Figure 7.4: Calibration curves for cell density. The non-linear fitted exponential relationship be-
tween the frequency measured and cell density, by standard at OD600, was determined using a
series of cultures of P. putida KT2440 wild type with known cell density. Frequencies were first
corrected with no-light measurements before calibration. The fitted lines were used to extract the
formula required for translation of data to cell density. Per tube, a separate standard curve was
prepared.
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Thermophilic nadB in mesophiles increases the resilience to temperature
fluctuations
In Chapter 6, the universal connection between NAD+ availability and thermo-
tolerance was established. For this, L-aspartate oxidase (nadB) was obtained from
either P. putida KT2440 itself, the thermophilic B. smithii DSM4216T or the psy-
chrophilic mesophile T. flocculiformis DSM 2094. The thermo-tolerance of each
strain is depicted in Figure 7.5.
Figure 7.5: Thermo-Tolerance of P. putida, B. smithii and T. flocculiformis. Depicted in a table of
optimum growth temperature and temperature range of strains of which the nadB gene originated
(right), and a schematic representation of temperature tolerance of P. putida KT2440 (Orange), B.
smithii DSM 4216T (Purple) and T. flocculiformis DSM 2094 (Red) (left).
To determine the performance of the recombinant strains in an industrial set-
up, the recombinant strains were tested using the millifluidics device. Pseudomonas
putida KT2440 ∆nadB strains carrying nadB from Bacillus smithii (pS638 nadBBsm)
was tested against the wild-type strain, a negative empty plasmid control (pS638
empty) and a positive control with nadB from P. putida (pS638 nadBPpu) (Figure
7.6).
Thermo-Tolerance in a Down-Scaled System
7
187
Figure 7.6: Thermo-Tolerance of recombinant strains in a downs-scaled system. P. putida KT2440
wild type (Green), P. putida ∆nadB pS638 empty (Purple), P. putida nadBPpu (Blue), nadBBsm
(Orange), and nadBTfl (Red) were tested for growth performance through exposure to stochastic
temperature fluctuations in a millifluidics system. Temperature is set to loop 50− 40− 30− 40◦C.
Cell growth was monitored over 65 hours using the automatic light-to-frequency sensor set-up, and
translated to cell densities using the standard curves.
The cell density was automatically monitored over 65 hours. Only the lag phase
and the exponential growth phase were considered to determine the strain perfor-
mance. It was seen that with a temperature fluctuation regime of 50−40−30−40◦C,
P. putida KT2440 ∆nadB pS638 nadBBsm equipped with the thermophilic ortholog
from B. smithii grows better than the other strains, mimicking the wild type P. putida
KT2440 which is unburdened by a plasmid.
The plasmid burden can be determined clearly by comparing P. putida KT2440
wild type and the positive control, P. putida KT2440 ∆nadB pS638 nadBPpu.
Discussion
Millifluidics compared to industrial scale
With the trend of down-scaling, the inability thus far to properly compare results
obtained at perfect laboratory scale with what industry can expect at imperfect in-
dustrial scale is being tackled. By designing experiments which integrate foreseen
variations and fluctuations, the irregularities that occur during the process of scaling
up can be caught already during development stage, and can be solved beforehand.
This could save much money in an industrial process in development and could
make it easier for new products and techniques to enter the market [1, 5].
188
Earlier research focused on modelling of large-scale conditions to design a scale-
down bioreactor [24–26]. These models show a multitude of other factors that in-
fluence microbial growth at large scale, and including both chemical gradients such
as dissolved oxygen, pH, or nutrient fluctuations, and physical gradients such as
pressure, viscosity, or temperature. Additionally, physiological effects on bacteria
caused by flow and peristaltic mixing are not taken into account. In the millifluidic
system there is a laminar flow, similar to blood-flow in capillaries, as opposed to
the turbulent flow expected in large-scale bioreactors. Physiological effects can have
great impact on bacterial growth and interactions, which we are only beginning to
understand [27–29].
This down-scaled millifluidics system is thus only a small step towards this am-
bitious goal. The device was designed to only integrate one type of fluctuation–
temperature–where many more exist. This choice was made since the recombinant
strains were adapted to increased thermo-tolerance. Since the general strain per-
formance at industrial scale is already known, the recombinant strain only had to
be tested for increased temperature tolerance through the temperature fluctuations
that exist within industrial set-ups.
The millifluidics device was specifically designed to expose multiple different
samples to long-term experiment using temperature fluctuations. For the fabrica-
tion of the millifluidic device we opted for PDMS and ESCARGOT method. Al-
though PDMS is not specifically good for heat transfer, this method is easy, cheap
and fast for experimenting and proof of concept works. Once the characteristics of
the millifluidic channels are determined, the millifluidic can be ordered and pur-
chase in aluminium or glass without the need of changing the rest of the system.
The ease and adaptability of the device ensures a multi-purpose use in further
research, which will focus on adding different types of external stress to improve
the millifluidics device for down-scaling. Additionally, the strains should be tested
at truly large scale to be able to make the correlation between the millifluidics and
industrial scale, and evaluate the value of these predictions.
Thermo-Tolerance in a Down-Scaled System
7
189
Conclusion
The designed millifluidics device proves an easy and adaptable way to estimate
the effect of temperature fluctuations that occur in large-scale bioreactors on a lab-
scale. Recombinant mesophiles equipped with the thermophilic ortholog for their
L-aspartate oxidase gene perform better through high temperature fluctuations in
a down-scaled system when compared to a positive control or even the wild-type
strain, indicating that a strain equipped with thermophilic L-aspartate oxidase actu-
ally benefits from fluctuations. This research proves both the value of this adapta-
tion for industrially applied mesophilic strains, and the importance of down-scaled
systems to validate research.
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Synthetic biology for feasible sustainable industry
According to the European Association for Bioindustries, the contribution of the in-
dustrial biotech market in the European Union is expected to be between €57,5 bil-
lion and€99,5 billion to the European economy by 2030 [1]. In response to Europe’s
desire to develop a sustainable circular economy, it is foreseen that this growth will
be largely driven by a step-wise replacement of fossil carbon materials by renewable
feedstock [2, 3].
In this research, the widespread application of microbes was appointed as the
way to achieve sustainable industry. However, in order to change completely from a
petrochemical to a bio-based economy, many bottlenecks will have to be overcome.
To consider the true potential of a micro-organism, its full growth and produc-
tion process and its ability to substitute or compete with a fossil-based production
line have to be considered. In the U.S., for example, the total demand of crude oil is
over one billion annually, or 109 metric tons per year. Electricity generation and the
production of biofuels that can thus far be achieved using microbes is about 190mil-
lion tons [4, 5], which means their yield has to drastically improve to have a chance
at replacing fossil fuels completely. The total potential of sustainable biomass in
the U.S. has been estimated to be at least 1.2 billion tons per year within 50 years.
The weight of sustainable biomass, however, does not equal its stored energy. As
fossil fuels contain more energy and carbon density, it was estimated that at least
seven times the amount of biomass is needed to equal the energy yield of crude oil.
Industry wants to move towards sustainability, but the tools and sources are sim-
ply not available yet for a complete rigorous change. In addition, much innovative
research never makes it through the Valley of Death to industrial application and
market commercialisation. Besides technical restrictions, this study has helped to
elucidate other crucial sector-based and social factors play a role Chapter 2.
The rapid increase in the ability to modify microbial genomes has revolution-
ized biotechnology and allowed for a substantial increase in innovation for indus-
trial use [6]. This fast development of industrial biotechnology is now also known as
the third industrial revolution, the first being the industrial revolution of machinery
and the second of electricity. Currently, the internet breaks the fourth industrial rev-
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olution, with everything connected to everything and automatic smart phones, cars
and homes are becoming a reality. The impact of the fourth industrial revolution
on the field of biotechnology cannot be ignored. Due to the ability to collect, store
and share massive amounts of data computational methods have breached research,
yielding much more information than we know how to handle.
This available data can be used to further focus research towards altering bacte-
rial genomes using directed approaches to gain or lose characteristics and traits as
wanted. If the right tools are available, the fourth industrial revolutionmay turnmi-
croorganisms into plug-and-play systems. The valuable ability to change anything
via an ordered approach has made both new and old techniques much safer to use.
With classical evolutionmethods, microbial traits can be cultured by enforcing them
with a strict environmental control. Forward genetics, genome sequencing and tran-
scriptomics analysis–and comparing the results to previously obtained data from
the organism of choice or any other organism that shares this trait–offers insight in
what has changed and all the effects this change has had. This insight has lead to
more predictability in the effect of modifications to the genome of microorganisms,
gradually leading to safer cell factories. This study has made progress in this field
by taking one industrially applied bacterial strain, Pseudomonas putida KT2440, as
a model organism, and increase its environmental robustness. Both classical evolu-
tion methods and available computational data through an ordered approach were
applied towards this goal, systematically taking on two main bottlenecks. First, the
strict aerobic nature of P. putida KT2440 was tackled in two different ways (Chap-
ters 4, 5, [7]). Next, the thermo-tolerance of P. putida KT2440 and other species was
improved, which was shown first on lab-scale, and next in a down-scaled milliflu-
idics system to indicate strain improvement on a large scale (Chapters 6, 7, [8]). This
finding was patented for application in industry (Appendix chapter 6).
Here, I will discuss the how this research has impacted aiding sustainable indus-
try, and science in general.
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The importance of keeping your end-user in mind
In Chapter 2, it became apparent that although the general aim of industry and
academia align, academics are expected to make more substantial headway by tak-
ing on riskier projects.
Industry and academia agreed that industry rarely comes with a clear demand,
but rather visit conferences and await interesting invitations into consortia so they
can cherry-pick the most applicable and easily adaptable novel research in their
production process. The reasons for this are clear: not only does industry fund
academic research, but as they make products for a final consumer, introducing
sector-based and social factors like government-enforced restrictions, patenting and
public perception.
At all times, the biotech industry has to keep their end-user in mind. This
simple claim was shown to have far-reaching implications. Production has to be
cost-effective, sustainable, and safe, so industry has adapted microorganisms for a
more sustainable production process, increasing the titre-rate-yield to improve cost-
effectiveness, and has to follow severe safety-regulations for their production hosts.
For food, feed, or food additives, only microbes that are generally regarded as safe
(GRAS, [9]) can be used. To oblige these strict regulations and protect their signa-
ture production process, patents are invaluable, but restrictive in their ownway. The
introduction of novel microbes is only considered as long as the production process
remains mainly the same, or if the titre-rate-yield is improved so much that it will
make up for the required changes to the production process. As the value of the
products increase, so does the flexibility of the industry. These same restrictions are
simply not applicable in academic research, and rightly so. Academics should have
the freedom to perform more fundamental research and keep a curiosity-driven ap-
proach to discover the unexpected. However, if the researcher aims for industrial
and thus market application of their research or invention, industrial restriction
must at least be kept in mind to increase chances of making it through the Valley of
Death. Close collaboration from an early stage on is key.
Additionally, the existing gap between academia and industry has naturally
filled with the rise of small companies. Start-ups companies are companies that
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are formed directly from an academic background to commercialise a promising
academic innovation. Some fear that start-up companies have increased the gap
between academia and industry. However, the case can be made that start-up com-
panies are a great opportunity to close the gap altogether, by easing the transition
of academic research to actual industrial application, and opening up room for aca-
demics to focus on education and research. Collaborations between academia and
industry should include some attention for the possibility of start-ups to develop,
leading to more attention to industrialising promising results and growing them
into market applications already from the development stage.
The GRAS myth and the status of KT2440
The American Food and Drug Administration (FDA) regulates market introduction
for new Food ingredients or food additives by approving them for specific uses as
GRAS (generally recognized as safe) substances [9–11]. The GRAS status serves as
an official status valued highly in industry, as it indicates a validated safety for con-
sumption. A substance may be GRAS only if its safety is based on the views of
experts. GRAS status may be based on a history of safe use in food prior to 1958, or
on scientific procedures, which require the same quantity and quality of evidence
as would be required to obtain a food additive regulation. The base for any given
GRAS status can be viewed via the application number on the GRASwebsite, https:
//www.accessdata.fda.gov/scripts/fdcc/?set=GRASNotices, although it is of-
ten indicated simply as "scientific procedures". The FDA response notices available
for GRAS evaluations offer somewhat more information on how the GRAS status
was awarded.
GRAS statuses are awarded based on colony forming units (CFU)/serving, aimed
use and/or user, strain occurrence, and characteristics. It is specified that a strain
is non-pathogenic and non-toxigenic, although it is not further proof or indication
of the nature of any proof is not offered in the FDA notice. The processing of the
strain is discussed. It is indicated that there exists prior peer-reviewed publications
on use of the strain and safe consumption of a strain. Finally, the notice indicates
the limitations on the GRAS status (if awarded) [9].
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A strain without a GRAS status therefore does not mean it is not safe for con-
sumption. It simply lacks enough proof for an official status. Additionally, GRAS
statuses seemingly tend to be given out to well-established strains, which means
that years of research and trials, and most importantly, a specific aim for strain use,
are required before a GRAS status can even be contemplated. In addition, the limi-
tations to a GRAS status are strictly defined. If the strain is not used according to its
intended use or dose described, the GRAS status does not cover it. Toxicity, in any
case, is a matter of quantity, not quality.
The dose makes the poison, Paracelcus, 1538 [12].
In the same way, it can be said that pathogenicity is a matter of opportunity,
not inherent to a strain. Examples of this can be found in our own gut. There is a
growing academic interest in the involvement of previously labelled commensal gut
microbes turned opportunistic pathogen in diseases or defects [13, 14]. Even though
thesemicrobes can be found naturally in the human gut, and have no negative effects
in most, if the right opportunity arises these bacteria can help or harm.
Since 2015, almost 4000 papers were published on P. putida KT2440. Besides
fundamental research and genomics, research has generally focused on increasing
the industrial value of this species. This includes building new metabolic path-
ways, for instance to allow P. putida to degrade cellulose, lignin [15–18] or plastics
[19, 20], redirecting its metabolism for industrial relevance [21–27], engineering
adaptable surface-display [28], elucidation and perfecting its ability to produce se-
lenium nanoparticles [29], tuneable biofilm formation to increase robustness [30,
31], biosensor development [32], increasing tolerance to micro- or anoxic conditions
[33–37], and increasing strain thermo-tolerance [38].
Although over 40 unique first authors described P. putida KT2440 as GRAS, in
chapter 3 [39] it was rediscovered not as GRAS, but as HV1 certified [40]. This
certification indicates the strain is safe to work with in an ML1 lab environment, as
long as the microbe is not ingested.
But what are the implications of this, and more importantly–what should they
be? I argue that (strain) safety should consistently be handled on a case-to-case
basis. Due to its extensive use in academic literature, the improvements in synthetic
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biology tools which can help increase strain safety and the lack of information on
the dosis and pathogenicity of this strain, the HV1-status of P. putidaKT2440 should
be seen as a promising step towards safe application of this strain in food, feed or
food additives.
Evolution plus ordered approach equals increased changes of
success
Classical genome engineering methods like adaptive laboratory evolution (ALE) ex-
periments have been employed towards lifestyle engineering [41–43]. This method
allows for a close replication of natural evolution to pushmicrobes towards a desired
lifestyle. This top-down approach allows for random changes to occur; any muta-
tion that improves cellular performance under stressful conditions will thrive and
can be isolated and characterized afterwards. A substantial benefit to this method
is that no a priori knowledge of the limiting factor(s) is required. Room is left in
the research process to use and possibly uncover those factors that have an effect
on the strain performance under the selected environmental conditions. The major
downsides of the application of random evolution methods are the time and work
intensity. The conditions in which an ALE experiment are performed are crucial,
since it concerns an iterative selection cycle. Any deviation from the desired con-
ditions can lead to loss of the carefully evolved bacteria before they can adapt, or
wild type bacteria still present might overgrow the evolved bacteria, both resulting
in loss of progress. Additionally, random evolution can yield unwanted mutations,
with only a few actually contributing to the desired characteristics. This means that
ALE experimentation must always be followed by the careful and extensive analysis
of all mutations that occurred.
The Design-Build-Test-Learn-cycle is a rational alternative approach. Prior
knowledge available on the organism of interest is applied through in silicomethods
towards systematical lifestyle engineering. This not only saves time and resources
beforehand, but offers the additional benefit that any changes made in the wild type
strain towards improvement are exactly known, offering a safety aspect. The DBTL-
cycle substantially shortens the time required for development by tackling foreseen
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problems head-on.
However, computational methods used in the Design-phase of the DBTL-cycle
have one main advantage, which is at the same time their main disadvantage: they
rely heavily on the underlying data. Metabolic models represent simplified bacteria
still capable of growth. However, models exclude many factors and gene or protein
interactions that are poorly understood or unknown. Models can be applied to at-
tempt to elucidate unknown interaction, by fitting a certain growth curve. However,
that does not necessarily mean the fit found is the correct one, due to the simplifi-
cation gap between model and reality [44]. Proper training models are thus invalu-
able to assess the reliability of computational methods. Another downside of this
approach is that problems are specified beforehand, and answers are only sought
in known factors. This leads to obvious solutions or discoveries, possibly missing
fundamental discoveries or new gene or protein interactions. As much on the spe-
cific functions and workings of microorganisms remains unknown, computational
methods should be handled carefully and critically.
An ordered approach to lifestyle engineering was applied in Chapters 4 and 5,
where an attempt was made to adapt the strict aerobic nature of P. putida KT2440 to
a facultative anaerobic lifestyle through anaerobic fermentation [7] or anaerobic res-
piration. In both attempts, various computational methods were applied to pinpoint
bottlenecks. In chapter 4, some of these bottlenecks were addressed and evolution-
ary methods were applied to determine and improve strain performance first under
micro-oxic conditions, then under anoxic conditions. To speed up the development
process, the DBTL-cycle was applied to develop a design of P. putida KT2440 capa-
ble of anaerobic fermentation. For this, two metabolic models were employed. In
silico, the adapted strain was able to grow under anoxic conditions. After build-
ing the design, the recombinant strains were tested under micro-oxic conditions in
oxygen gradients, and after multiple rounds of ALE using these oxygen gradients
the recombinant strains were able to grow, showing the benefit of using the DBTL-
cycle and ALE experiments combined. While saving time and resources by using
an ordered approach, you still benefit from the freedom and unexpected solutions
offered by adaptation experiments. However, the ultimate short-comings of relying
too much on computational methods was shown in Chapter 5, when the designs
202
made and adapted in Chapter 4 were tested under anoxic conditions, but proved
unable to grow.
In Chapter 5, genomics, transcriptomics and metabolic modelling were applied
to in silico design and test different recombinant strains. Together, these methods
proved most valuable. It was determined that to enable growth in anoxic conditions
through respiration, 69 genes of known function would have to be added to the
genome, and 5 vitamins to be supplemented through the medium. In addition, the
study revealed a possible implication for a number of genes of unknown function.
To add almost 70 genes to the genome is a Herculean task. Genome engineer-
ing and predictable gene expression were identified as topics of interest by both
academia and industry (Chapter 2), which is mirrored by the fast rise of methods to
allow for the programming gene expression like CRISPR [45]. Still, state-of-the-art
methods like yTREX [46] for integration of large operons or multiple genes allow in-
corporation of approximately 14 genes at one time in P. putida. This would have to
be repeated 5 times to include the amount of genes required for anaerobic respira-
tion. Moreover, heterologous gene introduction can have unexpected complications.
Introduced genes might not function, which can be due to incorrect regulation, in-
correct placement in the genome, incompatibility with the host transcription and
translation machinery, incorrect folding, and due to a myriad of unidentified prob-
lems [47, 48].
Another bottleneck to this design is that it excludes 244 domains of unknown
function that on statistical grounds could play a role in anaerobic respiration. Al-
though there is much data available on both genomics and transcriptomics, these
uncharacterised genes of unknown function proved the main bottleneck to come to
a complete design for Chapter 5.
Thermo-tolerance and down-scaled methods
The temperature range in which a microbial strain can grow is referred to as its
thermo-tolerance. P. putida KT2440 is a mesophilic strain with a relatively small
temperature range of 25◦C to 40◦C with an optimal growth temperature of 30◦C
[49]. In small scale laboratory conditions, this optimal growth temperature can be
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established. However, in large industrial-scale bioreactors, temperatures can deviate
as much as 10◦C due to uneven mixing and varying conditions [50, 51]. Thermo-
tolerance of an industrial strain, thus its ability to cope with such temperature vari-
ations, are thus an important aspect in industry. The strain thermo-tolerance was
tackled in Chapter 6. The largest bottleneck of P. putida KT2440 in NAD+ biogener-
ation via the aspartate pathway, L-aspartate oxidase, was replaced by the same gene
from the thermophilic strain Bacillus smithii DSM 4216T via a plasmid. As a result,
the exponential growth phase was twice as steep when compared to a positive con-
trol when growing the bacteria at 40◦C. In E. coli JW2558, this exchange decreased
the lag-phase ten times compared to a positive control when grown at 44◦C. The re-
dox balances was thus proven to be a major bottleneck in the temperature resilience
of any strain. This finding was patented (Appendix chapter 6).
For this innovation to be considered industrially interesting, it must be shown
how the thermo-tolerant recombinant strains weather the fluctuations that occur on
a large scale. Scale-up was deemed vitally important by both industry and academia
(Chapter 2) for innovations to survive through the so-called "Valley of Death" to mar-
ket commercialisation, since tests on laboratory scale are not reliable for industrial
scale and thus for industrial applications [52–56]. Instead of applying the recombi-
nant strains obtained (Chapter 6, [8]) in large-scale bioreactors, costing much time,
money and effort, it was decided to focus on down-scaling instead (Chapter 7).
Millifluidics and microfluidics are a well-known concept rising in importance as
their toolkit grows. However, these methods are mainly applied to perform fun-
damental single-cell research [57], affordable chemical synthesis [58], therapeutic
applications in the form of nanoparticles for easy drug delivery [59] or to develop a
lab-on-a-chip [60].
However, relatively few scientists seem to be working on using down-scaled sys-
tems to imitate large-scale conditions on a lab-scale [61], even though this was recog-
nised as vital for survival through the "Valley of Death" [52–54]. To determine the in-
dustrial thermo-tolerance of the adapted P. putida KT2440, a down-scaled milliflu-
idics system was built. This system was specifically designed to expose cell cultures
to realistic cyclic temperature fluctuations that occur during large scale fermenta-
tion. Due to its modular design this system can be expanded easily, incorporating
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different types of fluctuations to mimic industrial scale fluctuations better. Novel
techniques make aeration and mixing of fluids possible [62–68], offering an oppor-
tunity to test gradients of oxygen or medium components. So rather than perfecting
large-scale bioreactors, the fluctuations are simply applied during the development
stage so that their effects can be taken into account. As such, down-scaling offers the
answer to scale-up problems, speeding up the costly development stage by offering
reliable results through scale-up.
Concluding remarks
Microbial cell factories can have a large impact towards sustainable society, but their
application is currently limited for a multitude of different reasons. Lifestyle engi-
neering to improve microorganisms for industrial applications using in silico meth-
ods in combination with novel and classical genome engineering methods, followed
by testing the novel strains in down-scaled systems, offers an improved chance for
new research to make it through the Valley of Death. In silico methods can in
the long run enable the predictability of gene insertion that would streamline the
DBTL-cycle into a linear process and thereby revolutionize industrial biotechnol-
ogy. Down-scaling offers a way to test strains in the early development stage to
more reliably mirror large scale production outcomes.
The main aim for this research was to increase the robustness of industrially
applied P. putida KT2440 by applying an ordered approach and lifestyle engineer-
ing towards feasible sustainable industry. The work performed in this thesis has
not only attempted to elucidate the main bottlenecks by active outreach to indus-
try and academia, but has contributed to solving important industrial bottlenecks
of P. putida KT2440 by combining in silico research with wet-lab experiments and
method development of down-scaled systems. This research has yielded an indus-
trially applicable outcome in the form of a patent. This contribution has made steps
towards application of more research in industry by making attainable adjustments
in any micro-organism, thus hopefully aiding the final goal of approachable sustain-
ability.
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Due to the devastating effects environmental change can cause, sustainability has
occupied top priority worldwide for years past. Bacteria aid the environment and
battle environmental change by removing toxic pollutants. Industrial application of
microbes could thus improve sustainability in industry. However, not all microbes
are attractive for industrial application. The field of Systems and Synthetic Biology
in Biotechnology offers a vast array of tools to change this.
This thesis, entitled "Microbial Lifestyle Engineering", aims to improve the
lifestyle of industrially applied microorganisms. Due to their inherent robust-
ness, large redox capacity, adaptivity and genomic accessibility, the gram-negative,
prokaryotic bacteria Pseudomonas putida was used as a proof-of-principle, but was
extended to Escherichia coli and the eukaryotic yeast Saccharomyces cerevisiae.
Since this research was aimed tomake improvements for industrial purpose from
an academic point of view, Chapter 2 describes a series of interviews which were
conducted to determine how far those two worlds are apart. We uncovered the main
points of miscommunication and opportunities between both fields. While industry
focuses on today’s problems, academia focuses on uncovering solutions to tomor-
row’s problems. Both fields agree that in general better communication is required
so that more findings end up as applications.
In Chapter 3, a common misconception was eradicated. While the micro-
organism of interest Pseudomonas putida strain KT2440 is often characterised as
Generally Regarded as Safe, or GRAS, this description is incorrect. Extensive litera-
ture search yielded the original food and drug administration report which describes
that Pseudomonas putida KT2440 is HV1 certified, not GRAS. The HV1 certification
entails that the strain is safe to use at a P1 or ML1 laboratory without further safety
measures, but should not be ingested. This does not change its many industrial
applications, but does withhold it from use in the food industry.
Pseudomonas putida is a metabolically versatile, genetically accessible, and stress-
robust species with outstanding potential to be used as a workhorse for industrial
applications. Due to the importance of robustness under micro-oxic conditions for
a stable production process, the obligate aerobic nature of P. putida severely limits
its use for biotechnology applications. This was attributed to an inability to produce
enough ATP and maintain its redox balance without molecular oxygen.
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In Chapter 4, a combination of genome-scale metabolic modelling and compar-
ative genomics is used to pinpoint essential O2-dependent processes. These explain
the inability of the strain to grow under anoxic conditions: a deficient ATP gen-
eration and an inability to synthesize essential metabolites. Based on this, several
P. putida recombinant strains were constructed harbouring acetate kinase from Es-
cherichia coli for ATP production, and a class I dihydroorotate dehydrogenase and a
class III anaerobic ribonucleotide triphosphate reductase from Lactobacillus lactis for
the synthesis of essential metabolites. Initial computational designs were fine-tuned
by means of adaptive laboratory evolution. We demonstrated the value of combin-
ing in silico approaches, experimental validation and adaptive laboratory evolution
for microbial design by making the strictly aerobic Pseudomonas putida able to grow
under micro-oxic conditions.
Chapter 5 continues on this research, and shows that although the previously re-
combined strains did growth better under micro-oxic conditions, they did not lead
to growth or better survival under anoxic conditions. Subsequently, a semantic sys-
tems biology approach was used to design a derivative of P. putida KT2440 capable
of anaerobic respiration. We combined data from comparative genomics of 1624
different Pseudomonads with transcriptome data from the facultative anaerobe Pseu-
domonas aeruginosa and genome-scale metabolic modelling simulations. The results
indicate that to enable anaerobic respiration, at least 69 additional genes and 3 ex-
ternally added vitamins are required.
Chapter 6 was aimed at a different way of lifestyle engineering for industrial
improved use. The universally applied essential redox factor NAD+ is involved in
internal signalling, defense, detoxification, circadian regulation, chromosome seg-
regation, aerotaxis, sporulation, biofilm formation and dispersal. The redox balance
is often the first response to internal and environmental changes. Previous work de-
scribed the thermal stability of thermophilic L-aspartate oxidase; the main bottleneck
in the aspartate pathway for NAD+ biosynthesis.
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We determine the effect of exchanging the L-aspartate oxidase gene in different
mesophiles for a thermophilic ortholog. In E. coli, the exchange results in a 10 times
shorter lag phase when grown at 44◦C. In P. putida the generation time doubled
when grown at 40◦C. To determine how widespread the connection between NAD+
availability and thermo-tolerance is, the mesophilic or thermophilic aspartate path-
way was implemented in yeast, which generates NAD+ via the kynurenine pathway.
Not only was S. cerevisiae able to use the aspartate pathway for NAD+ generation,
but supplemented with the bacterial pathway the strain proved more robust when
grown at 41◦C.
To determine what effect this increased thermo-tolerance could have on an in-
dustrial scale, Chapter 7 describes the development of a millifluidics device. A
down-scaled microfluidics system was built for this purpose. When kept at room
temperature, the device can expose the cells to temperature fluctuations ranging
from 25◦C to 50◦C. The system was applied to monitor long-term recombinant
strain performance with respect to these fluctuations. The recombinant thermo-
tolerant strains were tested in this system over a three-day span. It was seen that
with a temperature fluctuation regime of 50−40−30−40◦C, P. putida KT2440 ∆nadB
pS638 nadBBsm equipped with the thermophilic ortholog from B. smithii grows bet-
ter than the other strains, including the wild type P. putida KT2440 which is unbur-
dened by a plasmid.
The discovery of the universal link between the NAD+ availability in microbes
and their thermo-tolerance was patented. Appendix chapter 6 shows the patent
summary. This invention relates to the field of molecular microbiology, metabolic
engineering, and fermentation technology. In particular, this relates to microbial
host cells that have been engineered for increased tolerance to temperature shifts,
for increased performance at temperatures different from optimal temperature of
a micro-organism and/or for changing at least one of the cardinal temperatures of
a micro-organism by replacing an endogenous NAD+ biosynthesis gene by a het-
erologous gene encoding a corresponding enzyme with another temperature profile.
With the patent, a full trajectory from lab to test to application was completed.
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Samenvatting
Door de drastische gevolgen die klimaatverandering teweeg kan brengen is duur-
zaamheid wereldwijd al jaren van hoge prioriteit. Microben hebben een groot aan-
deel in de klimaatbalans omdat ze toxische verontreinigingen uit de natuur kunnen
filteren. Microben worden in industriële processen toegepast om de industrie te
verduurzamen. Niet elk micro-organisme is aantrekkelijk voor industriële applica-
tie. Het veld van Systeembiologie in Biotechnologie biedt nieuwe methoden om hier
verandering in te brengen.
Deze scriptie, diens titel vrij vertaalt naar "Het Aanpassen van Microbiele Le-
venswijze", is erop gericht om industrieël toegepaste micro-organismen te verbete-
ren. Door zijn inherente robuustheid, grote redox capaciteit, aanpassingsvermogen
en vrij verkrijgbaar genoom wordt de gram-negatieve prokaryote bacterie Pseudom-
onas putida gebruikt als model-organisme, maar het onderzoek is uitgebreidt met
Escherichia coli en het eukaryote gist Saccharomyces cerevisiae.
Hoofdstuk 2 omschrijft het industriële landschap ten tijde van dit onderzoek.
Dit onderzoek was erop gericht om bacteriën te verbeteren vanuit een academisch
oogpunt, maar voor industriële toepassing. Om te bepalen hoe ver deze velden uit
elkaar liggen werd er een serie interviews gehouden met participanten zowel uit
de academia als uit de industrie. Door hun compleet verschillende doelstellingen
komen de meningen en prioriteiten van academia en industrie niet altijd overeen.
De voornaamste punten van miscommunicatie en verschillende kansen zijn bloot-
gelegd in dit hoofdstuk. Terwijl de industrie voornamelijk focust op de problemen
van vandaag zoekt academia oplossingen voor de problemen vanmorgen. Beide par-
tijen zijn het erover eens dat communicatie met rasse streden verbeterd zou moeten
worden, zodat meer uitvindingen vanuit het onderzoek toegepast worden.
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In Hoofstuk 3 wordt een veelvoorkomende misconceptie rechtgezet. Ondanks
dat de bacterie van interesse, Pseudomonas putida KT2440, vaak wordt omschreven
als "generally regarded as safe"(GRAS), is deze omschrijving incorrect. Dit officiële
label wordt uitgegeven door het Amerikaanse Voedsel enMedicijn Administratiebu-
reau (FDA) en geeft aan dat stoffen of microben veilig geïngesteerd kunnen worden.
Echter, intensief literatuuronderzoek bracht het officiële FDA rapport naar boven
waarin Pseudomonas putida KT2440 gecertificeerd wordt als HV1, niet als GRAS.
Deze certificatie houdt in dat er met de bacterie veilig op een p1 of ML1 lab ge-
werkt kan worden zonder verdere veiligheidsmaatregelen, maar niet geïngesteerd
kan worden. Dit verandert niets aan de vele hedendaagse toepassingen van dit
micro-organisme, maar weerhouden het gebruik ervan in de voedselindustrie.
Pseudomonas putida is een metabolisch veelzijdig, genetisch toegankelijk en
stress-robuuste bacteriële soort met een uitstekende potentie om gebruikt te worden
als werkpaard voor industriële toepassingen. Terwijl industrie het belang onder-
vindt van stabiele bacteriële groei onder micro-zuurstof condities om het productie-
proces consistent te houden, weerhoudt de obligaat aerobe natuur van P. putida, die
stamt uit het onvermogen om genoeg ATP te produceren en de redox-balans te on-
derhouden in afwezigheid van moleculaire zuurstof, de bacterie van een doorbraak
voor weidse toepassing in biotechnologie. In Hoofdstuk 4 wordt een combinatie
van genoom-schaal metabolische modellen en vergelijkende genomics gebruikt om
essentiële zuurstof-afhankelijke reacties te vinden. Deze verklaren waarom de bac-
terie niet kan groeien onder zuurstofloze omstandigheden: een tekort aan ATP ge-
neratie en het onvermogen om essentiële metabolieten te synthetiseren. Gebaseerd
op deze uitkomst zijn meerdere P. putida recombinanten gegenereerd, die acetaat
kinase (van Escherichia coli) voor ATP productie, een klasse I dihydroorotaat dehy-
drogenase, een klasse III anaerobe ribonucleotide trifosfaat reductase (beiden van
Lactobacillus lactis) voor de synthese van essentiële metabolieten dragen, of alledrie.
Deze computationele ontwerpen werden getest met behulp van adaptieve labora-
torium evolutie. We demonstreerden hiermee de waarde van het combineren van
verschillende in silico methoden met experimentele validatie en adaptieve lab evo-
lutie om een microbieël ontwerp te maken via een gerichte aanpak, door de strict
aerobe Pseudomonas putida KT2440 succesvol te laten groeien onder micro-oxische
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condities.
Hoofdstuk 5 omschrijft het vervolg van dit onderzoek, en toont dat alhoewel de
eerder gemodificeerde bacteriën groeiden onder micro-oxische omstandigheden, ze
groei noch beter uithoudingsvermogen laten zien onder anoxische condities. Ver-
volgens werd een semantische systeembiologie aanpak gebruikt om een ontwerp te
maken voor een afgeleide van P. putidaKT2440 die in staat is tot anaerobe groei door
respiratie. We combineerden data van vergelijkende genomics van 1624 verschil-
lende Pseudomonas stammen met transcriptomics data van de facultatief anaerobe
Pseudomonas aeruginosa, en met genoom-schaal metabolische model simulaties. De
resultaten tonen aan dat om Pseudomonas putida KT2440 het vermogen te geven om
anaerobe respiratie uit te voeren, minstens 69 additionele genen en 3 extern toege-
voegde vitamines nodig zijn.
Hoofdstuk 6 schakelt over naar een andere manier om de microbiële levens-
wijze te verbeteren voor industriële toepassingen. De universeel toegepaste essenti-
ële redox factor NAD+ speelt een rol in interne signalering, verdediging, detoxifica-
tie, circadiaanse klok regulatie, chromosoom segregatie, aerotaxatie, spoorvorming,
biofilm formatie en verspreiding. De redox balans is vaak de eerste om te reage-
ren op interne en externe veranderingen. Eerder onderzoek omschreef de thermo-
stabiliteit van thermofiele L-aspartaat oxidase, een enzym essentieel voor de bio-
generatie van NAD+ via de aspartaat route in P. putida. L-aspartaat oxidase is het
voornaamste knelpunt in de route.
In dit hoofdstuk bepaalden we het effect van NAD+ beschikbaarheid op thermo-
tolerantie door L-aspartaat oxidase van verschillende mesofiele soorten te vervangen
voor een thermofiele ortholoog. In E. coli resulteerde deze uitwisseling in een 10
keer kortere lag-fase wanneer de bacteriën gegroeid worden op 44◦C. In P. putida
leidt dit tot een verdubbeling van de generatietijd wanneer de bacteriën op 40◦C
groeien. Om te bepalen hoe universeel de verbinding tussen NAD+-beschikbaarheid
en thermo-tolerantie is werden zowel de mesofiele als thermofiele systeem in de gist
Saccharomyces cerevisiae gezet, die normaliter NAD+ genereert door middel van de
kynurenine route. Niet alleen werkte de aspartaat route in de gist, S. cerevisiae toont
hogere robuustheid tegen hogere temperaturen tot 41◦C wanneer deze is uitgerust
met het aspartaat NAD+ biogeneratie systeem.
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Om te bepalen welk effect deze verhoogde thermo-tolerantie heeft op industriële
schaal omschrijftHoofdstuk 7 de ontwikkeling van een millifluidica systeem, welke
gebruikt wordt om de recombinante cellen over een lange termijn bloot te stellen
aan temperatuurfluctuaties van minimaal 25◦C tot maximaal 50◦C. De recombi-
nante cellen met het L-aspartaat oxidase gen van de thermofiele B. smithii groeiden
significant beter dan de controlestammen wanneer ze tijdens de fermentatie aan sto-
chastische temperatuurfluctuaties werden blootgesteld.
De ontdekking van de universele link tussen de beschikbaarheid in NAD+ in
microben en hun thermo-tolerantie is gepatenteerd. Appendix hoofdstuk 6 pre-
senteert de samenvatting van het patent. Deze uitvinding relateert aan het veld
van moleculaire microbiologie, metabolische bouwkunde, en fermentatie techno-
logie. De uitvinding betreft specifiek microbiële gastheercellen die aangepast zijn
om een hogere tolerantie tegen temperatuur fluctuaties te hebben, voor een verbe-
terde prestatie op temperaturen verschillend van de optimum-temperatuur van een
micro-organisme en/of voor het veranderen vanminimaal één van de kardinale tem-
peraturen van een micro-organisme door het vervangen van een endogeen NAD+
biosynthese gen door een heteroloog die codeert voor hetzelfde enzym met een ver-
schillend temperatuurprofiel. Met dit patent is een volledig traject van laboratorium
tot test tot applicatie afgerond.
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The Road not Taken
Robert Frost
Two roads diverged in a yellow wood,
And sorry I could not travel both
And be one traveler, long I stood
And looked down one as far as I could
To where it bent in the undergrowth;
Then took the other, as just as fair,
And having perhaps the better claim,
Because it was grassy and wanted wear;
Though as for that the passing there
Had worn them really about the same,
And both that morning equally lay
In leaves no step had trodden black.
Oh, I kept the first for another day!
Yet knowing how way leads on to way,
I doubted if I should ever come back.
I shall be telling this with a sigh
Somewhere ages and ages hence:
Two roads diverged in a wood, and I-
I took the one less traveled by
And that has made all the difference.
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